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1. Summary 
 
Streptococcus pyogenes, also known as group A streptococcus (GAS), is an important human 
pathogen responsible for a variety of diseases ranging from mild (e.g. tonsillitis) to life-threatening 
infections (e.g. invasive infections of skin and soft tissues that can develop into necrotizing fasciitis, 
sepsis or lethal toxic shock syndrome). 
Bacterial pathogens are recognized by cells of the innate immune system through pattern 
recognition receptors (PRRs). Among them, the family of Toll-like receptors (TLRs) is the best 
characterized class of PRRs and virtually all pathogenic bacteria are recognized by at least one of 
them. However, PRRs and bacterial products responsible for the activation of an immune response 
against S. pyogenes are not known yet. 
We were able to demonstrate that activation of an inflammatory response in murine bone marrow-
derived macrophages (BMDMs) against S. pyogenes, involving the production of cytokines such as 
TNF-α and IL-6, depends on the adaptor molecule MyD88, but not on the prototype receptors for 
bacteria TLR22, TLR4 and TLR9. Further, streptococcal RNA has been identified to be an important 
factor for the induction of these cytokines in response against this pathogen. 
Moreover, we could show that infection of innate immune cells with S. pyogenes causes the 
production of type I interferons (IFNs) and subsequent activation of the Jak/Stat signaling pathway. 
Experiments using BMDMs from mice deficient in components of the interferon pathway (IRF3, IRF1, 
STAT1, IFNAR1) and siRNA-mediated knock down of another important gene (TBK1) from this 
pathway revealed that IFN-production occurs downstream of an unknown PRR via IRF3, TBK1 and, 
but without the involvement of any described TLRs. A partial dependence on the universal adaptor 
MyD88 was observed. Surprisingly, IFN-β is also induced, though to a lesser extent, by S. pyogenes 
lacking SLO and SLS, the genes encoding cytolysins that were shown to be required for IFN 
production in response to other Gram-positive bacteria. Furthermore, S. pyogenes extracts digested 
with either DNase I, RNase A or Proteinase K suggest that in macrophages bacterial DNA is required 
for the induction of IFN-β production, whereas in dendritic cells RNA was identified as IFN-β inducer. 
However, the receptor molecules which promote the induction of the interferon response remain 
elusive. 
An experimental mouse model of skin infection using IFNAR1-deficient mice emphasized the 
important role of type I IFNs during the host immune response against S. pyogenes. IFNAR1-deficient 
mice showed a decreased survival and succumbed to infection earlier than control mice. Therefore it 
can be concluded that production of type I IFNs during streptococcal infection is beneficial for the 
host. 
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Taken together, our work demonstrates that infection of innate immune cells with S. pyogenes leads 
to the induction of multiple signaling pathways within the host leading to the production of 
inflammatory mediators such as TNF-α and IL-6 as well as type I IFNs. The production of type I IFNs in 
response to S. pyogenes is protective for the host and macrophages and dendritic cells use different 
signaling molecules for the induction of these cytokines. Further, we were able to show that S. 
pyogenes is able to avoid the standard arsenal of pattern recognition receptors deployed by the host, 
which may contribute to the known high capability to cause severe inflammatory diseases.  
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2. Zusammenfassung 
 
Streptococcus pyogenes, auch bekannt als Gruppe A Streptokokkus (GAS), ist ein bedeutendes 
humanes Pathogen, das für eine Reihe von Krankheiten verantwortlich ist. Diese Krankheiten können 
relativ harmlos sein, wie zum Beispiel Mandelentzündung, aber auch lebensgefährlich, wie zum 
Beispiel invasive Infektionen der Haut und der darunterliegenden Gewebe, die zu einer 
nekrotisierenden Fasziitis, Sepsis oder zu einem streptokokkalen toxischen Schock-Syndrom führen 
können. 
Bakterielle Pathogene werden von Zellen des angeborenen Immunsystems durch spezielle 
Rezeptoren erkannt, die auf die Erkennung von bestimmten bakteriellen Mustern von Bakterien 
spezialisiert sind. Die Toll-like Rezeptoren (TLRs) sind die wohl am besten charakterisierte Familie 
unter diesen Rezeptoren und jedes Pathogen wird von mindestens einem dieser Rezeptoren erkannt. 
Rezeptormoleküle, die für die Aktivierung einer Immunantwort gegen S. pyogenes verwendet 
werden, sind jedoch noch nicht bekannt. 
Wir konnten zeigen, dass S. pyogenes zur Aktivierung einer inflammatorischen Antwort in aus dem 
Knochenmark von Mäusen gewonnenen Makrophagen führt, die durch  die Produktion von 
Zytokinen wie TNF-α und IL-6 gekennzeichnet  ist. Diese Aktivierung ist abhängig von dem Adapter-
Molekül MyD88, jedoch unabhängig von den wichtigsten Rezeptoren für bakterielle Produkte wie 
TLR2, TLR4 und TLR9. Weiters wurde streptokokkale RNA als wichtiger Faktor für die Aktivierung 
einer inflammatorischen Antwort gegen dieses Pathogen identifiziert. 
Zusätzlich konnten wir zeigen, dass die Infektion von Zellen des angeborenen Immunsystems mit S. 
pyogenes zu einer Produktion von Typ I Interferonen (IFNs) und einer anschließenden Aktivierung des 
Jak/Stat Signaltransduktionsweges führt. Experimente mit Makrophagen, denen bestimmte 
Komponenten des IFN- Signaltransduktionsweges fehlen (IRF3, IRF1, STAT1, IFNAR1) oder in denen 
die Signalkomponente TBK1 mittels siRNA inaktiviert wurde, führten zu dem Schluss, dass die IFN-
Produktion unterhalb eines noch nicht bekannten Rezeptors von IRF3, TBK1 und IFNAR1 abhängig 
aber unabhängig von bekannten TLRs ist, obwohl eine partielle Abhängigkeit von MyD88 beobachtet 
wurde. 
Überraschenderweise konnten auch Streptokokken, welchen die zwei Zytolysine SLO und SLS fehlten, 
eine IFN-β Produktion hervorrufen, obwohl für andere Gram-positive Bakterien gezeigt wurde, dass 
diese Zytolysine für die Produktion von IFN-β wichtig sind. Ferner deuteten mit Enzymen verdaute 
streptokokkale Extrakte darauf hin, dass in Makrophagen streptokokkale DNA und in dendritischen 
Zellen RNA für die Induktion der IFN-Produktion benötigt wird. Allerdings sind auch in diesem Fall die 
Moleküle die für diese Induktion verwendet werden, noch nicht bekannt. 
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Mittels eines kutanen Infektionsmodells, in dem IFNAR1-defiziente Mäuse mit S. pyogenes infiziert 
wurden, wurde die bedeutende Rolle der Typ I Interferone in der Immunantwort auf eine 
Streptokokken-Infektion untermauert. IFNAR1-defiziente Mäuse starben früher und in größerer 
Anzahl als Kontroll-Mäuse. Dieses Ergebnis lässt darauf schließen, dass die Produktion von Typ I 
Interferonen während eine streptokokkalen Infektion dem Wirt einen Vorteil verschafft. 
Zusammengefasst wurde in dieser Studie gezeigt, dass die Infektion von Zellen des angeborenen 
Immunsystems mit S. pyogenes zur Produktion von inflammatorischen Zytokinen wie TNF-α, IL-6 und 
Typ I Interferonen führt. Interferone schützen den Wirt vor einer streptokokkalen Infektion und in 
Makrophagen und dendritischen Zellen werden unterschiedliche Signalmoleküle für die Induktion 
der Interferon-Produktion verwendet. Weiters konnten wir zeigen, dass S. pyogenes die Fähigkeit 
besitzt, dem Standard-Arsenal an Pathogen-Rezeptoren des Wirts zu entkommen. Dies könnte zu der 
bekannten Eigenschaft des Bakteriums beitragen, sehr unterschiedliche und auch schwere 
Infektionskrankheiten hervorzurufen. 
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3. Introduction 
 
3.1. Innate Immune Responses to Infection 
The vertebrate immune system is divided into 2 major categories: the innate and the adaptive 
immunity. Innate immunity is defined as a rapid, non-specific response to infection, whereas the 
adaptive immunity involves slowly-developing, long-lasting and highly evolved antigen-specific 
responses such as cell-mediated immunity and antibody production (1).  
In addition to the barrier function of the epithelium and skin mucosa, several other cell types like 
macrophages, dendritic cells and neutrophils, contribute to innate immunity by patrolling through 
the body and killing the unwanted intruders. Further, soluble effectors such as complement proteins 
and antimicrobial peptides as well as pattern recognition receptors are acting together in order to 
defend the host against infection. 
 
3.1.1. Phagocytes 
Phagocytes are cells of the innate immune system which play an important role in the response to 
invading pathogens. The group of phagocytes includes macrophages, dendritic cells, neutrophils, 
mast cells and monocytes. These cells constitute the first line of defense since their major function is 
to ingest particles, which may be harmful for the body.  
 
Leukocytes, also known as white blood cells, are a diverse group of cell types important for the host´s 
immune response. They share a common origin in hematopoietic stem cells (HSCs) and develop along 
distinct differentiation pathways in response to internal and external cues (see Fig. 1). HSCs produce 
myeloid (MP) and lymphoid (LM) committed precursors. MPs give rise to monocyte, macrophage, 
and DC precursors (MDPs) and these precursors then give rise to monocytes, some populations of 
macrophages and common DC precursors (CDPs). CDPs in turn develop into preclassical dendritic 
cells (pre-cDcs) and plasmacytoid dendritic cells (pDCs) (2). 
 
 
 
 
 
 
 
8 
 
Figure 1: Differentiation of DCs and macrophages in mice (from (2)) 
 
 
 
 
Macrophages are extremely versatile cells involved in a number of complex functions in health and 
disease. They are widely distributed throughout the body and show a remarkably diversity in their 
phenotype dependent on their anatomical location. Macrophages in the central nervous system are 
known as microglia, in the lung as interstitial or alveolar macrophages and in the liver as Kupffer cells 
(3). Differentiation and functional specialization is dependent on the tissue microenvironment, which 
consist of other cell types as well as growth factors and cytokines (4).Macrophages are involved in 
steady-state tissue homeostasis by removing apoptotic or possibly aberrant cells and by the 
production of growth factors (2). In addition, they express a large variety of receptors that mediate 
their function as professional phagocytes. 
Scavenger receptors (SR), such as SR-A, CD36 and macrophage receptor with collagenous structure 
(MARCO), in addition to C-type lectins, are surface receptors and binding of microbes to these 
receptors leads to phagocytosis/ endocytosis of pathogens. 
Complement receptors (Integrins) and Fc receptors (Ig superfamily) function in the endocytosis or 
phagocytosis of particles coated with serum complement proteins or antibodies (5) (6). Once a 
microbe has been taken up by a macrophage, it is trapped in the phagosome which fuses then with 
lysosomes that contain various hydrolytic enzymes. These function to digest the invading pathogens. 
Further, macrophages express receptors that are not involved in mediating phagocytosis/ 
endocytosis but are important in mediating immune responses against microbes. These receptors 
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include the members of the Toll-like receptor (TLR) family, the NOD-like receptors (NLRs) and RIG-like 
helicases (RLHs). Ligand recognition by these receptors leads to the activation of signaling cascades 
resulting in the expression of proinflammatory cytokines, which enhance local antimicrobial defense 
systems. 
The production of proinflammatory cytokines by macrophages also mediates a cross-talk between 
the innate and the adaptive immune system. Macrophages produce cytokines that help activating 
adaptive immune responses and in turn, interferon-gamma (IFN-γ), which is produced by T- and 
natural killer (NK) cells, was shown to be important for macrophage activation. This cytokine converts 
resting macrophages into powerful effector cells with increased antigen-presentation capacity and 
increased synthesis of proinflammatory cytokines such as TNF-α, interleukin ( IL)-6 and IL-12, and 
toxic mediators such as nitric oxide (7). 
Macrophages also play an important role in the adaptive immune response by the uptake of 
microbial antigens that are proteolytically processed and presented in forms that can activate T-cell 
responses (8). 
 
Dendritic cells are highly specialized antigen-presenting cells (APCs), thereby linking the innate with 
the adaptive immune system by initiating and controlling the magnitude and quality of adaptive 
immune responses. This cell type was first described by Steinman and Cohn in the early 1970´s, and 
since then it became clear that there are many distinct subtypes existing, each with particular 
localization and functions in the immune system.  
In their immature stage of development, DCs can be found in both peripheral tissues and lymphoid 
organs and also in the blood. They start out as immature cells with high endocytic activity and 
function to detect, capture and phagocytose pathogens, leading to TLR activation. Upon signal 
transduction through TLRs, DCs undergo a complex differentiation program termed collectively DC 
maturation (9). 
This maturation process involves: (i) changes in morphology such as the loss of adhesive structures 
and the acquisition of high cellular motility; (ii) loss of endocytic/phagocytic receptors; (iii) secretion 
of chemokines in coordinated waves according to the type of immune cells that need to be attracted; 
(iv) upregulation of costimulatory molecules, such as CD40, CD80, and CD86; (v) translocation of 
MHC class II compartments to the cell surface and (vi) secretion of cytokines that differentiate and 
polarize the attracted immune effectors (10). Upon activation, DCs travel to lymphoid tissues such as 
the spleen and the lymph nodes, where they interact and activate antigen-specific T-cells (11).  
As already mentioned, DCs are very heterogeneous and DC subtypes differ in location, migratory 
pathways and detailed immunological function (12). 
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Classical dendritic cells (cDCs) posses a high phagocytic activity as immature cells and a high cytokine-
producing capacity when maturated. These cells can move from tissues to the T-cell and B-cell zones 
of lymphoid organs via afferent lymphatics and high endothelial venules and regulate T-cell 
responses in steady state and also during infection (2). 
Plasmacytoid dendritic cells (pDCs) differ from cDCS in their surface phenotype, tissue localization, 
cytokine secretion and antigen presentation function. These cells are constantly produced in the 
bone-marrow and released into the blood stream, therefore they present in the bone-marrow and all 
peripheral organs. One major characteristic of pDCs is that they are professional type I interferon 
(IFN) producing cells. It has been shown, that human pDCs produce 200-1000 times more type I IFNs 
than any other blood cell type. However, pDCs can also act as APCs and control T-cell responses (13) 
(2).  
 
 
3.1.2. Microbe Recognition  
Mammalian organisms can be infected by a variety of microorganisms, including viruses, bacteria, 
fungi and protozoa. The innate immune response is responsible for the early detection and 
destruction of invading pathogens and relies on a limited set of germline-encoded pattern 
recognition receptors (PRRs). By contrast, the adaptive immune response relies on enormously 
diverse receptors generated by random somatic gene rearrangements to detect the microbes and 
also provides the host with immunological memory (14). 
For the initiation of an immune response, pathogen-associated molecular patterns (PAMPs) have to 
be recognized by the PRRs. PAMPs are characterized as microbial structures that are evolutionarily 
conserved and therefore shared by different microorganisms. An important feature of PAMPs is that 
they are mainly expressed by pathogens but not by the host. Therefore PRRs can also discriminate 
between self and non-self (15). 
After recognition of a PAMP by a PRR, multiple intracellular signaling pathways are triggered which 
cause activation of gene expression and synthesis of a broad range of molecules, including cytokines, 
chemokines, adhesion molecules and immunoreceptors resulting in proinflammatory and 
antimicrobial responses (16). 
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Surface Receptors 
Among the large group of PRR, the family of Toll-like receptors (TLRs) is best characterized. These 
receptors were initially discovered in Drosophila melanogaster, where the Toll protein is a critical 
component of host defense against fungal and Gram-positive bacterial infection (17). During the last 
15 years, the mammalian homologues of Toll have been identified, extensively studied and 
functionally characterized as critical components of the innate immune system. At present, 10 TLRs 
have been described in humans (TLRs 1-10) and 12 TLRs in mice (TLRs 1-9 and 11-13). These 
receptors are expressed by a variety of cell types, but professional immune cells such as 
macrophages and dendritic cells are the most prominent cells in this respect (18). 
TLRs are type I transmembrane proteins consisting of an ectodomain that contains varying numbers 
of leucine-rich-repeat (LRR) motifs , which are responsible for both, receptor dimerization and ligand 
recognition. Further, they own a cytoplasmic domain homologous to the interleukin 1 receptor (IL-
1R), termed the Toll/IL-1R homology (TIR) domain that is required for the initiation of downstream 
signaling (19). 
TLRs can be divided into subfamilies, dependent on their cellular distribution. TLR1, TLR2, TLR4, TLR5, 
TLR6 and TLR10 are expressed on the cell surface and mainly recognize bacteria-derived PAMPs like 
lipoteichoic acid (LTA), lipopolysaccharide (LPS), peptidoglycan (PGN) and lipoproteins. 
Others (i.e. TLR3, TLR7; TLR8 and TLR9), are located in intracellular compartments, including 
endosomes and lysosomes, and are specialized in the recognition of nucleic acids, as virus-derived 
dsRNA and ssRNA as well as unmethylated 2´deoxyribo cytidine-phosphate guanosine (CpG) from 
both, viruses and bacteria (16). These intracellular TLRs are expressed on the ER in resting cells from 
where they get trafficked to the endosomal compartment in response to PAMP-mediated 
stimulation. This process is mediated by the ER protein UNC93B that interacts with the 
transmembrane regions of TLR3, TLR7, TLR9 and TLR13 (19). The intracellular location is important 
for the recognition of foreign nucleic acids and for the discrimination of self from non-self nucleic 
acids. Engagement of these receptors induces antiviral immune responses by producing 
proinflammatory cytokines and type I interferons (15). Table 1 shows a detailed list of TLRs and their 
ligands. 
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Table 1: Toll-like receptors and their ligands (from (20)) 
 
 
 
 
Upon ligand binding, the TLR dimerizes and undergoes conformational changes required for the 
subsequent recruitment of different combinations of cytosolic TIR-domain containing adaptor 
molecules. These include myeloid differentiation primary response protein (MyD88), MyD88-
adaptor-like (MAL, also known as Toll/interleukin-1 receptor domain-containing adapter protein 
(TIRAP)), TIR-domain-containing adaptor protein inducing IFN-β (TRIF, also known as TIR domain-
containing adapter molecule 1 (TICAM1)), TRIF-related adaptor molecule (TRAM, also known as 
TICAM2) and sterile α- and armadillo-motif-containing protein (SARM) (21). 
MyD88 is used by almost all TLRs except TLR3. It recruits the IL-1 receptor-associated kinase (IRAK) 
family of kinases, which further trigger the activation of nuclear factor-κB (NF-κB), p38 and ERK. 
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Mal gets recruited by the lipoprotein receptor TLR2 and the lipopolysaccharide (LPS) receptor TLR4 
and appears to function as a stabilizer of MyD88 by acting as a bridging molecule (22). Since the 
surfaces of MyD88, TLR2 and TLR4 are largely positively charged, MyD88 is not able to interact with 
these receptors. Given the fact that Mal is mainly electronegative, TLR2 and TLR4 are able to bind, 
thereby allowing MyD88 to join the complex (23). 
TRIF is the sole adaptor protein used by TLR3 and is needed for the induction of NF-κB.  
Further, TRIF together with TRAM as bridging-molecule, serve as adaptor protein for TLR4. Since TLR4 
is known to use also MyD88 for signaling, this receptor is very unique because it is the only one 
among the TLR family that uses two different adaptor molecules. It was not clear, how these two 
competing signaling molecules are coordinated by TLR4 until it has been recently shown that TLR4 
first induces MyD88/Mal- dependent proinflammatory signaling at the plasma membrane, then 
becomes endocytosed and activates TRIF/TRAM signaling from the early endosome, resulting in the 
production of type I interferons (IFNs), such as IFN-β and IFN-α. Therefore, the subsequent use of 
two different adaptor molecules by TLR4 is providing access to distinct pool of signaling molecules 
(24) (25). 
SARM was recently identified as the fifth member of the family of TLR-adaptor proteins. In contrast 
to the other four adaptor proteins, it was found to be a negative regulator of TLR signaling by 
inhibiting TRIF. The mechanism how SARM inhibits TRIF has yet not been elucidated, but there are 
two possibilities: either SARM prevents TRIF from accessing its downstream signaling molecules such 
as Tank-binding kinase 1(TBK1) or TNF receptor –associated factor 6 (TRAF6) or SARM recruits an 
inhibitory protein (26). 
After recruitment of different combinations of adaptor proteins, TLRs activate three major signaling 
pathways: mitogen-activated protein kinases (MAPKs), interferon-regulatory factors (IRFs) and 
nuclear factor-κB (NF-κB). Activation of MAPKs results in the induction of the transcription factor 
activator protein-1 (AP-1) that, together with the transcription factor NF-κB, leads to the production 
of inflammatory cytokines. Further, IRF3 and/or IRF7, IRF1 and IRF5 get activated and these 
transcription factors are essential for the expression of type I IFNs and IFN-stimulated genes (18). 
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Figure 2: TLR signaling pathways (from (20)) 
 
 
 
 
To illustrate the principles of TLR signaling, TLR4 was chosen for description, since this receptor can 
initiate both of the major signaling pathways: the MyD88-dependent and the MyD88-independent 
(TRIF-dependent) pathway. The MyD88-dependent pathway downstream of TLR4 leads to the 
expression of inflammatory cytokines such as TNF-α, IL-6 and IL-12. The major role of the TRIF-
dependent pathway is the expression of type I IFNs (14). 
After ligand binding, MyD88 associates with the receptor and subsequently recruits members of the 
IL-1 receptor-associated kinase (IRAK) family, leading to a sequential activation of IRAK4, IRAK1 and 
TNF receptor-associated factor 6 (TRAF6). TRAF6 acts as an E3 ubiquitin protein ligase which, 
together with an ubiquitination complex (E2), ubiquinates TRAF6 itself and other substrates, 
including transforming growth factor-activated protein kinase 1 (TAK1) and the IκB kinase (IKK) 
subunit NF-κB essential modifier (NEMO). Ubiquitinated TRAF6 then recruits TAK1-binding protein 2 
(TAB2) and TAB, which brings TAK1 into proximity of the signaling complex, leading to its activation. 
Activated TAK1 phosphorylates in turn members of the MAPK kinase (MKK) family, including MKK3, 
4, 6 and 7. MKK3/6 subsequently phosphorylate and thereby activate p38, whereas MKK 4/7 activate 
c-Jun N-terminal kinase (JNK) (16).  
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Further, TAK1 mediates the activation of the IKK complex consisting of IKKα and IKKβ protein kinases 
and the regulatory molecule IKKγ/NEMO. The IKK complex mediates the phosphorylation of the 
inhibitor of NF-κB (IκB) proteins and this phosphorylation targets the IκBs for ubiquitination and 
degradation by the 26 S proteasome, releasing NF-κB into to nucleus where it binds to κB sites 
present in the promoters and enhancers of a broad range of proinflammatory genes (27). 
The TRIF-dependent pathway requires the recruitment of TRAM and TRIF. The interaction of TRIF 
with receptor-interacting protein 1 (RIP1) is important for the activation of NF-κB (14).  
Further, TRIF is responsible for the activation of TRAF-family-member-associated NF-κB activator 
(TANK) binding kinase 1 (TBK1, also known as NAK or T2K) via TRAF3. TBK1 comprises a family with 
inducible IκB kinase (IKK-i, also known as IKK-ε) and these kinases are able to phosphorylate 
interferon-regulatory factors (IRF) -3 and 7. Next, phosphorylated IRF3 and IRF7 form homodimers, 
translocate into the nucleus and bind to interferon stimulated response elements (ISREs), resulting in 
the expression of interferon-β (28). 
 
 
Cytoplasmic Receptors 
Besides the TLRs, which are located either on the cell surface or the lumen of intracellular vesicles 
such as endosomes or lysosomes, the existence of cytosolic detection systems  for intracellular 
pathogens have been reported. Pattern recognition receptors located in the cytosol include 
nucleotide-binding oligomerization domain (NOD)-like receptors and retinoic acid-inducible gene-I 
(RIG-I) like receptors. In addition, several studies indicate cytosolic DNA recognition. This occurs 
independently of TLRs, NLRs and RLRs and seems to be involved in the defense against both, bacteria 
and DNA viruses. 
 
 
Nucleotide-binding and oligomerization domain (NOD)-like Receptors (NLRs)  
The mammalian NLR family consists of more than 20 members. They  all share a modular domain 
organization of a C-terminal leucine-rich repeat (LRR) domain, a central nucleotide-binding NACHT 
domain and an N-terminal protein-protein-interaction domain composed of a caspase activation and 
recruitment domain (CARD), pyrin domain (PYD) or baculovirus inhibitor of apoptosis` repeat (BIR) 
domain (29). The LRR domain is involved in ligand recognition whereas the NACHT (also known as 
NOD) domain facilitates self-oligomerization and has ATPase activity. The CARD or pyrin domains 
interact with different downstream adaptor molecules. Upon activation of NOD molecules the 
recruitment of the downstream signaling molecules is induced thereby leading to upregulation of 
inflammatory genes (16). 
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NOD1 and NOD2 are the best characterized PRRs among the NLRs and have been shown to be 
involved in the detection of distinct structural motifs derived from peptidoglycan (PGN) of 
intracellular bacteria. They are mainly expressed by antigen-presenting cells and epithelial cells since 
it is very likely that these cell types come into contact with PGN during an infection (30). 
NOD1 recognizes g-D-glutamyl-meso-diaminopimelic acid (iE-DAP), which can be found in the PGN 
structures of all Gram-negative as well as in several Gram-positive bacteria such as Bacillus subtilis 
and Listeria monocytogenes. NOD2 recognizes muramyl dipeptide (MDP), which is the largest 
component of the PGN motif that is present in both, Gram-positive and Gram-negative bacteria and 
is implicated in the recognition of Streptococcus pneumoniae and Mycobacterium tuberculosis (15). 
Stimulation of NOD1 and NOD2 induces recruitment of the CARD-containing serine/threonine kinase 
RICK (also known as RIP2) to the receptors via CARD-CARD interactions, which leads to NF-κB 
activation and also to the activation of MAP kinase pathways. NOD1 was shown to activate JNK and 
NOD2 activates p38 and ERKs (14). 
Other NLRs, such as NALP1, NALP3, IPAF and NAIP5 are components of a molecular complex called 
inflammasome. The inflammasome complex comprises one or some of the NLR proteins and caspase-
1, which becomes activated and cleaves substrates such as IL-1β and IL-18 to produce mature 
proteins whose potent proinflammatory activities direct host responses to infection (31). Several 
families of inflammasomes have been described according to the recognition of different danger 
signals or PAMPs through their respective NLR. For example, NALP3 has been shown to be involved 
in the recognition of ATP, uric acid crystals, viral RNA and bacterial DNA (16).  
 
 
RIG-I like receptors (RLRs) RIG-I, MDA5, LGP2 
TLR3, TLR7, TLR8 and TLR9 are able to recognize viruses in the endosomal compartment and elicit 
antiviral responses such as the production of type I IFNs. However, viruses are known to enter the 
cytoplasm of a host cell and generate dsRNA during the course of replication. Therefore, intracellular 
receptors are required for efficient immune responses against viruses. 
In this regard, the three members of the RIG-I-like receptor family have been reported to recognize 
viral RNA in the cytoplasm: retinoic-acid-inducible protein I (RIG-I, also known as DDX58)), melanoma 
differentiation associated gene 5 (MDA5, also known as helicard) and laboratory of genetics and 
physiology 2 (LGP2) (15). 
RIG-I was shown to recognize ssRNAs that contain a triphosphate moiety in their 5´terminus as well 
as short dsRNAs. Relatively short poly (I:C) (approx. 300 bp, generated by RNase III digestion) can also 
serve as a RIG-I ligand, even without a 5`triphosphate. 
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In contrast to RIG-I, MDA5 preferentially recognizes longer dsRNAs, including synthetic poly (I:C). 
Long dsRNA is produced during replication of sense-strand ssRNA viruses, such as picornaviruses (31) 
(19). 
RLRs are composed of two N-terminal caspase recruitment domains (CARDs), a central DEAD box 
helicase/ATPase domain and a C-terminal regulatory domain (RD). The helicase domain and the RD 
have been shown to interact with specific RNA species and CARDs are important for the initiation of 
downstream signaling (18) (32). 
The receptors use the adaptor protein interferon promoter stimulator-1 (IPS-1) to induce the 
production of type I IFNs. This occurs via homotypic interaction with the CARD domain of IPS-1. 
Downstream of RIG-I/IPS-1, TBK1 and IKK-i become activated and thereby phosphorylate IRF-3 and 
IRF-7, leading to the expression of type I IFNs (28). 
In contrast to RIG-I and MDA5, LGP2 does not have a CARD domain. While it has been demonstrated 
that LGP2 is a positive regulator of the MDA5-mediated immune response, the role of this protein in 
the RIG-I mediated response remains controversial (31) . 
 
 
Recognition of cytoplasmic DNA 
Several studies indicate that when DNA enters the cytoplasm, it is not only recognized by TLR9 in 
endosomes but also by TLR9- and RLR-independent recognition machineries in the cytoplasm. 
Recognition of DNA in the cytoplasm results in the activation of the protein kinase TBK1, which 
phosphorylates the transcription factor IRF3, leading to a type I interferon response. This is in 
contrast to TLR9, which triggers an interferon response without the involvement of TBK1 (15). 
Recently, DNA-dependent activator of IFN-regulatory factors (DAI, also known as DLM-1 and ZBP1) 
was identified as a DNA sensor and activator of immune responses. DNAs from various sources were 
shown to bind to DAI, thereby inducing type I IFN production and induction of other genes involved 
in innate immunity. However, it seems as if DAI is not the only cytosolic DNA sensor, since DAI 
knockdown using RNAi had little or no effect on the IFN response to B-DNA (33) (34). 
Further, stimulator of IFN-genes (STING, also referred to as MITA and MPYS) was shown to form a 
complex with both, IPS-1 and RIG-I and is needed for virus-induced signal transduction through these 
molecules (35). Overexpression of STING upregulates type I IFN genes and suppresses viral 
replication, while STING-deficient cells show diminished type I IFN induction after stimulation with 
cytosolic dsDNA or infection with Listeria monocytogenes or HSV-1 (27).  
Recently, a previously unknown cytosolic DNA-sensing pathway has been identified. In that pathway, 
RNA polymerase III transcribes microbial DNA into dsRNA containing a 5´-triphosphate, which is a 
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potent inducer of the RNA helicase RIG-I. Subsequent recognition of the dsRNA leads to an efficient 
type I IFN response (36). 
Although cytosolic DNA recognition was mainly linked to the production of type I IFNs, absent in 
melanoma 2 (AIM2) has been recently described to be a cytosolic DNA sensor which is able to 
activate the inflammasome (31). Stimulation with TLR ligands alone does not lead to the activation of 
the inflammasome, but it has been shown that introduction of dsDNA induces proinflammatory 
signaling and maturation of pro-IL-1β. The AIM2 inflammasome is composed of AIM2, apoptosis-
associated speck-like protein containing a CARD (ASC) and caspase-1, where AIM2 interacts with ASC 
to recruit procaspase-1 to the complex., leading to the production of IL-1β (32) (37). 
 
 
3.1.3. Cytokines and Chemokines 
 
Inflammatory Cytokines  
Inflammatory cytokines are primarily derived from mononuclear phagocytes, dendritic cells and 
other antigen-presenting cells. They are particularly effective in the generation of a potent immune 
response and provide signals that are contributing to the initiation and guidance of the nature of the 
adaptive immune response. Cytokines produced by antigen-presenting cells include TNF-α, 
interleukin (IL)-1, IL-6 (and other glycoprotein 130 (gp130)-utilizing factors), IL-12, IL-15, IL-18, IL-23, 
IL-27 and IL-32, CXCL8 (IL-8) and other members of the chemokine family (38). 
 
IL-1, IL-6 and TNF-α are known to be the key cytokines involved in the acute inflammatory response. 
TNF-α is the primary mediator of septic shock. Further it is a potent activator of neutrophils, 
mediating adherence, chemotaxis, degranulation and the respiratory burst. TNF is also responsible 
for severe cachexia in chronic inflammations and cancer and induces antitumor immunity by directly 
acting on cancerous cells (38). 
It has been shown that disregulation of IL-6 signaling contributes to inflammation-associated disease 
condition such as inflammatory arthritis, sepsis, inflammatory bowel disease, obesity and insulin 
resistance (39)  
Many cytokines that are released during an inflammation are able to further increase inflammation 
by enhancing the activation of immune cells at the site of inflammation or by acting on responsive 
cells throughout the body. Thereby, signaling cascades are activated which result in the 
enhancement or the prolongation of inflammatory responses (40). 
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Interferons 
In 1957, Isaacs and Lindenmann discovered a substance that protected cells from viral infection and 
named it interferon (IFN) (41). Over the years a whole family of these proteins was discovered and at 
present there are two main types of interferons existing: type I and type II IFNs and in addition, IFN-
like cytokines. 
The type I interferons are consisting of 7 classes: IFN-α, IFN-β, IFN-ε, IFN-κ, IFN-ω, IFN-δ and IFN-
τ. Type II interferon consists of a single IFN-γ gene (42). Recently, a novel class of cytokines, the 
lambda IFNs (IFN-λ) have been identified and shown to functionally resemble type I IFNs (43). 
 
Type I IFNs exert various effects on antibacterial immunity. They are the principle factors inducing 
the antiviral state, lead to cytokine and chemokine production and promote antibody isotype 
switching (40). Further, they lead to the activation and maturation of dendritic cells, thereby 
influence antigen-presentation, T-cell activation and the development of adaptive immunity.  
To limit pathogen spread, these cytokines are able to decrease the survival of infected cells. 
Moreover, type I IFNs lead to the activation of STAT4 in natural killer (NK)-cells and TH1 cells, which 
together with IL-18-derived signals, activates IFN-γ expression (44). 
 
IFN-γ is one of the most important cytokines responsible for cell mediated immunity.  
It is produced by TH1 cells, natural killer (NK) cells and cytotoxic T cells. This cytokine increases MHC 
class I and II expression, stimulates antigen presentation and production of cytokines by antigen-
presenting cells (38).  
Moreover, IFN-γ was shown to activate genes with antimicrobial functions such as inducible nitric 
oxide synthase (iNOS, also known as NOS2) that generates nitric oxide and the phagocyte (NADPH) 
oxidase, which generates oxygen radicals (44). 
 
 
Chemokines 
Chemokines are a group of small (8-12 kD) proteins that possess the ability to induce cell migration 
or chemotaxis in numerous cell types including neutrophils, monocytes, lymphocytes, eosinophils, 
fibroblasts and keratinocytes. 
Chemokines were initially described as inflammatory mediators produced at sites of infection or 
injury or in response to proinflammatory stimuli. Their main feature is to recruit and activate 
leukocytes to mount an effective immune response and initiate wound healing (38). This is achieved 
by a process known as ´rolling´, where lymphocytes interact transiently with the vascular 
endothelium, searching for activating signals from chemokines. Once a cell has ceased rolling, it is 
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able to cross the endothelium and migrates along a concentration gradient to the source of the 
chemokine (38). 
In addition, chemokines have been shown to be also involved in lymphoid organ development, TH1 
and TH2 development, hematopoiesis, metastasis and angiogenesis (45). 
Chemokines are divided into four main groups according to the number and relative position of their 
cysteine residues. The major chemokine families are termed CXC- and CC- chemokines (with 50 or 
more members in the 2 families), whereas the CX3C- and CX-chemokines represent the two smaller 
families of cytokines. The CXC-chemokines are further divided into two subfamilies, dependent on 
the presence or the absence of Glu-Leu-Arg (ELR) sequence preceding the first cysteine residue. ELR + 
chemokines preferentially attract neutrophils, whereas ELR- chemokines act on lymphocytes (46). 
Each family of chemokines interacts with a reciprocal family of heterotrimeric, 7-transmembrane, G-
protein-coupled receptors (GPCRs) that are almost exclusively expressed by lymphocytes (47). 
Chemokine signaling leads to the activation of several signaling pathways such as MAPK, protein 
kinase B (PKB), phospholipases A, C and D, phosphoinositol kinase (PI3K) and the JAK/STAT pathway 
(38) (47).  
 
 
Cytokine Signaling  
Cytokines act on cells through trans-membrane cell-surface receptors. After binding of a cytokine to 
its receptor, an intracellular signal transduction pathway is activated which ultimately leads to 
induction of gene transcription and synthesis of new proteins.  
A large number cytokines, such as interleukins, interferons and hematopoietic growth factors, 
activate the Janus kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signaling 
pathway.  
The family of STAT proteins consists of latent cytoplasmic transcription factors that become tyrosine 
phosphorylated by the JAK enzymes in response to cytokine stimulation. The STAT family comprises 
seven members: STAT-1, STAT-2, STAT-3, STAT-4, STAT-5a, STAT-5b and STAT-6. The family of JAKs 
consists of: JAK-1, JAK-2, JAK-3 and tyrosine-kinase 2 (TYK2). The different members of the JAK and 
STAT families have different functions in cytokine signaling (48). 
As an example for cytokine-induced signaling, signal transduction induced by interferons will be 
described in more detail (see also Figure 3). 
 
 
 
 
21 
 
Figure 3: Signal transduction by the IFN receptors (from (44)) 
 
 
 
 
Signal transduction by the IFN-receptors is activated by the binding of type I and type II IFNs to their 
respective receptors (type I IFNs: IFNAR, type II IFNs: IFNGR). Binding activates the Janus kinases 
(JAKs) that are permanently bound to these receptors (for IFNAR: JAK1 and TYK2 and for IFNGR: JAK1 
and JAK2). The activated JAKs in turn phosphorylate tyrosine residues in the receptor. The 
phosphorylation creates then docking sites for STAT1 (for IFNGR) or a STAT1-STAT2 complex (for 
IFNAR). The receptor-associated STATs are phosphorylated on tyrosine residues by the receptor-
associated JAKs. In the case of type I IFNs, phosphorylated STATs form STAT1-STAT2 heterodimers 
and to a lesser extend STAT1-STAT1 homodimers. After type II IFN stimulation only STAT1-STAT1 
homodimers are formed. STAT1 homodimers translocate into the nucleus, where they bind to IFN-γ-
activated-site (GAS) promoter sequences. STAT1-STAT2 heterodimers associate with a third protein, 
IFN regulatory factor 9 (IRF9) to form IFN-stimulated gene factor 3 (ISGF3) and to bind to the IFN-
stimulated response element (ISRE) promoter sequence in the nucleus in order to stimulate gene 
transcription (44). 
For full responses to both, type I and type II IFNs, the transactivation domain of STAT1 has to be 
phosphorylated on serine 727. This modification occurs only, when the protein is tightly bound to 
chromatin (49) (50) (51). 
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3.2. Streptococcus pyogenes 
Streptococcus pyogenes, also known as Group A Streptococcus (GAS), is a gram-positive, non-motile, 
non-spore forming coccus. It occurs in pairs or in chains. Individual cells are round to ovoid and 0.6-1 
µm in diameter. Due to the fact, that these bacteria are members of the lactobacilli, GAS is a 
fermentative, facultatively anaerobic organism that grows best in nutrient-rich environments. 
A characteristic feature of these bacteria is a prominent zone of β-hemolysis when grown on solid 
agar containing intact red blood cells. β-hemolysis is described as a complete lysis of red blood cells 
by the bacterium resulting in a clear zone surrounding the colony grown on blood agar (52). S. 
pyogenes has been classified into serotypes by Rebecca Lancefield according to the variety of M 
virulence protein expressed on the cell surface. 
Recently, a new approach for the identification of M-protein serotypes on a molecular basis has been 
developed. For this method, called emm typing, a large portion of the emm gene is amplified using 
highly specific primers. Located within this amplified region is the hypervariable sequence encoding 
M serospecificity, which allows direct sequencing. Genes that have the same emm type, share > 95% 
nt sequence identity (53, 54); ( ://www.cdc.gov/ncidod/biotech/strep/strepindex.htm). 
Up to now, more than 200 different serotypes have been described and it was shown that these M-
protein serotypes strongly correlate with the disease caused by a particular strain of S. pyogenes 
(55).  
 
 
3.2.1. Streptococcal Pathogenesis and Clinical Manifestations 
S. pyogenes is one of the most frequently found pathogens in humans and causes a wide spectrum of 
disease, ranging from uncomplicated mild infections (e.g. pharyngitis, tonsillitis, skin infections) to 
severe invasive disease such as sepsis, streptococcal toxic shock syndrome (STSS) and necrotizing 
fasciitis, which is also referred to as “flesh-eating disease”.  
Before the invention of antimicrobials, diseases caused by S. pyogenes were very common and a 
huge medical problem in these days. It was reported, that this bacterium was the leading cause of 
puerperal infections, responsible for inestimable deaths of parturient women. Further, it was the 
major cause of deaths in burns patients.  
With the introduction of penicillin into the clinical practice in the 1940ies, the number of 
streptococcus-caused diseases abated and it was believed that this pathogen is practically eliminated 
in the developed countries (54, 56). 
In the mid-late 1980ies, clinics observed a resurgence of serious S. pyogenes infections, in Europe, in 
North America and other parts of the world (57, 58). 
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A current WHO study shows that diseases caused by S. pyogenes lead to 500.000 deaths each year 
worldwide and that the prevalence of severe diseases caused by this bacterium is at least 18 million 
cases (59). 
Transmission of bacteria occurs directly from human-to-human, mostly via respiratory droplets or 
skin contact. The mucosal epithelium of the oropharynx and the epidermal layer of the skin 
represent the primary ecological niches of S. pyogenes, since it´s very likely that the bacterium enters 
the host via these sites (53). 
Nevertheless, the bacterium can thrive in almost every tissue of the body including normally sterile 
tissues causing maladies like deep soft tissue infection, meningitis, pneumonia and pericarditis. 
 
Table 2: Diseases caused by Streptococcus pyogenes (adopted from (54)) 
 
Category of Disease 
 
Examples of Infection 
Superficial Infections pharyngitis, skin and soft tissue infections, 
impetigo, erysipelas, vaginitis, post-partum 
infections 
 
Deep Infections bacteraemia, necrotizing fasciitis, deep soft 
tissue infections, cellulitis, myositis, puerperal 
sepsis, pericarditis, meningitis, pneumonia, 
septic arthritis 
 
Toxin-mediated Diseases scarlet fever, toxic-shock like syndrome 
 
Immunologically-mediated Diseases rheumatic fever, post-streptococcal 
glomerulonephritis, reactive arthritis 
 
 
 
Pharyngitis (also known as sore throat or strep throat) is the most common infection caused by S. 
pyogenes and is considered as a non-invasive infection.  
It is defined as an inflammation of the throat and the pharynx and possibly the larynx and the tonsils. 
This disease occurs primarily in childhood (from 5-15 years), but is very rare in children younger than 
3 years. 15-30% of cases are caused by S. pyogenes. Adults are most often affected in the late teens 
or early 20s (60). Pharyngitis is highly prevalent in late fall through early spring (55) (53).  
In addition, S. pyogenes causes more severe invasive diseases such as sepsis, necrotizing fasciitis (NF) 
and streptococcal toxic shock syndrome (STSS). 
Necrotizing fasciitis, also known as “flesh eating disease” is a rare but potentially fatal infection 
involving the skin, the subcutaneous tissue, fascia and muscles (52).  
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It is characterized by rapid destruction of tissue, systemic toxicity and with high morbidity and 
mortality (61). At the beginning of the disease, it is difficult to differentiate NF from other superficial 
infections of the skin. It often starts with a local, quite trivial injury (e.g. insect bites or scratches) and 
if diagnosis is delayed, worsens within hours or days. Studies show that rapid surgical intervention is 
important for the survival of the patient (52) (62). 
Streptococcal toxic shock syndrome (STSS) often goes hand in hand with deep tissue infections like 
necrotizing fasciitis and cellulitis (63). This syndrome manifests as shock and organ failure and affects 
patients in all ages. 
 
As a further complication, post-streptococcal sequelae such as acute rheumatic fever (ARF) and acute 
post-streptococcal glomerulonephritis (APSGN) can occur. These diseases are considered to be 
immunologically mediated.  
Rheumatic fever usually follows a streptococcal pharyngitis and appears as an acute systemic febrile 
illness about 3 weeks after throat infection. The major outcomes of this disease include arthritis, 
carditis, the erythema marginatum rash, Sydenhams´s chorea and subcutaneous nodules (54, 60). 
Arthritis, which is an inflammation of the joints, can be observed in 60-80% of ARF patients. It usually 
affects the large joints of the lower extremities, followed by the upper extremities. 
Carditis, considered as one of the most serious complications of ARF, manifests as myocarditis, 
pericarditis and endocarditis (60). It occurs in 30-45% of ARF patients and leads to chronic rheumatic 
heart disease (RHD). It was estimated, that 60% of all ARF patients will develop RHD and that over 2 
million children are affected with RHD worldwide (64) (55) (59).  
Acute post-streptococcal glomerulonephritis (APSGN) is the second major sequel of streptococcal 
infections leading to an acute nephritic syndrome. It affects mainly children, young adults and also 
individuals over 40. Interestingly, males are affected twice as often as females (55). Patients suffer 
from hematuria (red or smoky urine), headache, anorexia, nausea, vomiting and due to the swelling 
of the renal capsule, flank or back pain (60). 
APSGN usually occurs about 10 days after throat or skin infection by specific nephritogenic serotypes 
of S. pyogenes. Although it is now rare in the industrialized nations, it still is a concern in the 
developing countries with 9-29 new cases per 100.000 individuals per year (65).  
Post-streptococcal sequelae have been linked to insufficient health care and poor hygienic 
conditions. For this reasons, poststreptococcal syndromes remain the diseases of underprivileged 
and developing countries (60). Due to the fact, that S. pyogenes is still causing high mortality rates, 
even in industrialized countries and reports showing the occurrence of macrolide-resistant strains of 
S. pyogenes (58, 66), the development of a vaccine against this bacterium is of great importance. 
25 
 
Several attempts have been made to design a vaccine against S. pyogenes. For example, the 
streptococcal M-protein is one of the most important virulence factors of S. pyogenes as it confers 
resistance to phagocytosis by cells of the host immune system. The M-protein consists of two 
polypeptide chains configured in an alpha-helical coiled coil complex that is anchored to the cell 
membrane via its C-terminus. The protein is composed of four repeat regions: the hypervariable (A), 
the variable (B) and two conserved regions (C, D) (67).Two regions of the M-protein have been 
targeted for vaccine development: the hypervariable N-terminal region and the conserved C-terminal 
region (68). 
Due to the multiplicity of M-types expressed by S. pyogenes it is difficult to find a single antigen, 
which provides protection against all serotypes of this bacterium. Further, the development of M 
type-based vaccines is complicated by the fact that certain M types elicit both, protective antibodies 
and antibodies that cross-react with human tissues (heart, brain, kidney) (69).  
Another approach to design an effective vaccine is the use of well described virulence factors of S. 
pyogenes as an antigen, including streptococcal C5a peptidase, cysteine protease, fibronectin-binding 
proteins, streptococcal carbohydrate and streptococcal pili. Further, reverse vaccinology was used to 
identify novel antigens (70). This approach for vaccine development is based on the in silico analysis 
of the whole genomic sequence of a pathogen in order to identify a suitable antigen (71). In these 
days, several vaccine candidates against S. pyogenes are in varying stages of preclinical and clinical 
development. But only one of the candidates, the multivalent N-terminal vaccine, has entered clinical 
trials during the last 30 years (70).  
 
 
3.2.2. Interaction with the Host 
The human immune system is a complex of biological structures and processes that protects the 
organism against unwanted intruders like bacteria or viruses. If microbes are somehow able to enter 
the organism, it is very likely that they will encounter cells of the innate immune system, which 
confer the first line of defense against invaders. Upon detection, these cells trigger an immune 
response resulting in the eradication of the pathogen. 
The great success of S. pyogenes in establishing disease results from its ability to efficiently 
circumvent host defense mechanisms. The bacterium makes use of a huge armament of virulence 
factors, which helps the bacterium to colonize, multiply rapidly and spread within the host, thereby 
causing numerous, sometimes life-threatening, diseases. 
Key components of the bacterium´s armament are surface bound M-proteins that inhibit 
phagocytotic defenses and promote invasion of host cells, capsules of hyaluronic acid (HA) mimic 
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human tissue HA and proteases that specifically destroy chemotactic signals that should attract 
phagocytes (72). 
Further, S. pyogenes produces pyrogenic exotoxins which act as bacterial superantigens. They include 
SpeC, SpeG, SpeH, SpeI, SpeJ, SpeK, SpeL, SpeM, SSA, the highly polymorphic SMEZ and the 
bacteriophage-encoded SpeA. SMEZ is the most potent superantigen and also the most 
immunoactive agent of S. pyogenes (73). 
Superantigens produced by S. pyogenes are potent immunostimulators and systemic intoxication can 
lead to the life-threatening toxic shock syndrome (TSS). This is due to the ability of superantigens to 
bind simultaneously to major histocompatibility complex (MHC) class II molecules and the T-cell 
receptor (TCR). This binding leads to activation of a large number of T cells expressing specific V-beta 
subsets of the T cell repertoire resulting in a sudden and massive cytokine storm (74). 
The presence of a superantigen in the blood stream rapidly elevates the amount of cytokines to toxic 
levels and it is believed that the production of interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α) 
and interferon-γ (IFN-γ) are the main responsible cytokines causing this massive toxicity. 
 
 
Figure 4: GAS virulence factors interact with the host at many levels (from (75)) 
 
 
 
 
Epithelial Cell Adherence 
For a microbial pathogen, the initial step to cause a disease is the attachment to a mucosal or 
cutanous surface of the host. The attachment is usually hindered by the normal flora and numerous 
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electrostatic and mechanical forces. S. pyogenes uses multiple and complex strategies to attach and 
invade the human host, involving different adhesins and invasins. 
Adherence of S. pyogenes is a two-step mechanism, consisting of unspecific and specific interactions 
with the host. First, the unspecific step allows a temporally limited, weak attachment via 
hydrophobic interactions on the surface of the bacterium with hydrophobic domains on the host 
cells, where lipoteichoic acid (LTA) is believed to be the responsible structure. The second step relies 
on the expression of specific adhesins on the surface of S. pyogenes which allow the bacterium to 
establish a firm adherence (76). So far, at least 17 adhesin candidates have been reported, but the 
most important and most extensively studied ones are the M-protein, fibronectin binding proteins 
and lipoteichoic acid (74). 
In addition, several extracellular host cell proteins have been described in the context of attachment 
or adherence to S. pyogenes: collagen, fibronectin, vitronectin and the integral membrane proteins 
CD46 (membrane cofactor protein of keratinocytes) and CD44 (hyaluronate-binding receptor on 
keratinocytes) (55). These proteins are regarded as host extracellular matrix (ECM) and serve as 
prime target for interactions between bacteria and the host, because they are firmly bound to the 
surface of an eukaryotic cell and are present in a large number of species and types {Kreikemeyer, 
2004 #227. 
The M-protein mediates binding to collagen and fibronectin but it can also interact with the plasma 
proteins fibrinogen and plasminogen {Sanderson-Smith, 2008 #231}(77). 
It was also shown that it is important for the adhesion of the bacteria to HEp-2 cells in tissue culture 
and to Keratinocytes, but not to buccal or tonsillar epithelial cells. All in all, the role of M-protein in 
context of adherence seems to be dependent on the M-protein serotype and on the host cell source, 
such as the skin or the phayrinx (55). 
 
Fibronectin (Fn) binding proteins (FnBPs) are another group of proteins mediating adhesion of 
streptococcal cells to the host epithelium. These include protein F1, SfbI and the related proteins 
SfbII, FBP54, protein F2 and PFBP (74). S. pyogenes strains differ in the genetic potential to express 
FnBPs SfbI, SfbII and F2 and it was observed  that strains possessing two or more genes for these 
FnBPs bound Fn significantly more than strains possessing one or none of the genes (78). Among 
them, protein F is the best studied fibronectin binding protein of S. pyogenes. Studies with protein F 
and the highly homologous protein SfbI (streptococcal fibronectin binding protein I) revealed that 
these proteins have the ability to inhibit binding of Fn to streptococcal cells when expressed in 
Escherichia coli. Further, inactivation of the gene (prtF), which codes for protein F, led to a mutant 
which was not longer able to adhere to respiratory epithelial cells (79, 80).  
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It was discovered recently, that S. pyogenes produce long, surface-exposed, pilus-like structures 
composed of members of a family of ECM- binding proteins. These pili are encoded by genes located 
in the FCT (fibronectin, collagen-binding, T-antigen) gene region and up to now, 4 major variants of 
the FCT region have been described. Each FCT region contains genes coding for pilus structural 
subunits (the backbone protein, which corresponds to the T antigen of the Lancefield T serotypes 
(and ancillary proteins) and for sortase enzymes required for pilus assembly (81, 82). Streptococcal 
mutants, where either pilus backbone structural protein or the sortase C1 have been deleted, show 
an impaired attachment to a pharyngeal cell line (83). Streptococcal pili mediate adhesion to human 
tonsil epithelium, primary human keratinocytes and skin but are not used by the bacterium for 
adhesion to HEp-2 and A549 cells (84). Recently it was reported that, in contrast to group B 
streptococcal and pneumococcal pili, pilus expression reduces virulence of S. pyogenes in murine 
models of necrotizing fasciitis, pneumonia and sepsis. The observed attenuated virulence associated 
with pilus expression was not due to differences in phagocytic uptake, complement deposition or 
antimicrobial peptide sensitivity (85). So it seems like that pili have not only an important role during 
attachment to the host and subsequent invasion but surprisingly also in the restriction of invasive 
disease pathogenesis. 
 
 
Intracellular Invasion and Spread through Tissues 
The success of a pathogen depends on its ability to colonize host tissues and persist by ensuring its 
long-term survival. Therefore, adhesion to the host cell is a major prerequisite for colonization and 
invasion. Several proteins involved in streptococcal adherence are also involved in epithelial cell 
invasion.  
Although S. pyogenes is predominantly an extracellular pathogen, several studies indicated that this 
bacterium invades and persist within human epithelial cells (86, 87). The reason for that might be 
that the intracellular status of the bacterium serves a niche, where the bacterium is protected 
against antibiotics and/or host defense mechanisms (78). Another possibility could be that the 
bacterium uses the entry into the host cell for invasion of deeper tissues. 
Internalization is a complex process and two different pathways have been described. 
Strains expressing the FnBP SfbI, use this protein for binding to Fn as a bridging molecule and the 
α5β1 integrin as cellular receptor. In tonsils, the interaction of the bacterium with integrin-bound 
fibronectin leads to the induction of transforming growth factor-β1 (TGF-β1) from fibroblasts, which 
further upregulates the expression of α5 integrin and Fn on epithelial cells and fibroblasts. This 
results in the formation of a higher density of α5β1 receptors and a more efficient ingestion of 
bacteria (88).The thereby activated uptake process is characterized by the generation of large 
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membrane invaginations and a lack of actin recruitment or cell injury. This type of uptake is also 
known as “zipper mechanism” and involves the formation of an intimate contact between the host 
cell membrane and the bacterium leading to a tight engulfment of the pathogen by the cell 
membrane in a zipper-like fashion (89). 
However, not all streptococcal strains express the SfbI protein, but many of those are still 
internalized by host cells. In that case, the uptake process involves major rearrangements of 
cytoskeletal proteins, leading to recruitment and fusion of microvilli and the generation of cellular 
leaflets (90). 
 
The streptococcal capsule is an important virulence factor of S. pyogenes and plays a major role in 
the protection from phagocytosis by host immune cells. The capsule is composed of a polymer of 
hyaluronic acid containing repeating units of glucuronic acid and N-acetylglucosamine.  
Streptococcal isolates vary in the amount of hyaluronic acid capsule they produce and variants 
showing increased encapsulation are linked to greater invasive disease potential (55) (91).  
In contrast to M-protein and fibronectin-binding proteins, the hyaluronate capsule of S. pyogenes 
was shown to impair adherence to and invasion of epithelial cells and human keratinocytes (74, 92). 
On the other hand, a study using a murine model for necrotizing fasciitis shows that the loss of the 
hyaluronic acid capsule significantly attenuated local soft-tissue necrosis, systemic bacterial 
dissemination and mortality. This goes in line with another study that revealed that the streptococcal 
capsule is recognized by the hyaluronic acid-binding protein CD44 on human keratinocytes. Binding 
of S. pyogenes induced marked cytoskeletal rearrangements, resulting in the disruption of 
intercellular junctions thereby allowing the bacterium to remain extracellular when it penetrates the 
epithelium (93). 
 
Hyaluronidase, DNases, Streptokinase and the streptococcal pyrogenic exotoxin B (SpeB) are 
extracellular products of S. pyogenes that are considered as spreading factors by promoting 
liquefaction of pus and helping the bacterium to get through tissue planes. 
Hyaluronidase enzymatically degrades hyaluronic acid which is present in the connective tissue and 
DNases (DNases A, B, C and D) are responsible for the degradation of DNA (74). 
Expression of DNase is crucial for S. pyogenes to avoid destruction by neutrophils, since these cells 
can kill invading microbes by engulfment of the bacteria within neutrophil extracellular traps which 
are consisting of DNA and chromatin (75).  
A common defense mechanism to prevent invading pathogens from spreading involves the 
encapsulation of bacteria at confined sites by deposition of fibrin networks. This allows a directed 
inflammatory response at the affected area in order to eradicate the invaders.  
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S. pyogenes circumvents this defense mechanism by acquisition of the serine protease plasmin at the 
bacterial cell surface. Streptococcal Streptokinase is a plasminogen-activating protein that combines 
with plasminogen to make functional plasmin. This protease is then able to hydrolyze fibrin thereby 
promoting the spread of S. pyogenes through tissues (82, 94). 
 
The cysteine protease SpeB is a crucial virulence factor of S. pyogenes and plays a major role during 
colonization of the host by modulation of functions of cell surface proteins. Further, it contributes to 
tissue destruction during necrotizing fasciitis. This toxin is produced by virtually all S. pyogenes 
strains, but the degree of expression varies from strain to strain. Although at the beginning believed 
as a superantigen, it is now thought that its contribution to disease results entirely from the protease 
activity (74). The functions of this virulence factor a diverse, including degradation of host ECM 
proteins (i.e. fibrin and fibronectin) and human immunoglobulins, activation of IL-1β and the release 
of proteins from the surface of S. pyogenes (95) (96). SpeB was also shown to degrade a variety of 
chemokines (i.e. IP10/CXCL10, I-TAC/CXCL11, PF4/CXCL4, GROα/CXCL1, GROβ/CXCL2, GROγ/CXCL3, 
ENA78/CXCL5, GCP-2/CXCL6, NAP-2/CXCL7, SDF-1/CXCL12, BCA-1/CXCL13, BRAK/CXCL14, 
SRPSOX/CXCL16, MIP-3α/CCL20, Lymphotactin/XCL1, and Fractalkine/CX3CL1), thereby destroying 
most of their signaling and antibacterial properties (97). Further a study shows that during localized 
infections, some S. pyogenes strains can lose SpeB activity, leading to an accumulation of plasmin 
activity on the cell surface of the bacterium. Loss of SpeB activity helps the bacterium to leave the 
local site of infection and to enter the blood stream, thereby promoting dissemination to other parts 
of the host (75). 
 
 
Immune System Avoidance 
Impairment of Phagocyte Recruitment  
Once a pathogen managed to invade the host, the innate immune system induces an inflammatory 
response to clear the bacterial infection. Phagocytes recognize and kill the invading pathogen via a 
process called phagocytosis, therefore they are the most important effectors cells in this initial 
phase. These cells are recruited to the site of infection via chemoattractants, which are molecules 
that form a gradient in the tissues in order to guide the phagocytes to the site of infection and 
inflammation. Chemoattractants for phagocytes can be bacterial-derived products such as N-formyl 
peptides from the bacterial cell wall but can be also host-derived, like leukotriene B4, platelet-
activating factor, the complement-derived anaphylotoxin C5a and chemokines such as CXCL8 
(interleukin-8 (IL-8)) (46) . 
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S. pyogenes produces a serine protease (SpyCEP, also known as ScpC) that degrades human IL-8, 
growth regulated oncogene-alpha (Gro-α /CXCL1) and granulocyte chemoattractant protein-2 (GCP-
2/CXCL6) (98). Further, it was shown to degrade also the murine chemokines keratinocyte 
chemoattractant (KC/CXCL1) and macrophage inflammatory protein 2 (MIP-2/CXCL2) (99). IL-
8/CXCL8 is a chemokine which plays an important role in neutrophil transmigration and activation. 
SpyCEP/ScpC specifically cleaves the C-terminus of IL-8 leading to a functional inactivation of the 
chemokine (91). In a murine model of necrotizing fasciitis, SpyCEP/ScpC was shown to be important 
for S. pyogenes virulence since it was necessary and sufficient for systemic bacterial dissemination 
within soft tissues and the respiratory tract (98).  
The C5a peptidase ScpA is another immunomodulating enzyme of S. pyogenes that inhibits 
recruitment of phagocytes to the site of infection. This cell-wall-anchored serine endopeptidase 
specifically cleaves the chemotactic complement factor C5a, which is known to be important for the 
activation of neutrophils and macrophages (100). The cleavage of C5a requires the expression of a 
plasmin receptor (Plr), also known as surface dehydrogenase (SDH) or glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH) which binds C5a with a higher affinity than ScpA. It seems that the 
Plr/SDH/GAPDH mediates the recruitment of C5a to the streptococcal cell surface since it has no 
protease activity, while ScpA is responsible for the cleavage of C5a (46) (101). 
ScpA mutants show a reduced ability to colonize the murine nasopharynx and active immunization 
with ScpA confers resistance to nasal colonization by S. pyogenes in a mouse model (102). 
Furthermore, it was demonstrated that the important cytolytic toxin streptolysin S (SLS) of S. 
pyogenes is also involved in the suppression of migration of phagocytes to the site of streptococcal 
infection during the early period of infection. This function seems to be independent of the lytic 
activity of SLS but dependent on the ability to inhibit production of chemotactic signals by the host 
cells (103). 
 
 
Avoidance of Phagocyte Killing  
After internalization by a phagocyte, pathogens get trapped in intracellular membrane-bound 
compartments where an array of bactericidal mechanisms is deployed to destroy the pathogen. 
These mechanisms include generation of reactive oxygen species (ROS) and reactive nitrogen 
intermediates (RNI), the production of antimicrobial peptides including lysozyme and 
myeloperoxidase and the fusion of endocytic organelles with phagosomes, which are acidified and 
mature into phagolysosomes. 
In order to generate a functional phagosome, neutrophils make use of specialized secretory 
organelles, the primary (azurophilic) and the secondary (specific) granules (104).  
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S. pyogenes was shown to survive within phagocytes and is also able to escape from the phagosome 
into the cytoplasm of polymorphonuclear neutrophils (PMNs) (105). The ability to survive within 
these cells is associated with the expression of the streptococcal M- and M-like surface proteins, 
since mutants for the respective proteins are rapidly killed by the neutrophils (106). Further, strains 
of S. pyogenes that express the M-protein, inhibit the secretion of azurophilic granules and the 
formation of pinosomes (107). To cope with hydrogen peroxide and organic peroxides during an 
inflammatory response, S. pyogenes expresses the gluthathione peroxidase GpoA. Using several 
different murine models, it was shown that this peroxidase is important for the bacterium to adapt 
to oxidative stress and for streptococcal virulence (108).  
 
The two pore-forming cytotoxins Streptolysin O (SLO) and Streptolysin S (SLS) are key virulence 
factors of S. pyogenes and are, among other things, also involved in promoting resistance to 
phagocyte killing by triggering the death of phagocytes before bacterial killing is accomplished. These 
two haemolysins are produced by almost all S. pyogenes strains. 
SLO derives its name from its oxygen lability and belongs to a large family of highly conserved pore-
forming toxins, which can be found in more than 20 different species, including the genera 
Clostridium, Streptococcus, Listeria, Bacillus and Arcanobacterium (109). 
It is reversibly inhibited by oxygen and irreversibly inhibited by cholesterol. It is toxic to a variety of 
cell types and fractions, including erythrocytes, polymorphonuclear leukocytes, platelets and tissue 
culture cells (74). SLO has been shown to impair the phagocytotic capacity of polymorphonuclear 
leukocytes (110). Further, it protects the bacterium from host cell killing by preventing the 
internalization of the bacteria into the lysosome (111). 
A recent study revealed that SLO is also the responsible virulence factor for the induction of 
apoptosis in macrophages and neutrophils, thereby contributing to streptococcal immune evasion 
and virulence. Apoptosis appeared to be caspase- dependent and was promoted by release of 
cytochrome c and permeabilization of mitochondrial outer membranes caused by SLO (112).  
Like SLO, SLS damages the membranes of polymorphonuclear leukocytes, platelets and subcellular 
organelles and is responsible for the hemolytic zone around S. pyogenes colonies grown on blood 
agar plates (113).This hemolysin exists in intracellular, cell-surface-bound and extracellular forms and 
is produced by S. pyogenes growing in presence of serum, serum-albumin, alpha-lipoprotein and 
ribonucleic acid (74).  
SLS was shown to excert cytocidal activity on host neutrophils, thereby promoting resistance of S. 
pyogenes to killing by phagocytes (91). 
SLS-negative mutant strains, which were obtained by insertion of the Tn916 transposon in the sag 
operon promoter of M1 or M18 serotype strains, show reduced virulence in a murine model of soft 
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tissue infection (114). In contrast to these findings, studies using other streptococcal M-types (M3, 
M5) with a sagA deletion revealed that there was no effect on virulence in similar animal models 
(110)(115).  
 
Moreover, the streptococcal DNase Sda1 has been reported to be deployed by S. pyogenes to avoid 
destruction by neutrophils. This cell type has three different strategies to eradicate invading 
microbes. As professional phagocytes, they are able to recognize invaders and kill them by 
phagocytosis. In addition, they secrete highly reactive antimicrobial effector molecules. Another way 
to kill pathogens is the release of neutrophil extracellular traps (NETs), which are composed of 
decondensed chromatin and antimicrobial proteins (116). 
The streptococcal DNase Sda1 has been shown to degrade NETs, thereby maintaining bacterial 
survival in neutrophils and mouse blood. Further, this DNase is necessary and sufficient to promote 
virulence in a murine model of necrotizing fasciitis (117). 
 
 
Interference with the Complement System 
The plasma proteins of the complement system are important mediators of the innate immune 
response against pathogens. The major functions of the complement cascade are to label 
immunogenic particles or pathogens with C3b and iC3b to facilitate phagocytic uptake via 
complement receptors, to generate chemoattractants (e.g. C5a) to recruit phagocytes to the site of 
infection and to directly lyse gram-negative bacteria through the membrane attack complex (MAC) 
(67). On the other hand, bacterial pathogens evolved various strategies to circumvent the 
complement response.  
The complement system is divided into three different initiation pathways: the classical (CP), the 
lectin (LP) and the alternative (AP) pathway. All of them converge at the cleavage of the central 
complement protein C3 by the two C3 convertases C4b2a and C3bBb.  
The host expresses complement regulators such as factor H (FH), factor H-like 1 (FHL1), C4b-binding 
protein (C4BP) and membrane cofactor protein (MCP, CD46), which function to downregulate 
convertase activity to prevent tissues from excessive complement activity (67).  
S. pyogenes is able to interact with these proteins via the M- and M-like proteins. 
C4BP is a plasma glycoprotein that is involved in the regulation of the classical complement pathway 
by accelerating the decay of the C3 convertase and by acting as a cofactor in the FI-mediated 
proteolytic inactivation of C4b. S. pyogenes was shown to bind C4BP via the hypervariable N-terminal 
region in the M-protein to the C4b- binding site in C4BP. This interaction occurs with a high affinity 
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and confers bacterial protection against classical complement activation and resistance to 
phagocytosis (118). 
The hypervariable region and/or the conserved C-repeat region of many streptococcal M-proteins 
have also been shown to bind factor H and its splice variant factor H-like 1 for immune evasion. 
However the significance of M-protein binding to complement regulators is controversial since a 
study analyzing the capacity of several clinical isolates of S. pyogenes to bind to regulators of 
complement activators revealed that the most virulent M1 and M3 strains did not bind to these 
proteins (119). 
FH regulates the activation of complement by acting as a cofactor for factor I-dependent cleavage of 
C3b and by disrupting the alternative pathway C3 convertase. FHL-1 was identified as an alternative 
splicing product of the FH gene and was shown to have FH complement regulatory protein activity 
(67). Aquisition of FH and FHL-1 can limit the deposition of the opsonin C3b on bacteria, thereby 
decreasing the bacteriums susceptibility to phagocytosis. However, it has been demonstrated that 
binding of factor H to a certain M1 strain is not mediated by the M-protein or M-like proteins but by 
the cell surface protein Fba. This protein prevents deposition of C3b on the streptococcal surface and 
promotes survival of S. pyogenes in human whole blood (120).  
The ultimate step of the complement cascade is the cleavage of C5 by the C5 convertases, which 
results in the formation of C5b, the molecule that is responsible for the formation of the membrane 
attack complex (MAC), which consists of proteins C5b-C9. This complex functions to destroy target 
cells, like for example gram-negative bacteria. 
S. pyogenes expresses the streptococcal inhibitor of complement (SIC), which was found to 
specifically block the formation of the MAC. This is achieved by the prevention of insertion of C5b67 
into the cell membrane (67). Since gram-positive bacteria are anyway protected from lysis by the 
complement system by their peptidoglycan-containing cell walls and hyaluronic acid capsules, the 
relevance of inhibition of the MAC complex is questionable. 
The SIC molecule has also been shown to inhibit a variety of antimicrobial peptides and proteins 
including lysozyme, secretory leucocyte proteinase inhibitor (SLPI), LL-37, human neutrophil peptide-
1 (hNP-1), and the human β-defensins 1, 2, and 3 (121). This function might be more relevant for the 
protection of S. pyogenes from the host immune system. 
 
 
Evasion of Antibody-mediated Opsonization 
A second form of opsonization is provided by the production of immunoglobulins (Igs) against 
specific bacterial epitopes during the humoral immune response. Immunoglobulins can be divided 
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into four different classes (IgG, IgM, IgA, IgD, IgE) based on differences in the amino acid sequences 
in the constant region of the heavy chains. 
They consist of antigen-recognizing Fab regions, which are linked through a flexible hinge region to 
the constant Fc effector region. 
The Fc effector region is responsible for the activation of the classical pathway of complement and 
mediates the contact with Fc receptors on phagocytes. 
Immunoglobulins have various functions during the humoral and inflammatory immune response 
against a pathogen: they (1) interact with Fc receptors (FcRs) on phagocytes and complement 
components, (2) activate phagocytes, (3) modulate B-cell functions (e.g. memory induction, 
activation and/or feedback inhibition of antibody production), (4) neutralize toxins, (5) mediate 
antibody-dependent cellular cytotoxicity, (6) activate natural killer cells and eosinophils, (7) induce 
mast cell degranulation and mediate opsonization of antigens, thereby causing enhanced 
phagocytosis (122). 
S. pyogenes evolved several virulence factors to circumvent or destroy components of this important 
branch of host defense. 
The streptococcal cysteine proteases SpeB and IdeS (also designated as Mac-1) have been shown to 
cleave IgG in the hinge region. SpeB has been reported to cleave also the carboxy-terminal parts of 
the heavy chains of IgM, IgA, IgD, IgE antibodies, whereas IdeS has a high specificity to IgG.  
These two proteases act at different phases of the immune response against S. pyogenes. Whereas 
IdeS protects the bacterium in the early phase of infection (i.e. during colonization and growth), SpeB 
is important during later phases, when the infection is losing momentum (123)(124).  
Mac-2, a variant of IdeS (Mac-1), has a weak endopeptidase activity against IgG compared to IdeS, 
but it is able to bind to the immunoglobulin receptors FcγRII and FcγRIII. Binding results in the 
inhibition of IgG recognition by Fc receptors, leading to an enhanced survival of the bacterium (125). 
Further, the endoglycosidase EndoS, cleaves the asparagine-linked glycan on IgG, thereby impairing 
opsonophagocytosis, activation of the classical complement pathway and recognition of IgG by 
phagocyte Fc receptors (123). 
The function of antibodies is also hindered, when the pathogen is able to bind to the Fc region of IgG, 
resulting in the decoration of the bacterial surface with the host molecule.  This mechanism of 
immune invasion is for example applied by the streptococcal fibronectin binding protein I (SfbI), thus 
preventing antibody-dependent cell-cytotoxity and phagocytosis by macrophages (126). Moreover, 
several types of M-protein and protein H of S. pyogenes have been reported to bind to the Fc 
domains of IgG, thereby inhibiting complement activation on the bacterial cell surface (91). 
Another strategy of S. pyogenes to avoid antibody-mediated recognition is the upregulation of 
hyaluronic acid capsule expression. The capsule then shields the bacterial cell-wall attached 
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immunogenic determinant G-related alpha2-macroglobulin-binding protein (GRAB) from detection 
by antigen-specific antibodies (127). 
 
 
3.2.3. Innate Immune Responses to Streptococcus pyogenes 
Activation of the immune system upon any type of infection is fundamentally dependent on the 
recognition of the pathogen by the cells of the innate immune system.  
In case of the important human pathogen S. pyogenes, the molecules needed for the pathogen 
recognition and downstream signaling events that mediate an effective immune response are largely 
not known.  
It has been shown that macrophages play an important role during an infection with S. pyogenes, 
since depletion of macrophages in mice using carrageenan significantly increased susceptibility to S. 
pyogenes infection (128). Further it has been demonstrated that also dendritic cells are important 
contributors to the host defense against S. pyogenes (129). 
Recently it has been shown by our group that this bacterium induces an inflammatory response in 
murine bone-marrow derived macrophages (BMDMs), resulting in the production of 
proinflammatory cytokines such as TNF-α and IL-6. Surprisingly, this response appeared to be 
independent of the main bacterial receptors TLR2, TLR4 and TLR9 but dependent on the important 
TLR-adaptor protein MyD88 (130).  
The importance of this protein during S. pyogenes infection was also proofed using a murine in vivo 
model. S. pyogenes-infected, MyD88-deficient mice harbored significantly more bacteria in their 
organs and succumbed much earlier to infection compared to C57BL/6 animals (129). Further, a 
recent report shows that in dendritic cells, streptococcus-mediated production of proinflammatory 
cytokines such as IL-12 and IL-6 is, like in macrophages, also dependent on MyD88 (131).  
S. pyogenes has also been shown to activate Stat1, Stat3 and IRF1 in human macrophages (132).  
Our group was the first to demonstrate that mouse innate immune cells are able to produce IFN-β in 
response to an extracellular Gram-positive bacterium (S. pyogenes) (130). In addition, it was shown 
that group B streptococcus (GBS) is able to induce IFN-β production and that IFN-β is critical for host 
defense against these bacteria (133). The IFN-β production in response to GBS appears to be induced 
in dendritic cells by bacterial RNA in a TLR7-dependent way whereas in macrophages bacterial DNA, 
recognized by a so far unidentified receptor, is the IFN inducer (134) (135). Overall, reports on the 
molecular mechanism underlying IFN-β induction by pathogens suggest that individual pathogens 
developed specific and often unique ways how to elicit IFN production in innate immune cells.  
Recently, S. pyogenes was also shown to activate the inflammasome, which is a multiprotein-
complex known to mediate the activation of caspase-1 that leads to the production of the 
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proinflammatory cytokines IL-1β and IL-18 (136). In the case of S. pyogenes, the NLR family pyrin 
domain-containing 3 (NLRP3) and the adaptor protein apoptosis-associated speck-like protein (ASC) 
were crucial for caspase-1 activation and IL-1β secretion. Inflammasome activation during 
streptococcal infection proceeds independently of TLR signaling but is depending on NF-κB and the 
streptococcal cytolysin Streptolysin O (SLO) (136).  
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4. Aims  
 
Although S. pyogenes is an important pathogen causing a wide range of diseases, very little is known 
about the molecules and processes which are fundamental for its recognition and the activation of 
the innate immune system.  
It was decided to address this issue by investigation of S. pyogenes infection in murine bone-marrow-
derived macrophages (BMDMs), since these cells confer, among others, the first line of defense 
against bacterial infections. 
One aim of this thesis was the identification of the molecule responsible for the recognition of S. 
pyogenes and the characterization of signaling pathways leading to a proinflammatory response 
against this bacterium. Therefore, primary macrophages from several TLR-deficient mouse lines have 
been analyzed for their potential to initiate proinflammatory responses against S. pyogenes, since it 
is likely that these sensor molecules are involved in its recognition.  
 
The second aim was the identification of mechanisms responsible for type I interferon (IFN) 
production in BMDMs in response to S. pyogenes. We were able to show that S. pyogenes induces an 
IFN response in macrophages by a yet unknown receptor. Therefore, we wanted to investigate the 
molecule responsible for the initiation of IFN signaling and also the signaling events occurring after 
induction of IFN production. 
Further, we were interested in the nature of the streptococcal ligand, inducing the proinflammatory 
(i.e. TNF-α production) as well as the type I IFN response to S. pyogenes. We assumed that the 
identification of the ligand would eventually facilitate the search for the receptor molecule. 
Therefore, streptococcal fractions were treated with either RNase A, DNase I or Proteinase K or the 
combination of them. The potential of streptococcal DNA, RNA or proteins to induce immune 
responses was assessed by the measurement of TNF-α and IFN-β production. 
 
The third aim of this thesis was the establishment of an in vivo mouse model to identify the role of 
type I IFN production in the host defense against invasive infection with S. pyogenes. Therefore, a 
subcutaneous infection model was established which resembles invasive infections in humans. 
Applying this model, we assessed the role of type I IFN production after S. pyogenes infection in vivo 
using IFNAR1-deficient mice. 
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5. Results 
 
5.1. Group A streptococcus activates type I interferon production and MyD88-
dependent signaling without involvement of TLR2, TLR4, and TLR9 
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Bacterial pathogens are recognized by the innate immune sys-
tem through pattern recognition receptors, such as Toll-like
receptors (TLRs). Engagement of TLRs triggers signaling cas-
cades that launch innate immune responses. Activation of
MAPKs and NF-B, elements of the major signaling pathways
induced by TLRs, depends in most cases on the adaptor mole-
cule MyD88. In addition, Gram-negative or intracellular bacte-
ria elicit MyD88-independent signaling that results in produc-
tion of type I interferon (IFN). Here we show that in mouse
macrophages, the activation of MyD88-dependent signaling by
the extracellularGram-positive humanpathogen groupA strep-
tococcus (GAS; Streptococcus pyogenes) does not require TLR2,
a receptor implicated in sensing of Gram-positive bacteria, or
TLR4 and TLR9. Redundant engagement of either of these TLR
molecules was excluded by using TLR2/4/9 triple-deficient
macrophages. We further demonstrate that infection of macro-
phages by GAS causes IRF3 (interferon-regulatory factor 3)-de-
pendent, MyD88-independent production of IFN. Surprisingly,
IFN is induced also by GAS lacking slo and sagA, the genes
encoding cytolysins that were shown to be required for IFN pro-
duction in response to other Gram-positive bacteria. Our data
indicate that (i) GAS is recognized by a MyD88-dependent
receptor other than any of those typically used by bacteria, and
(ii) GAS as well as GAS mutants lacking cytolysin genes induce
type I IFNproduction by similarmechanisms as bacteria requir-
ing cytoplasmic escape and the function of cytolysins.
Group A streptococcus (GAS4; Streptococcus pyogenes) is an
important human Gram-positive pathogen responsible for a
wide spectrum of infections, ranging from mild diseases (e.g.
tonsillitis) to serious illness (e.g. necrotizing fasciitis, sepsis, or
severe poststreptococcal sequelae) (1). The persistence of GAS
in the human population and the severity of someGAS diseases
are the result of activities of a number of virulence factors that
enable the pathogen to escape immune surveillance or, on con-
trary, induce an overreaction of the immune system (2, 3).
Although GAS is generally regarded as an extracellular patho-
gen, recent findings suggest that GAS can survive (although not
multiply) within various host cells, such as neutrophils, macro-
phages, epithelial cells, and fibroblasts (4–7). The surviving
bacteria may serve as a reservoir for recurrent GAS diseases.
Immune responses to bacteria are initiated by recognition of
bacterial components called pathogen-associated molecular
patterns through host cell-encoded pattern recognition recep-
tors (PRRs) (8, 9). Typically, pathogen-associated molecular
patterns are components of the bacterial cell wall (e.g. lipopo-
lysaccharide and lipoteichoic acid), but they may also be
derived from the inside of bacteria (e.g. DNA). The primary
function of PRRs is to trigger signaling cascades that activate
antimicrobial defense programs. The best studied class of PRRs
is the Toll-like receptor (TLR) family, which consists of 13
transmembrane glycoproteins in mammals (8). Virtually all
pathogenic bacteria are recognized by one or more TLRs, with
TLR2 being the receptor for lipoteichoic acid of Gram-positive
bacteria, TLR4 the receptor for lipopolysaccharide of Gram-
negative bacteria, and TLR9 the receptor for bacterial DNA
containing unmethylated CpG sequences. Ligand binding to
TLR3, TLR4, TLR7, and TLR9 but not to TLR2 launches two
distinct signaling pathways that result in the production of
proinflammatory cytokines (e.g. TNF and IL-1) and type I
IFNs, respectively. Five TIR domain-containing adaptor mole-
cules are involved in signaling downstream of TLRs: MyD88,
TIRAP (or MAL), TRIF (or TICAM1), TRAM (or TICAM2),
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and SARM, a negative regulator of TRIF (10).MyD88, an essen-
tial signaling component of all TLRs except TLR3, is required
for activation of MAPKs and NF-B that cause production of
proinflammatory cytokines. Signaling components that are
required for the production of type I IFNs are less uniform, and
they are partially TLR- and cell type-specific. Recently, much
attention has been paid to the elucidation of pathways leading
to TLR-independent production of type I IFN in response to
intracellular bacteria and/or intracellular DNA (11–14).
Although the identity of the critical PRR remains unknown, it is
generally believed that it is a cytoplasmic molecule that recog-
nizes bacterial products (possibly bacterial DNA) in the cyto-
plasm. Signaling downstream of this unknown PRR employs
the serine threonine kinase TBK1 or, less frequently, its relative
IKK (15–18), which phosphorylates primarily the transcription
factor IRF3, causing the activation of the IFN- gene, the first
type I IFN to be expressed (19, 20). Other cytoplasmic PRRs,
such as the NOD proteins, recognize bacterial products in the
cytoplasmand activateMAPKs andNF-Bbut not IFNproduc-
tion (21).
Despite a considerable knowledge of GAS virulence factors,
the PRRs that are responsible for recognition of this pathogen
by the host are unknown. Remarkably little information is avail-
able also about the signaling pathways triggered by GAS in
infected innate immune cells that are known to be required for
defense against GAS (22). Here we show that GAS activates p38
MAPK, NF-B, TNF, and IL-6 production in infected bone
marrow-derived mouse macrophages (BMDMs). Similar to
other bacteria, these responses depend onMyD88. However, in
contrast to most other pathogenic bacteria, the MyD88-medi-
ated signaling was independent of TLR2, the receptor for
Gram-positive bacteria, and the other bacterial receptors TLR4
and TLR9. We also rule out the involvement of IL-1 receptor
signaling. We further demonstrate that GAS also elicits
MyD88-independent signaling that results in type I IFN pro-
duction. The IFN production did not require the presence of
the GAS-encoded cytolysins SLO and SLS. This finding is sur-
prising, since during infections with other Gram-positive bac-
teria, either the cytolysin itself or cytolysin-mediated cytoplas-
mic escape of bacteria from phagocytic vesicles was implicated
in triggering IFN production (12, 23–25). However, the
requirement for IRF3 in the IFN production suggested that
other aspects of the GAS-induced IFN production resembled
the well established TBK1/IRF3 signaling pathway. This is the
first description of activation of MyD88-dependent and -inde-
pendent pathways uponGAS infection. Our data implicate that
GAS is recognized by a yet unknown receptor upstream of
MyD88 and establish GAS as a Gram-positive pathogen capa-
ble of inducing type I IFN synthesis without molecules usually
required for entry of bacterial products into the cytoplasm of
infected cells.
EXPERIMENTAL PROCEDURES
Bacterial Strains—Escherichia coli DH5- and TOP10 were
used as hosts for cloning. S. pyogenes serotype M1 (ATCC
700294) is a clinical strain originally isolated from an infected
wound. The isogenic sagA- and slo-deficientmutantswere con-
structed using a thermosensitive strategy described previously
(26). First, usingwild-type genomicDNAas template and prim-
ers containing flanking restriction sites, a 1111-bp sagA
upstream fragment (primers OLEC120/OLEC143), a 1200-bp
sagA downstream fragment (primers OLEC123/OLEC144), a
1159-bp slo upstream fragment (primersOLEC248/OLEC249),
and a 1033-bp slo downstream fragment (primers OLEC250/
OLEC251) were amplified. After digestion with the respective
restriction enzymes, the upstream and downstream fragments
were cloned into thermo-sensitive plasmids pRDN18 (sagA-
deficient mutant) and pEC84 (slo-deficient mutant) (26). After
introduction of the recombinant plasmids into S. pyogenes
ATCC 700294, a series of temperature shifts with appropriate
antibiotic selection was performed, thus leading to the final
deficient mutants (strain EC548 (sagA-deficient mutant) and
EC997 (slo-deficient mutant)) in which the entire coding
sequence of the gene was deleted in a nonpolar fashion. To
create the sagA/slo-deficient strain (EC1142), the deletion of slo
was performed as mentioned above in the background of the
sagA-deficient strain. The correct deletion event in themutants
was checked by PCR, Southern blot, and sequencing analysis.
SLS and SLO hemolysis assays further confirmed that the
sagA-, slo-, and sagA/slo-deficient mutants were defective in
SLS and/or SLO activity as described (27, 28). DNA manipula-
tions are described in the supplemental materials.
Bacterial Culture—S. pyogenes strains were grown at 37 °C
with 5% CO2 without agitation in Todd-Hewitt broth (BD Bio-
sciences) supplemented with 0.2% yeast extract and on tryptic
soy agar supplemented with 3% defibrinogated sheep blood.
Transformation ofE. coli and S. pyogeneswas performed as pre-
viously described (29, 30).Whenever required, antibiotics were
added to the medium at the following final concentrations:
erythromycin, 300g/ml forE. coli and 3g/ml for S. pyogenes;
spectinomycin, 100 g/ml for both E. coli and S. pyogenes. Bac-
terial cell growth was turbidimetrically monitored at 620 nm
with a microplate reader.
Macrophage Cell Culture—Primary BMDMs were obtained
from the femur bone marrow of 6–10-week-old mice. Cells
were cultivated in Dulbecco’smodified Eagle’s medium supple-
mented with 10% fetal calf serum in the presence of L cell-
derived CSF-1, as described (31). MyD88/, TLR2/,
TLR4/, TLR9/, TLR2/4/9/, IFNAR1/, IRF3/, IL1-
RI/, and control WT mice, all on a C57Bl/6 background,
were housed under specific pathogen-free conditions (32–36).
GAS Infections—For infection assays, BMDMs were seeded
at 5 106 cells/dish in 10-cm dishes containing medium with-
out antibiotics. The next day, S. pyogenes cultures grown in
THY were harvested at midlogarithmic phase, washed with
phosphate-buffered saline, and added to the BMDMmonolay-
ers at a multiplicity of infection (MOI) of 100. After 30 min of
incubation at 37 °C, nonadherent extracellular bacteria were
eliminated by removing the culture medium, and adherent
extracellular bacteria were subsequently killed by incubation
with fresh medium (without fetal calf serum) containing 60
g/ml penicillin. At specific time points after infection, super-
natants were collected for ELISA, and whole cell extracts were
prepared for Western blot analysis. At least three mice of each
genotype were used in all infection experiments.
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Antibodies—Antibodies to Tyr701-phosphorylated Stat1
(pY701-S1) and phosphorylated p38 (pp38) were purchased
from Cell Signaling (Frankfurt/Main, Germany). Antibodies to
IB- and p38were purchased fromSantaCruz Biotechnology,
Inc. (Santa Cruz, CA). Antibody to Stat1- C terminus was
previously described (37).
ELISA andWestern Blot Analysis—For ELISAs, supernatants
of infected macrophages were collected and diluted 1:5 in rea-
gent diluent. TNF and IL-6 were assayed using DuoSET
ELISA kits (R&D Systems, Minneapolis, MN). Western blot
analysis was performed using fluorophore-linked secondary
antibodies (Molecular Probes-Invitrogen (Lofer, Austria) and
Rockland (Gilbertsville, PA)) and an Odyssey infrared imaging
system (LI-COR Bioscience, Lincoln, NE).
qRT-PCR—Total RNA was iso-
lated using Trizol LS reagent
(Invitrogen). Reverse transcription
of total RNA was performed using
oligo(dT)18 as primer and Moloney
murine leukemia virus reverse tran-
scriptase (Fermentas, St. Leon-Rot,
Germany). The cDNA of the IFN-
and Mx2 genes was subsequently
analyzed by qRT-PCR as described
in the supplemental materials.
RESULTS
GAS Activates Inflammatory Sig-
naling Independently of TLR2,
TLR4, and TLR9—To investigate
the role of bacteria-recognizing
TLRs in responses toGAS infection,
we examined the activation of the
transcription factor NF-B by
assaying the degradation of its
inhibitor (IB) and the phosphoryl-
ation of p38 MAPK in infected
BMDMs. Activation of both NF-B
and p38 MAPK was shown in
numerous studies to be essential
for production of proinflammatory
cytokines (38–42). Furthermore,
macrophages express all compo-
nents of the TLR signaling cascade
and are known to be required for
defenses against GAS infection (22).
We first compared the activation of
p38 MAPK and NF-B in WT and
TLR2/ BMDMs, since many
Gram-positive pathogens are recog-
nized by this receptor. GAS induced
in both WT and TLR2/ BMDMs
a rapid and sustained activation of
p38 MAPK (Fig. 1A). The degrada-
tion of IB was maximal after 1 h of
infection. IB gradually reappeared
at later time points but did not reach
the original level during the time
frame of observation (up to 4 h). The internalization of GAS
(monitored by fluorescence microscopy) was equally efficient
in cells of both genotypes (data not shown). These data demon-
strate that TLR2 was not required for GAS-induced signaling.
Other TLRs frequently engaged by bacteria are TLR4 and
TLR9. TLR4 is the receptor for lipopolysaccharide of Gram-
negative bacteria, but it has been shown to recognize also cell
wall components of mycobacteria and several cytolysins of
Gram-positive bacteria (25, 43, 44). TLR9, aCpGDNAreceptor
localized in endosomal and lysosomal membranes of macro-
phages and, most prominently, dendritic cells, can bind DNA
from both Gram-positive and Gram-negative species (35, 45).
Similar to TLR2/ BMDMs, the activation of p38 MAPK and
degradation of IB in TLR4/ and TLR9/ BMDMs was
FIGURE1.GAS-induced inflammatory signalingand theproductionof TNFand IL-6dependsonMyD88
but not on TLR2, TLR4, and TLR9. A–E, BMDMs from TLR2/ (A), TLR4/ (B), TLR9/ (C), TLR2/4/9/ (D),
MyD88/ (E), andWT control mice were infectedwith GAS (MOI 100). At the indicated time points, whole cell
extracts were prepared and analyzed by Western blotting using antibodies to phosphorylated p38 MAPK
(pp38; top) and to IB (bottom). Equal loading was controlled by reprobing the membrane with antibody to
total p38 MAPK. F and G, BMDMs derived from TLR2/4/9 triple-deficient (TLR2/4/9/) (F), MyD88/ (G), and
controlmicewere infectedwith GAS (MOI 100). At the indicated time points, supernatants were collected, and
TNF (left) and IL-6 release (right) was measured by ELISA. The data represent one of at least three infection
experiments carried out independently with different mice of each genotype.
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indistinguishable fromWTBMDMs (Fig. 1,B andC). To exam-
ine whether a combination of TLR2, TLR4, and TLR9 was used
for GAS recognition, we analyzed GAS-induced signaling in
TLR2/4/9 triple-deficient BMDMs. As depicted in Fig. 1D, the
signaling events in triple-deficient BMDMs were comparable
with WT cells. These data exclude a redundant function of
TLR2, TLR4, and TLR9 in GAS recognition and demonstrate
that macrophages sense GAS using a PRR other than the most
common bacterial receptors.
GAS-induced Inflammatory Signaling Depends on MyD88—
All TLRs except for the double-stranded RNA receptor TLR3
require MyD88 for activation of MAPKs, NF-B, and the sub-
sequent proinflammatory cytokine production. To investigate
whether MyD88 was involved in GAS-induced inflammatory
signaling, we examined the activation of p38MAPK and degra-
dation of IB in infected MyD88/ BMDMs. The experiment
revealed thatGAS-induced activation of p38MAPKwas almost
completely abolished, and the degradation of IB was strongly
diminished in MyD88/ cells when compared with WT cells
(Fig. 1E). A weak p38 MAPK activation and IB degradation
were observed in MyD88/ cells at later time points of infec-
tion. Thus, the GAS-induced inflammatory signaling was
markedly reduced and delayed in MyD88/ cells. The activa-
tion of MAPKs and NF-B plays a fundamental role in induc-
tion of proinflammatory cytokines, such as TNF or IL-6. To
estimate the effect of reduced GAS-induced inflammatory sig-
naling in MyD88/ BMDMs, we determined the amounts of
secreted TNF and IL-6 in supernatants of GAS-infected
MyD88/ and controlWT cells. In parallel, we also measured
TNF and IL-6 production by infected TLR2/4/9 triple-defi-
cient cells. Infection of WT BMDMs with GAS resulted in a
robust cytokine production that was only slightly reduced (by
less than 20%) in TLR2/4/9 triple-deficient cells (Fig. 1F). In
marked contrast, TNF and IL-6 production was completely
abolished inGAS-infectedMyD88/BMDMs (Fig. 1E). These
data show that GAS-induced proinflammatory cytokine pro-
duction is absolutely dependent on MyD88. The slight but
reproducible reduction of cytokine production by TLR2/4/9
triple-deficient BMDMs indicates that one of these TLRs or a
combination of them plays aminor role in GAS-induced proin-
flammatory cytokine production. However, the largest part of
GAS-induced inflammatory cytokine production is mediated
by a receptor (or receptors) different from the most common
bacteria-specific TLRs. Importantly, this receptor signals via
MyD88. The only other known pathways that use the adaptor
MyD88 for signaling are the IL-1/IL-18 pathways (32).
Although IL-18 is most relevant for the activation and IFN-
production byTh1 cells (46), IL-1 has been reported be released
by innate immune cells upon infection with various pathogens
that are sensed in the cytoplasm by components of the inflam-
masome (47–49). To investigate whether IL-1 release by GAS-
infectedmacrophages is responsible for theMyD88-dependent
inflammatory signaling, we infected cells deficient in IL1-RI,
themost important IL-1 receptor chain (50). As shown in Fig. 2,
the activation of p38MAPK, the degradation of IB, and TNF
productionwere not affected by the deficiency in IL-1 signaling.
These data further strengthen our notion that GAS is sensed by
a yet unidentified receptor upstream of MyD88.
GAS Induces Type I Interferon—Gram-negative and intracel-
lular bacteria are known to elicitMyD88-independent signaling
that causes activation of the transcription factor IRF3 and sub-
sequent transcription of the type I IFN-. The mechanisms of
IFN production induced by these two types of bacteria differ
upstream of IRF3. Whereas Gram-negative bacteria use TLR4
to stimulate IFN production, intracellular bacteria are recog-
nized by a still unknown cytoplasmic receptor. Engagement of
TLR9 can also trigger IRF3/IRF7-mediated type I IFN expres-
sion. GAS has been previously reported to induce IFN produc-
tion in primary human macrophages (51). We asked whether
GAS can exert similar effects in mouse macrophages and what
the role ofMyD88 or the bacteria-specific TLRs therein is. First,
tyrosine phosphorylation of the crucial IFN-activated tran-
scription factor Stat1 was analyzed. Tyrosine phosphorylation
of Stat1 is a good indicator for autocrine IFN- production,
since this cytokine is the first IFN to be synthetized upon chal-
lenge of macrophages with bacteria or their products (52–54).
Infection of BMDMs with GAS revealed induction of Stat1
FIGURE 2. IL-1 signaling is not required for responses of BMDM to GAS
infection. A and B, BMDMs from IL-1RI/ and control (WT) mice were
infected with GAS (MOI 100) for the indicated periods. p38 MAPK activation
(pp38) (A) and degradation of IB (B) were determined by Western blot anal-
ysis. Equal protein loading was confirmed by reprobing the membrane with
antibody to total p38 MAPK. C, BMDMs derived from IL-1RI/ and control
mice were infected with GAS (MOI 100). At the indicated time points, super-
natants were collected, and TNF release was measured by ELISA. The data
represent one of at least three infection experiments carried out independ-
ently with different mice of each genotype.
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tyrosine phosphorylation after 4 h of infection of WT BMDMs
(Fig. 3,A andB). This late tyrosine phosphorylation is similar to
challenges with other bacteria (e.g. Listeriamonocytogenes) that
do not induce IFN synthesis through direct engagement of an
IFN-inducing TLR (23). Consistently, Stat1 activation pro-
ceeded independently of MyD88 and TLR2, TLR4, and TLR9
signaling, as shown by GAS infection of BMDMs from
MyD88/ (Fig. 3A), TLR2/, TLR4/, TLR9/ (all in Fig.
S1), or TLR2/4/9 triple-deficient (Fig. 3B) mice. In fact, Stat1
tyrosine phosphorylation was slightly but reproducibly
increased in MyD88/ and TLR2/4/9 triple-deficient
BMDMs (Fig. 3,A and B) when normalized to total Stat1 levels.
Since the Stat1 levels were generally slightly lower in BMDMs
derived from the gene-targeted mice compared with WT con-
trols, the Western blots were reprobed with p38 antibody to
allow a more accurate normaliza-
tion. Reduced Stat1 levels have been
already previously observed in cells
that are deficient in IFN or TLR/
MyD88 signaling (11, 55, 56). To
directly assess IFN- expression, we
performed qRT-PCR to determine
IFN-mRNA levels in cells infected
with GAS. The data shown repre-
sent relative IFN- mRNA levels
normalized to GAPDH mRNA. We
did normalize to uninfected cells,
since the IFN- mRNA was very
often below the levels that could be
reliably detected by qRT-PCR. The
experiment confirmed that the
IFN- expression was independent
of TLR2, TLR4, and TLR9 (Fig. 3D).
The IFN-mRNAwas also induced
upon infection of MyD88/ cells
with GAS, albeit the amount was
reduced if compared with WT cells
(Fig. 3C). The reduced IFN-
mRNA levels in MyD88/ did not
result in diminished IFN signaling,
since Stat1 activation was increased
in these cells if compared with the
controlled BMDMs (Fig. 3A). The
functional activation of IFN/Jak/
Stat signaling in MyD88/ and
WT cells was further confirmed by
the induction of the type I IFN tar-
get gene Mx2 (57). The transcrip-
tion ofMx2was induced in both the
control and MyD88/ BMDMs
with a kinetics that correlated well
with the activation profile of Stat1
(Fig. 3E). Moreover,Mx2 transcrip-
tion was more strongly induced in
MyD88/ cells that also display
increased Stat1 activation. Thus,
despite the decreased IFN-
mRNA, the IFN/Jak/Stat1 signaling
was more efficiently turned on in MyD88/ cells, suggesting
that the increased Stat1 phosphorylation was caused by a
more efficient phosphorylation or a lower dephosphoryla-
tion rate. To prove the autocrine/paracrine role of the type I
IFN in Stat1 activation, we examined Stat1 activation and
IFN responses using BMDMs lacking the type I IFN receptor
chain 1 (IFNAR1/). As shown in Fig. 4A, Stat1 tyrosine
phosphorylation was completely abolished in GAS-infected
IFNAR1/ cells despite robust induction of IFN- gene
transcription in these cells (Fig. 4A). Consistently, the induc-
tion of the type I IFN-responsive gene Mx2 was entirely
dependent on signaling by the IFNAR1 receptor (Fig. 4C). In
most cell types, activation of the transcription factor IRF3
launches a feed forward type I IFN amplification loop
through induction of IFN- that drives the expression of
FIGURE 3.GAS induces IFN-production and Stat1 activation independently ofMyD88, TLR2, TLR4, and
TLR9. A and B, BMDMs from control (WT), MyD88/ (A), and TLR2/4/9 triple-deficient (TLR2/4/9/) (B) mice
were infectedwithGAS (MOI 100), andwhole cell extractswerepreparedafter the indicated timeperiods. Stat1
Tyr701 phosphorylation and expression were determined by Western blotting using antibody to phosphoryl-
ated Stat1 (pY-S1) and total Stat1. Differences in Stat1 expression levels were revealed by reprobing the
membrane with antibody to total p38 MAPK (p38). Note the double band on the pY-S1 blot represents the
phosphorylated formsof both Stat1 splicing isoforms Stat1- and Stat1-. Loading control (S1)was performed
with antibody directed to the C terminus of Stat1, which is absent in the Stat1- isoform. C andD, BMDMs from
wild type,MyD88/ (C), and TLR2/4/9 triple-deficient (TLR2/4/9/) mice (D) were exposed to GAS (MOI 100).
After the indicated time points, total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for
IFN- and GAPDH (for normalization) expression. Note that the data show relative IFN-mRNA levels normal-
ized toGAPDHbutnot touninfected samples. E, GAS-induced IFN- stimulates transcriptionof type I IFN target
gene Mx2. BMDMs from MyD88/ and control (wild type) mice were exposed to GAS, and 2.5, 4, and 6 h
postinfection (hours p.i.), total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for Mx2
after normalizing to GAPDH and uninfected samples. Bars, S.D. of three experiments.
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IFN-s (19, 20, 58). Thus, a failure in activation of IRF3
results in a deficient production of both the immediate
IFN- and the late phase IFN-s. To further elucidate the
mechanism of GAS-induced IFN production, we infected
IRF3/ BMDMs with GAS and examined the activation of
the transcription factor Stat1 and induction of the Stat1 tar-
get gene Mx2. Both the tyrosine phosphorylation of Stat1
and the transcription of the type I IFN-inducible gene Mx2
were diminished in IRF3/ (Fig. 4, B and D), whereas the
MyD88 pathway was not affected by the IRF3 deletion, as
revealed by p38 MAPK activation. These data demonstrate
that GAS has the ability to induce IFN- synthesis and IFN
signaling in a way that mechanistically resembles the IFN-
activation by intracellular Gram-positive pathogens.
GAS Stimulates IFN Signaling Independently of Cytolysins—
The TLR-independent IFN- induction by GAS was surpris-
ing, since GAS is generally regarded as an extracellular
pathogen that has only a limited capacity to survive in host
cells (4–7). For the so far characterized induction of IFN-
production by Gram-positive bacteria, the expression of
cytolysins was required (12, 23, 24). Cytolysins are thought
to enable cytoplasmic escape of phagocytosed bacteria. In
addition, cytolysins were also
shown to directly stimulate IFN
production (25). The GAS genome
contains genes for two cytolysins.
The slo gene encodes SLO (strep-
tolysin O), which resembles other
known cytolysins (e.g. listeriolysin,
pneumolysin, and anthrolysin) in
terms of sequence, sensitivity to
oxygen, and cholesterol binding
(59, 60). The other cytolysin, SLS
(streptolysin S), is encoded by the
sagA gene, which is unrelated to
the cholesterol-binding cytolysins
(60). To examine whether the
GAS-derived cytolysins play a role
in GAS-induced IFN signaling,
sagA (SLS)-deficient, slo (SLO)-
deficient, and double sagA/slo-de-
ficient mutants were generated
and used in infection assays. Anal-
ysis of Stat1 activation revealed
that neither the deletion of the sin-
gle cytolysin genes (data not
shown) nor the double deletion
(Fig. 5A) caused a reduction of
GAS-induced IFN signaling. The
inflammatory signaling was also
not dependent on the expression
of the GAS cytolysins, as shown by
p38 MAPK activation (Fig. 5B).
These findings suggest that the
ability of GAS to induce IFN-
synthesis may not require a con-
tact of GAS components with the
still unknown cytoplasmic recep-
tor that is used by other Gram-positive bacteria for IFN-
induction.
DISCUSSION
GAS is the etiological agent of a variety of human diseases.
The heterogeneity of GAS diseases arises in part from the high
diversity of GAS-mediated host-pathogen interactions in
which virulence factors, GAS genome composition, prophage
DNA, and plasticity of the GAS transcriptome play key roles (2,
61–64). A major factor influencing the severity of GAS infec-
tions is also the genetic inventory of the host. In humans, the
differences in susceptibility to severe GAS diseases were
mapped to the major histocompatibility complex locus (65).
More severe infections and a generalized toxic shock syndrome
appear to be associated with higher expression of inflammatory
cytokines in both humans and mice (66). Cytokine production
in GAS responses is regulated by T cells through GAS superan-
tigens and the as yet poorly understood activation of innate
immune cells. Our findings demonstrate that GAS is able to
induce cytokines in macrophages through MyD88-dependent
and -independent pathways. The identity of the GAS-recogniz-
ing receptor upstream of MyD88 poses an intriguing question,
FIGURE 4.GAS-induced IFN signaling depends on IRF3 and IFNAR1. A and B, BMDMs from control (WT),
IFNAR1/ (A), and IRF3-deficient (IRF3/) (B) mice were infected with GAS (MOI 100), and whole cell
extracts were prepared 2.5, 4, and 6 h postinfection. Stat1 Tyr701 phosphorylation and expression were
determined by Western blotting using antibody to phosphorylated Stat1 (pY-S1) and total Stat1. Differ-
ences in Stat1 expression levels were revealed by reprobing the membrane with antibody to total p38
MAPK (p38). C andD, BMDMs from IFNAR1/ (C), IRF3/ (D), and control (WT) mice were exposed to GAS
for the indicated times, and total mRNA was extracted, reverse-transcribed, and analyzed by qRT-PCR for
Mx2 after normalization to GAPDH. E, BMDMs from IFNAR1/ and control (WT) mice were infected with
GAS (MOI 100). IFN- expression was analyzed by qRT-PCR after normalization to GAPDH. Bars, S.D. of
three experiments.
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since our study rules out the exclusive involvement of the most
prominent bacteria-recognizing receptors, TLR2, TLR4, and
TLR9, or their combination. Other MyD88-dependent TLRs
are the flagellin receptor TLR5 and the single-stranded RNA
receptors TLR7 and TLR8 (8). Involvement of these receptors
inGAS-inducedMyD88-dependent signaling is not likely, since
flagellin or a similar protein has not been found in GAS, and
single-stranded RNA is associated with viral recognition. How-
ever, the role of these receptors cannot be entirely excluded,
because PRRs are, in general, not specific for a single molecule.
For example, TLR2 was reported to cooperate with dectin-1 in
recognition of fungi (67). We ruled out the role of signaling
through the IL-1R, which is known to be MyD88-dependent.
IL-1 can be released by infected cells as a result of inflamma-
some-mediated caspase 1 activation, which is required for
IL-1 processing (68). Although we did not address the GAS-
mediated IL-1 production, a role for IL-1 as a possiblemediator
of the MyD88-dependent responses can be excluded. A func-
tion of IL-18 as another molecule requiring MyD88 for signal-
ing is rather unlikely, since the IL-18 receptor is predominantly
expressed onTh1 cells, whereas a prolonged treatmentwith e.g.
IL-18 plus IL-12 is required for stronger expression in mono-
cytic cells (69, 70). The ability of GAS to induce MyD88-de-
pendent signaling independently of TLR2/4/9 may not be
unique, since other Gram-positive pathogens have been
reported to initiate inflammatory responses in the absence of
multiple TLRs. For example, heat-inactivated group B strepto-
cocci and Streptococcus pneumoniae as well as spores of Bacil-
lus anthracis induce MyD88-dependent responses in TLR2-,
TLR4-, and TLR9-deficient macrophages or splenocytes (71–
73). Despite the fact that TLR2/4/9 triple-deficient cells were
not used in these studies, they support our hypothesis that some
Gram-positive pathogenic bacteria are recognized by an as yet
unidentified receptor upstream of MyD88.
The surprising finding thatGAS is able to induce IFN- inde-
pendently of cytolysins represents another so far unique feature
of GAS-induced responses in innate immune cells. In this
regard, GAS-derived streptolysins are different from several
other cytolysins that have been reported to induce IFN- syn-
thesis through activation of TLR4 (25). Another proposed
mechanism of IFN- induction by Gram-positive bacteria (e.g.
L. monocytogenes) involves listeriolysin O-dependent libera-
tion of bacteria and/or bacterial components from phagosomes
(12, 23, 24). Although GAS is a prototype extracellular patho-
gen, it can be efficiently internalized by many phagocytic and
nonphagocytic cells. However, GAS survives only for a short
period of time in host cells due to degradation in lysosomal and
autophagosomal compartments (5, 6). Interestingly, Bacillus
subtilis engineered to express streptococcal SLOwasnot able to
survive or multiply in infected cells, as opposed to listeriolysin
O-expressing B. subtilis (74). This observation suggests that
SLO,which displays a high degree of similaritywith listeriolysin
O, cannot mediate cytoplasmic escape. Thus, the reported data
together with our findings support the hypothesis that GAS
stimulates IFN- synthesis by a novel mechanism that does not
require cytoplasmic escape. Interestingly, the signaling events
that culminate in Stat1 activation and transcription of IFN-
responsive genes follow the well established pathway involving
the transcription factor IRF3 and the type I IFN receptor but
independent of MyD88. The increased IFN signaling in
MyD88/ cells may be explained by reduced expression of the
inhibitor of IFN signaling SOCS1 (75). SOCS1 expression is
known to be dependent on p38 MAPK (76), which we show in
our study to be strongly reduced in GAS-infected MyD88/
cells.
Ourwork demonstrates the ability of GAS to inducemultiple
inflammatory responses via in part novel recognition mecha-
nisms. MyD88-dependent TLR2/TLR4/TLR9-independent
signaling and cytolysin-independent IFN- induction are so far
exceptional characteristics of host cell responses to infection.
SinceGAS induces proinflammatory cytokine and IFN produc-
tion in human macrophages (51), we assume that our findings
are not restricted to themurine system, which, in the context of
the whole organism, is considerably more resistant to GAS
infection (66). The efficient stimulation of multiple signaling
pathways may contribute to the known high capability of GAS
to cause severe inflammatory diseases.
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Abstract 
 
Streptococcus pyogenes is a Gram-positive human pathogen that is recognized by so far 
unknown pattern recognition receptors (PRRs). Engagement of these receptor molecules during 
S. pyogenes infection causes innate immune cells to produce inflammatory mediators such as 
Tnf, but also type I interferon (IFN) which was unexpected for a Gram-positive bacterium with an 
extracellular life cycle. Here we show that signaling elicited by type I IFN is required for 
successful defense of mice against lethal subcutaneous cellulitis caused by S. pyogenes. 
Mechanistic analysis revealed that macrophages and conventional dendritic cells (cDCs) employ 
different signaling pathways leading to IFN-beta production. Macrophages required IRF3, TBK1 
and only partially MyD88 whereas in cDCs the IFN-beta production was dependent on IRF1 and 
fully required MyD88. Furthermore, in macrophages the IFN-beta production was dependent on 
the endosomal delivery of streptococcal DNA while in cDCs streptococcal RNA was identified as 
the IFN-beta inducer. Despite a role of MyD88 in both cell types no known TLR was required for 
generation of IFN-beta response. These results demonstrate that the innate immune system 
employs several strategies to efficiently recognize S. pyogenes, a pathogenic bacterium that 
succeeded in avoiding recognition by the standard arsenal of TLRs. 
 
 
Introduction 
 
Streptococcus pyogenes, also known as group A streptococcus (GAS), is a Gram-positive 
human pathogen causing an exceptionally broad range of infectious diseases [1]. The bacterium 
colonizes the throat and the skin where it can evoke usually mild illness such as pharyngitis 
(strep throat) or scarlet fever (rash). Systemic infections with S. pyogenes are less frequent but 
they can develop into life-threatening diseases such as necrotizing fasciitis and streptococcal 
toxic shock syndrome that occur in ~10000 cases in the US annually resulting in ~1500 deaths 
[2]. The wide spectrum of S. pyogenes-related diseases arises from diversity in the genetic 
inventory of both the host and the pathogen [3]. For example, in a recent Europe-wide 
epidemiology survey of the streptococcal M-protein, a key virulence factor occurring in over 100 
variants, the M-protein types 1 and 3 (M1 and M3 serotypes) were found to be associated with 
particularly high mortality rates in invasive streptococcal diseases [4]. On the host side, certain 
variants of the HLA class II and the TNF microsatellite haplotypes are implicated in increased 
susceptibility to severe invasive infections [5,6]. Interestingly, a genetic linkage analysis in 
mouse strains displaying different susceptibilities to S. pyogenes infections demonstrated a 
3 
 
dominant contribution of the genetics of the innate immune system [7]. Further animal studies 
confirmed an essential role of macrophages and dendritic cells (DCs) in protection against S. 
pyogenes infections [8,9]. Cells of the innate immune system can combat the pathogen directly 
by phagocytosis, and indirectly, by launching the primary immune response characterized by the 
production of inflammatory mediators that results from the recognition of the pathogen by the 
pattern recognition receptors (PRRs) [10]. PRRs recognize various pathogen-derived products 
commonly referred to as pathogen-associated molecular patterns PAMPs. Binding of PAMPs to 
their cognate PRRs triggers signaling cascades that culminate in the production of cytokines, 
chemokines and antimicrobial compounds. The recognition of bacteria is achieved by 
membrane-bound PRRs of the TLR family and by several classes of cytoplasmic PRRs. In 
mouse, 12 TLRs (TLR1 - TLR9, TLR11 - TLR13) are known [10,11]. They all signal using the 
adaptor MyD88 except of TLR3 which employs the adaptor TRIF. TRIF is used also by TLR4, 
together with MyD88. Further downstream events include the activation of MAPKs and 
transcription factors of the NF-κB and IRF families. TLRs can be classified also by their 
subcellular localization. TLR3, TLR7, TLR8 and TLR9 are localized in the endosomal 
compartments whereas the remaining TLRs reside at the cell membrane and are exposed to the 
outside environment [12]. However, this static view of TLR localization is becoming increasingly 
challenged by recent findings revealing that TLR2 and TLR4 acquire different signaling 
properties after internalization triggered by ligand binding [13,14]. Thus, the dynamic trafficking 
of TLRs is an important component of the regulation of TLR function. Signaling from the cell 
membrane-bound TLRs generally leads to the production of NF-κB driven cytokines e.g. Tnf and 
IL-6 while signaling from the endosomal TLRs triggers the induction of both, the IRF-driven 
interferon beta (IFN-β) and the NF-κB-driven cytokines. The initially cell surface-localized TLR2 
and TLR4 turn into IFN-β inducers after becoming compartmentalized into endosomes. Bacterial 
products that reach the cytoplasm (from e.g. intracellular bacteria), thereby escaping detection 
by cell surface- or endosome-associated TLRs, can be recognized in MyD88-independent way 
by cytoplasmic PRRs. They include the nucleotide-binding and oligomerization domain (NOD)-
like receptors (NLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and the DNA-
sensors DAI, AIM2 and LRRFIP1 [10,15]. NLRs and AIM2 cause activation of the 
inflammasome-dependent IL-1β release although the non-inflammasome function of the NLR 
members NOD1 and NOD2 in NF-κB-driven cytokine production is also critical for the immune 
response [16]. RLRs, DAI and LRRFIP1 are involved in type I IFN production in response to 
bacteria-derived nucleic acids.  
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Despite the knowledge about the critical contribution of the innate immune system to the 
severeness and diversity of diseases caused by S. pyogenes the recognition of this bacterium 
by the innate immune cells is still not understood. Only recently studies by us and others 
demonstrated that murine bone marrow-derived macrophages (BMDMs) and conventional DCs 
(cDCs) responded to infection with S. pyogenes by a TLR2-, TLR4- and TLR9-independent 
production of the NF-κB-driven cytokines TNF and IL-6 [17,18]. The lack of requirement for 
TLR2 is surprising since S. pyogenes is a Gram-positive bacterium that contains the TLR2 
ligand lipoteichoic acid [19]. The S. pyogenes-elicited TNF and IL-6 production was strictly 
dependent on the adaptor MyD88 that was demonstrated by Medina and coworkers to be 
required for survival of mice in subcutaneous infection models [20].  
Our previous study showed that S. pyogenes was capable to induce IFN-β in BMDMs which was 
the first evidence for a Gram-positive bacterium with an extracellular life cycle to do so [17]. 
Subsequently, the Group B Streptococcus was also shown to induce IFN-β in BMDMs and cDCs 
[21,22]. The detailed mechanism of IFN-β induction by S. pyogenes and the role of type I IFN 
signaling in host defense in a valid infection model remained to be elucidated. Depending on the 
pathogen, type I IFN signaling can have protective or deleterious effects in models for bacterial 
infectious diseases [23]. Here we show that mice deficient in type I IFN signaling (IFNAR1-/-) are 
susceptible to invasive S. pyogenes infection in a model for innate immune system-controlled 
subcutaneous infectious disease. Infection studies revealed that cDCs require MyD88 and IRF1 
for IFN-β production while BMDMs possess MyD88-dependent and independent pathways that 
however both require IRF3. In both cell types the IFN-β induction was not regulated by any 
known TLR. Analysis of bacterial components indicates that S. pyogenes-derived RNA is the 
IFN-β inducer in cDCs whereas bacterial DNA is the inducer in BMDMs. Our data also propose 
that the S. pyogenes-mediated induction of IFN-β is achieved by different sensing mechanisms 
than the previously described induction by Group B Streptococcus which further illustrates the 
diversity of these streptococcal species. 
 
 
 
 
Results 
 
Type I IFN signaling is required for host protection against S. pyogenes infection in lethal 
cellulitis 
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S. pyogenes was recently reported by us to induce IFN-β in bone marrow-derived macrophages 
(BMDMs) [17]. Depending on the pathogen, type I IFNs may be beneficial or harmful to the host 
[23]. To test how type I IFNs contribute to the host defense against S. pyogenes we examined 
the survival of type I IFN receptor 1 (IFNAR1)-deficient and control (WT) mice in a lethal 
subcutaneous infection model. This mode of infection resembles human skin infections with S. 
pyogenes which result in cellulitis and may develop into severe streptococcal toxic shock 
syndrome [24]. The survival of animals was monitored for 6 days in order to examine the host 
response during the innate immune system-dominated phase of infection. IFNAR1-deficient 
mice displayed 75% lethality rate whereas only 25% WT controls died demonstrating that type I 
IFNs were essential for a full blown host defense (Fig. 1A).  
 
Macrophages and dendritic cells employ different mechanisms for IFN-β induction by S. 
pyogenes  
Macrophages (BMDMs) and cDCs, two cell types critically contributing to the innate immune 
responses, were shown to be required for protection of mice against S. pyogenes infections and 
for preventing dissemination of bacteria from the primary subcutaneous inoculation site [8,9]. 
Both cell types are known to respond to S. pyogenes infection by a robust Tnf and IL-6 
production that is MyD88-dependent and involves a so far unindentified receptor different from 
the most common receptors for bacterial components i.e. TLR2, TLR4 and TLR9 [17,18]. In 
addition, both cell types were also reported to induce IFN-β although the precise mechanism 
remained unknown [17,22]. We directly compared the requirement for MyD88 in S. pyogenes-
induced IFN-β production by infecting BMDMs and cDCs derived from MyD88-/- and WT mice. 
IFN-β amounts were measured in supernatants collected 4 and 6 hrs after infection of cDCs, 
whereas for BMDMs the 6 and 8 h time points were assayed since the response was 
consistently slower and less strong in these cells compared to cDCs (data not shown). In 
BMDMs the amount of IFN-β was reduced to 50% in MyD88-deficient cells (Fig. 1B) while in 
cDCs the IFN-β production was fully dependent on MyD88 (Fig. 1C). We observed that the IFN-
β-driven activation of the transcription factor Stat1 was stronger in MyD88-/- as in WT BMDMs 
(Fig. 1D and [17]). We reasoned that the increased Stat1 activation despite of a reduced IFN-β 
production in MyD88-/- cells might be caused by the inability of MyD88-/- cells to efficiently 
activate expression of the Socs1 gene, an inhibitor of IFN signaling. Full expression of Socs1 
requires activation of the p38 MAPK [25] that was found to be reduced in S. pyogenes-infected 
MyD88-/- cells [17]. Consistently, Socs1 mRNA was reduced in S. pyogenes-infected MyD88-/- 
BMDMs (Fig. 1E). This result also illustrates that direct measurements of IFN levels by ELISA 
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more accurately reflect the intensity of IFN production than indirect assays such as activation of 
Stat1.  
In cDCs, IFN-β production induced by a variety of stimuli is often regulated by the transcription 
factors IRF1 and IRF7 downstream of MyD88, whereas in BMDMs so far only IRF3-dependent 
MyD88-independent induction of IFN-β has been described [10]. To address the role of IRFs in 
S. pyogenes-induced IFN-β production we examined BMDMs and cDCs derived from IRF1-/- and 
IRF3-/- mice. In BMDMs, IRF1 was dispensable while IRF3 was absolutely essential for IFN-β 
induction (Fig. 2A, C). In contrast, IFN-β production in cDCs was strongly dependent on IRF1 but 
not on IRF3 (Fig. 2B, D). The data in cDCs are consistent with a study of Mancuso and 
colleagues describing partial dependency of S. pyogenes-induced IFN-β on IRF1 [22]. 
Interestingly, in that study Group B Streptococcus-induced IFN-β in cDCs was completely 
dependent on IRF1 indicating that the two streptococcal species employ different mechanisms 
for IFN-β induction in cDCs. In BMDMs, the complete dependency of S. pyogenes-induced IFN-
β on IRF3 (Fig. 2C) resembled the reported Group B Streptococcus-stimulated IFN-β in the 
same cell type [21]. However, Group B Streptococcus-induced IFN-β did not require MyD88 in 
BMDMs [21] whereas our data show that upon S. pyogenes infection about 50% of IFN-β 
depends on MyD88 (Fig. 1). Together, the data illustrate that IFNβ-production in response to S. 
pyogenes requires MyD88 and partially IRF1 in cDCs, while in BMDMs IRF3 fully controls IFN-β 
generation 50% of which is MyD88-dependent. In addition, S. pyogenes and Group B 
Streptococcus, two streptococcal pathogens, significantly differ in the requirement for MyD88 
and IRFs in IFN-β induction.  
 
S. pyogenes induces IFN-β by using receptors that differ from PRRs typically engaged by 
bacterial products  
Our findings that cDCs fully and BMDMs partially require MyD88 for S. pyogenes-induced IFN-β 
production prompted us to test the involvement of the IFN-β-inducing TLRs, namely TLR7 that 
signals via the MyD88 adaptor and the MyD88-independent TLR3. A role of TLR9 was excluded 
in our previous study and the study by Mancuso et al. [17,22]. TLR7-/- BMDMs and cDCs 
infected with S. pyogenes did not differ in their ability to generate IFN-β if compared to WT 
controls (Fig. 3A, B). Similarly, deficiency in TLR3 did not result in changes in IFN-β induction in 
S. pyogenes-infected BMDMs compared to WT cells (Fig. 3C). The role of TLR3 in cDCs has 
been ruled out previously [22]. Thus, neither TLR7 that was shown to be critically involved in 
Group B Streptococcus-induced IFN-β produced by cDCs [22] nor TLR3 could account for the 
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recognition mechanism causing IFN-β production by S. pyogenes-infected BMDMs and cDCs. 
To further characterize pathways engaged in S. pyogenes recognition we examined the function 
of the IRF3 activating kinase TBK1. Since IRF3 is essential for IFN-β generation by S. 
pyogenes-infected BMDMs but not cDCs (Fig. 2C, D) we silenced TBK1 in BMDMs using siRNA. 
This approach reduced TBK1 protein levels to approximately 20% of the non-target siRNA 
control (Fig. 3E) and resulted in a 50% drop of IFN-β (Fig. 3F). The result revealed that TBK1 
played an important role in S. pyogenes-elicited IFN-β induction in BMDMs despite the lack of 
evidence for the involvement of any upstream TLR known to signal via TBK1. TBK1 can be 
activated in a MyD88-independent way by the adaptor TRIF [10]. To examine whether the 
MyD88-independent part of S. pyogenes-induced IFN-β in BMDMs was regulated by TRIF we 
tested TRIF-/- cells. As depicted in Fig. 3D, TRIF deficiency did not result in a decrease of IFN-β 
production which was consistent with the lack of any effect of TLR3 (Fig. 3C), the TLR upstream 
of TRIF.  
Recently, the nucleotide-binding oligomerization domain (NOD) 1 and 2, two members of the 
intracellular PRRs of the nucleotide-binding domain- and leucine-rich-region-containing 
cytoplasmic receptors (known as NLRs), were unexpectedly found to be required for IFN-β 
induction under certain conditions. Binding of the NOD1 ligand, a peptide derived from bacterial 
peptidoglycan, to NOD1 in epithelial cells resulted in a TBK1-dependent production of IFN-β 
[26]. In the case of NOD2, binding of virus-derived single stranded RNA (ssRNA) to NOD2 
caused activation of IRF3 and induction of IFN-β [27]. The novel functions of NOD1 and NOD2 
prompted us to test the involvement of these PRRs in S. pyogenes-induced IFN-β. However, 
BMDMs from NOD1-/- and NOD2-/- mice produced similar amounts of IFN-β and displayed 
comparable activation of Stat1 as WT cells (Fig. S1A, B) 
Cumulatively, the MyD88-dependent production of IFN-β in response to S. pyogenes infection 
does not result from activation of TLR7, the TLR utilizing MyD88. Furthermore, the MyD88-
independent IFN-β induction in BMDMs cannot be explained by the activation of TLR3, NOD1 or 
NOD2, the PRRs employing TBK1 and IRF3 signaling for IFN-β induction despite the 
requirement of these two signaling components for IFN-β caused by S. pyogenes infection. 
 
Endosomal delivery of S. pyogenes-derived RNA and DNA activate IFN-β production in 
cDCs and BMDMs, respectively    
It is becoming increasingly clear that the recognition of nucleic acids by innate immune cell 
receptors is not limited to viral infections but appears to be a more universal way of sensing 
danger signals which may originate from viruses, bacteria or even mammalian cells [10]. The 
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response to nucleic acids by PRRs occurs either in the endosomal compartment or in the 
cytoplasm ensuring detection in both the phagosome and, in case phagosomal escape, in the 
cytoplasm. We assumed that the S. pyogenes-derived PAMPs were recognized primarily during 
phagocytosis since S. pyogenes has no intracellular life cycle, although streptolysin-mediated 
escape from phagosome to autophagosome with a short-lived cytoplasmic intermediate has 
been reported [28,29]. This assumption was supported by our findings that S. pyogenes-induced 
IFN-β is in cDCs completely and in BMDMs to 50% dependent on MyD88 signaling (Fig. 1) since 
the cytoplasmic PRRs do not signal via the MyD88 adaptor [10]. Furthermore, heat-killed S. 
pyogenes that is supposed to lack the ability to deliver bacterial products into the cytoplasm [30], 
retained, albeit in BMDMs to a lesser extent, its capacity to induce IFN-β (Fig. S2 and data not 
shown). To address the role of S. pyogenes-derived nucleic acids in the induction of IFN-β, 
extracts of sonicated S. pyogenes were treated with DNase I, RNase A, proteinase K or left 
untreated (control extract). The extracts devoid of S. pyogenes-derived DNA, RNA or protein as 
well as control extracts were delivered to the endosomes of cDCs and BMDMs using DOTAP 
that is known to be taken up together with the bound cargo by the endocytic pathway [31]. cDCs 
responded most robustly by IFN-β induction to extracts containing streptococcal RNA (Fig. 4A), 
whereas BMDMs required DNA for IFN-β induction (Fig. 4D). IFN-β induced by RNA from Group 
B Streptococcus as well as by live Group B Streptococcus was reported to be dependent in 
cDCs on TLR7 [22]. However, similar to infection with live S. pyogenes (Fig. 3) TLR7 was not 
needed for IFN-β production in response to RNA from S. pyogenes (Fig. 4A) indicating a distinct 
mode of IFN-β induction. To further substantiate the critical role of S. pyogenes-derived RNA in 
IFNβ induction by cDCs, we examined responses of IRF1-/- and MyD88-/- cells to extracts from S. 
pyogenes. The responses of cDCs to the bacterial RNA-containing extracts were reduced in 
IRF1-/- cells and completely abolished in MyD88-/- cells (Fig. 4B, C). This result virtually mirrored 
the infection of cDCs with live S. pyogenes (Fig. 2B), confirming that the extracts of S. pyogenes 
administered using DOTAP represented simplified yet still correct delivery of the S. pyogenes-
derived PAMPs to their authentic PRRs. Importantly, DOTAP-mediated delivery did not result in 
the activation of cytoplasmic nucleic acid sensors NLRs, RLRs (RIG-I, Mda5 and LGP2), DAI or 
the recently reported LRRFIP1 since these PRRs signal independently of MyD88 
[15,26,27,32,33]. This notion is of a particular relevance also for induction of IFN-β in BMDMs 
since direct delivery of Group B Streptococcus extracts containing DNA into the cytoplasm using 
lipofectamine was found to elicit IFN-β response [21]. To directly test the role of endosomes in 
the recognition of DNA from S. pyogenes we employed dynasore, an inhibitor of endocytosis 
used to assess the contribution of endosomes to various cellular responses [34,35]. 
9 
 
Pretreatment of BMDMs with dynasore inhibited the streptococcal extracts-induced IFN-β, 
confirming that the S. pyogenes–derived DNA was functionally sensed only after endosome-
mediated uptake (Fig. 4D). The finding that in BMDMs the S. pyogenes-derived DNA rather than 
RNA was the IFN-β inducer (Fig. 4C) prompted us to re-examine the function of TLR9 that is 
known to recognize, in endosome-dependent way, unmethylated DNA containing CpG motives 
frequently present in bacterial genomes. Treatment of TLR9-/- BMDMs with S. pyogenes extracts 
revealed that TLR9 did not mediate the recognition of S. pyogenes-derived DNA (Fig. 4E) 
confirming also our previous study showing no requirement for TLR9 in IFN-β induction by 
BMDMs infected with live S. pyogenes [17]. 
Together, our data reveal that bacterial RNA and DNA are key players in induction of IFN-β by 
S. pyogenes-infected cDCs and BMDMs, respectively. Although RNA and DNA were reported to 
be involved in IFN-β induction by Group B Streptococcus in cDCs and BMDMs, respectively, the 
mode of recognition and the PRRs involved are distinct for S. pyogenes-derived nucleic acids.  
 
Discussion 
Elucidating the mechanisms of pathogen recognition and the subsequent host immune response 
improves not only our understanding of the basic principles of host-pathogen interactions but 
has also practical implications for the development of new therapies of infectious diseases. 
Blockade or augmentation of the recognition process may be beneficial in cases of exacerbated 
or insufficient immune response, respectively. Agonists and antagonists of pathogen recognition 
by e.g. TLRs are currently one of the most promising therapeutic strategies [36]. Recognition of 
Gram-positive extracellular bacteria was long thought to be primarily driven by interactions 
between TLR2 and bacteria-derived LTA or lipoproteins [37]. It was therefore surprising that the 
recognition of S. pyogenes and Group B Streptococci was found to be independent of TLR2 
although both species produce TLR2 ligands [17,18,19,38,39]. In addition, both streptococcal 
species induce NF-κB-driven cytokines (e.g. TNF and IL-6) in a completely MyD88-dependent 
way employing so far unidentified receptors upstream of the essential MyD88 adaptor protein. 
Subsequently, studies by our lab and others demonstrated that both S. pyogenes and Group B 
Streptococcus were also able to induce IFN-β in innate immune cells. Despite these similarities, 
S. pyogenes and Group B Streptococcus share only about 200 out of ~2000 genes present in 
their genomes as judged by sequence comparison [40]. The homologous genes are mostly 
limited to housekeeping genes whereas the virulence factor genes are dissimilar. Hence, it is not 
surprising that S. pyogenes and Group B Streptococcus cause different set of infectious 
diseases [40]. S. pyogenes causes an exceptionally wide range of diseases and is regarded as 
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one of the most versatile pathogens known. Genetic data support the hypothesis that the 
responses of the host innate immune system contribute to the morbidity and diversity of the S. 
pyogenes-caused diseases [5,6,7]. Type I IFNs belong to the most potent modulators of the host 
response during the initial phase of infection that is controlled largely by the innate immune 
system [41]. The so far unknown role of type I IFNs in a relevant model for infection with S. 
pyogenes and the detailed mechanism of IFN-β induction in BMDMs and cDCs were for the first 
time addressed in this study.  
We provide evidence that type I IFN signaling is required for survival of mice challenged with S. 
pyogenes in a model for invasive subcutaneous infection. This finding should stimulate clinical 
research in this area since no epidemiology data on type I IFN production and responses in 
patients are available to date. During the innate immune system-controlled phase of infection 
type I IFNs, which are produced directly by cells encountering the pathogen, regulate in multiple 
ways the host response. They increase chemokine expression at the site of infection and 
thereby promote recruitment of effector cells such as neutrophils [42]. Type I IFNs influence also 
cell autonomous functions of immune cells by e.g. regulating anti-microbial products or 
controlling cell death [23]. These issues should be addressed in future studies of S. pyogenes-
caused infections.  
In bacterial infections the type I IFN-producing cells are predominantly macrophages and cDCs 
rather than plasmacytoid DCs [22,43]. In our study we therefore focused on macrophages and 
cDCs which were also previously shown to be crucial cell types for successful defense of mice 
against S. pyogenes infection [8,9]. We examined IFN-β production since this IFN is the first type 
I IFN to be synthesized during infections, and it drives the expression of other type I IFN species 
[44]. BMDMs and cDCs displayed common as well as unique features with regard to the 
induction of IFN-β. In both cell types MyD88 fulfilled an important role although in BMDMs about 
one half of the generated IFN-β was independent of MyD88. In cDCs the complete dependence 
on MyD88 was accompanied with a key function of IRF1 which was consistent with the current 
view of the IFN-β-inducing pathway positioning IRF1, IRF5 and IRF7 downstream of MyD88 [10]. 
However, the canonical MyD88/IRF axis is triggered by TLR7 or TLR9 which were ruled out as 
the S. pyogenes-sensing TLRs in cDCs in this and a previous study [22]. The involvement of 
TLR8, the only IFN-β-inducing MyD88-dependent TLR not experimentally tested by us, is 
unlikely since TLR8 may not be functional in the mouse as suggested by complete lack of TLR7-
deficient mice to respond to R-848 and ssRNA commonly used as TLR7 and TLR8 agonists in 
human cells [10,45]. Thus, the identity of the PRR responsible for triggering the MyD88/IRF 
pathway in response of cDCs to S. pyogenes remains to be determined.  
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In BMDMs, about half of the induced IFN-β was MyD88-independent yet it fully required IRF3, 
and the IRF3 kinase TBK1 was also critically involved. TBK1/IRF3 can be activated by TLR3 and 
TLR4 via the adaptor TRIF rather than MyD88. Our data demonstrate that TRIF-deficient cells 
respond normally to S. pyogenes suggesting that TLR3 and TLR4 were not the upstream 
activators of the TBK1/IRF3 module. We confirmed this conclusion by the analysis of TLR3-/- 
BMDMs. TLR4 was disqualified already in our previous study [17]. For the MyD88-dependent 
IFN-β production we could exclude also the involvement of TLR7 (this study) and TLR9 [17]. 
Thus, both the MyD88-dependent and -independent IFN-β production is induced by S. pyogenes 
independently of TLRs. TBK1/IRF3 can be activated by various cytoplasmic sensors [10]. The 
signaling by these cytoplasmic PRRs does not require MyD88 so that only the MyD88-
independent part of IFN-β induction could be potentially explained by these molecules. Our 
experiments using BMDMs deficient in NOD1 and NOD2, two cytoplasmic PRRs recently shown 
to activate the TBK1/IRF3 pathway [26,27] and known to recognize peptidoglycan from both 
Gram-positive and –negative bacteria [46], ruled out the role of these PRRs in S. pyogenes-
induced IFN-β induction.  
The nature of the IFN-β-inducing bacterial product was tested by delivering complete S. 
pyogenes extracts or extracts depleted of DNA, RNA or protein to the endosomes. The 
endosomal delivery was justified by the fact that IFN-β production in S. pyogenes-infected cells 
was reduced by the endocytosis inhibitor dynasore. Our data showing S. pyogenes-derived RNA 
as the principle IFN-β inducer in cDCs are consistent with a model wherein the S. pyogenes-
derived RNA is liberated from the bacterial cells upon phagocytosis. The bacterial RNA is then 
sensed by an endosomal receptor that triggers the IFN-β-inducing MyD88/IRF pathway. This 
model is further supported by our findings that in cDCs signaling by the S. pyogenes extracts 
was dependent on MyD88 and IRF1 thereby fully recapitulating signaling upon infection with live 
bacteria. Thus, we could rule out DOTAP-mediated misguiding of bacterial RNA to the 
cytoplasm where it could generate artificial IFN response due to the activation of cytoplasmic i.e. 
MyD88-independent PRRs. Thus, a signaling from cytoplasmic PRRs is not the dominant mode 
of IFN-β induction in cDCs infected with S. pyogenes. Bacterial RNA as the endosomal inducer 
of IFN-β in cDCs has been proposed for Group B Streptococcus [22]. However, S. pyogenes 
and Group B Streptococcus differ in terms of their requirement for TLR7 that is needed for 
sensing Group B Streptococcus but not S. pyogenes. Thus, the still unknown endosomal PRR 
for S. pyogenes-derived PAMPs and the PRR for Group B Streptococcus are different despite 
sharing same signaling components downstream of the receptors. In BMDMs the IFN-β-inducing 
S. pyogenes extracts required the presence of bacterial DNA rather than RNA. Since DOTAP 
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delivers to the endosomal compartment and taking into account that lack of any effect of TLR9 
we conclude that an endosomal PRR distinct from TLR9 is able to detect DNA from S. 
pyogenes. This PRR signals via TBK1 and IRF3 in a partially MyD88-dependent way. 
Comparison with Group B Streptococcus-induced IFN-β by BMDMs reveals some parallels but 
also important differences [21]. Both pathogens signal via bacterial DNA and employ the 
TBK1/IRF3 pathway. For Group B Streptococcus it was proposed that the bacterial DNA 
escapes in a pore-forming-toxin-dependent way from the phagosomes into the cytoplasm of 
infected cells where it is sensed by an unknown IFN-β-inducing PRR. However, the production 
of IFN-β was independent of MyD88 and required live bacteria, which is in marked difference to 
S. pyogenes. Currently, we cannot rule out that the MyD88-independent part of S. pyogenes-
induced IFN-β is caused by bacterial products liberated from the phagosome to the cytoplasmic 
PRRs. However, we do not favor this hypothesis since S. pyogenes lacking both pore-forming 
streptolysins SLO and SLS was still able to activate type I IFN signaling in BMDMs [17].  
This study delineates the importance of type I IFN induction by innate immune cells for 
successful defense against S. pyogenes. In a similar infection model, MyD88 was recently found 
to be required for full blown immune response and survival [20]. Since our data reveal that 
MyD88 plays a critical role in the induction of IFN-β it appears conceivable that the decreased 
IFN-β production contributed to the high susceptibility of MyD88-deficient mice to the infection. 
The comparison of BMDMs and cDCs revealed different mechanism of IFN-β induction. Both cell 
types employ unknown endosomal nucleic acid-sensing PRRs for IFN-β induction. It is striking 
that the PRRs required for the NF-κB-driven induction of TNF and IL-6 in S. pyogenes-infected 
BMDMs and cDCs have so far also not been identified [17,18]. Thus, in general, it appears that 
S. pyogenes evolved mechanisms allowing this pathogen to avoid the standard set of pathogen 
sensing molecules. This strategy may not be unique since Group B Streptococcus-induced TNF 
and IL-6 production is also independent of the typical PRRs for bacteria [38]. It remains to be 
elucidated whether other extracellular Gram-positive bacteria display similar properties. This 
study and other recently published reports [17,18,22] clearly demonstrate that innate immune 
cells posses yet not well understood backup strategies for a highly efficient TLR-independent 
detection of bacteria such as S. pyogenes.  
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Materials and Methods 
 
Bacterial strains and culture 
The Streptococcus pyogenes serotype M1 strain ISS 3348 (provided by Roberta Creti, Instituto 
Superiore di Sanita, Italy) was used for in vitro as well for in vivo experiments [47]. Bacteria were 
grown at 37 °C with 5% CO2 without agitation in Todd-Hewitt-Broth (BD Biosciences) 
supplemented with 0.2% yeast extract and on tryptic soy agar supplemented with 3% 
defibrinogated sheep blood. Bacterial cell growth was turbidimetrically monitored at 620 nm with 
a microplate reader until mid-log phase was reached. For preparation of heat-killed Streptococci, 
bacteria were grown to mid-log phase, washed twice with sterile PBS and incubated for 20 min 
at 70° C in a water bath.  
 
Mice 
IFNAR1-/-, MyD88-/-, IRF1-/-, IRF3-/-, TLR3-/-, TLR7-/-, TRIF-/- , TLR9-/- mice on C57BL/6 
background were housed under specific pathogen-free conditions. C57BL/6 WT mice were 
purchased from Charles River Laboratories. 
 
Experimental model of S. pyogenes infection 
Age- and sex-matched, pathogen free, 8-10 week old WT and IFNAR1-/- mice (all C57BL/6) were 
used in all experiments. S. pyogenes strain ISS 3348 was grown for 5 hours to mid-logarithmic 
phase at 37°C using Todd-Hewitt-Broth (BD Biosciences), harvested by centrifugation at 6.500 
rpm for 8 min, and washed twice in sterile isotonic saline. Bacteria were then resuspended at a 
concentration of 3x108 CFU per 50 µl as determined by plating serial 10-fold dilutions on sheep 
blood agar plates (Biomerieux). Mice were lightly anesthetized by inhalation of isoflurane 
(Baxter) and the fur at the flank was partially removed by shaving. The inoculum was injected 
subcutaneously in one flank of each mouse. Survival of mice was monitored every 4 - 8 hours. 
All experiments were approved by the Animal Care and Use Committee of the Medical 
University of Vienna and the Ministry of Science through the permission BMWF-66.009/0031-
II/10b/2008. Survival curves were analyzed by the Logrank Test in GraphPad Prism 4 
(GraphPad Software). All data are presented as mean SD. Comparison between two groups 
was performed using t-test. P values ≤ 0.05 were considered as significant. 
 
Cell culture 
Primary bone-marrow derived macrophages (BMDMs) and conventional dendritic cells (cDCs) 
were obtained from the femur and tibia bone-marrow of 6-10-week old mice (all C57BL/6). 
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Macrophages were cultivated in Dulbecco´s modified Eagle´s medium (DMEM) supplemented 
with 10% fetal calf serum (GIBCO) in the presence of L929-cell derived CSF-1, as described 
[17]. Dendritic cells were cultivated in DMEM supplemented with 10% fetal calf serum in the 
presence of X-6310 cell derived GM-CSF as described [48].  
 
S. pyogenes infection in vitro  
For infection assays, BMDMs and cDCs were seeded on 6-cm dishes (2 x 106 cells/ dish) in 
DMEM containing 10% FCS and L-cell-derived CSF-1 or X-6310 cell derived GM-CSF, 
respectively, without antibiotics. The cells were then infected as described previously [17]. In 
experiments with heat-killed S. pyogenes equal amounts of heat-killed and live bacteria (MOI 
100) were used for infection. Infections under conditions of blocked endocytosis were performed 
by pretreatment of cells with dynasore (Sigma-Aldrich, 80 µM) for 45 min prior to infection with 
S. pyogenes. 
 
Preparation and transfection of S. pyogenes extracts 
S. pyogenes was grown to OD620=0.3 and 5 mL aliquots of the bacterial suspensions were spun 
at 6.500 rpm for 8 min. The bacteria were resuspended in 400 μL sterile PBS followed by 
disruption using the Bandelin Sonopuls GM70 sonicator for 3 × 2 min. Remaining debris was 
removed by centrifugation at 13.200 rpm for 15 min at 4°C. The supernatants were pooled, 
adjusted to contain 2mM MgCl2, 50 mM KCl and 20mM Tris-HCl (pH 8) and divided into four 
aliquots. The same was done with sterile PBS for the reagent control. Remaining extract was 
frozen at -20 °C for later usage. Aliquots were digested with DNase I (Roche, 100U/mL), RNase 
A (Roche, 333 µg/mL) or proteinase K (Sigma-Aldrich, 1mg/mL) or left-untreated (control 
extract). Extracts treated with either DNase I or RNase A were incubated at 37 °C for 45 min, 
extracts digested with proteinase K were incubated for 1 hour at 37 °C. After incubation, EGTA 
for proteinase K (final 2 mM) treatment or EDTA (pH 8, final 2.5 mM) for DNase I and RNase A 
treatment were added to extracts. In case of the reagent control and control extract, both EGTA 
and EDTA were used. The extracts were then incubated at 70 °C for 10 min and centrifuged for 
5 min at 13.200 rpm at 4 °C. Supernatants were collected and subsequently frozen at -20 °C 
until usage. 10 µl of these extracts were then allowed to form complexes with DOTAP (Roche) 
and transfected according to the manufacturer´s instructions. 
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Cytokine measurement  
 IFN-β in supernatants of infected macrophages and dendritic cells was measured by ELISA 
using the VeriKine Mouse Interferon Beta Kit (PBL Biomedical Laboratories), according to the 
manufacturer´s instructions. Samples were applied undiluted. 
 
Antibodies 
Antibodies to Tyr701-phosphorylated Stat1 (pY701-S1) and TBK1 were purchased from Cell 
Signalling. The antibody against p38 MAPK was purchased from Santa Cruz Biotechnology. The 
antibody to Stat1-C-terminus was previously described [49].  
 
Western blot analysis  
After treatment, whole cell extracts were prepared and assayed by Western blotting as 
described previously [49]. Detection and quantification of signals were performed using the 
infrared imaging system Odyssey (LI-COR Biosciences) using fluorophore-linked secondary 
antibodies (Molecular Probes and Rockland). 
 
Quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated using Trizol® LS reagent (Invitrogen). Reverse transcription of total RNA 
was performed using oligo (dT)18 as primer and Mu-MLV reverse transcriptase (Fermentas) and 
the cDNA was subsequently used to amplify SOCS1 by qRT-PCR. qRT-PCR was run on iCycler 
(BioRad). For SOCS1 the Quantitect ®Primer Assay (QIAGEN) was used. For HPRT, the 
housekeeping gene for normalization, the following primers were used: HPRT-fwd 5’-
GGATTTGAATCACGTTTGTGTCAT-3’, and HPRT-rev 5’-ACACCTGCTAATTTTACTGGCAA-3’. 
Amplification of DNA was monitored by SYBR Green (Molecular Probes) [50]. 
 
siRNA–mediated silencing 
BMDMs were seeded on 6-cm dishes (2 x 106 cells) in DMEM containing 10 % FCS and L-cell-
derived CSF-1 without antibiotics. Mouse TBK1 (ON-TARGETplus, Dharmacon) siRNA (6 pmol) 
or a non-target control-siRNA were mixed with Opti-MEM I reduced serum medium (GIBCO) and 
transfected into BMDMs using Lipofectamine RNAiMAX (Invitrogen) according to the 
manufacturer´s instructions. 48 hrs after transfection, medium was replaced by medium without 
siRNA. After additional 24 hrs cells were infected with S. pyogenes (MOI=100) as described 
[17].  
 
16 
 
Acknowledgements 
We thank Shizuo Akira for the permission to use MyD88-/-, TLR3-/-, TLR7-/- , TLR9-/- and TRIF-/- 
mice. We thank Roberta Creti and Giuseppe Teti for providing bacterial strains, and Ivo Boneca 
for providing bone marrow from NOD1-/- and NOD2-/- mice. We appreciate the help of Birgit Rapp 
with bacterial cultures.  
 
 
 
References 
1. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. 
Lancet Infect Dis 3: 191-200. 
2. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, et al. (2007) The 
epidemiology of invasive group A streptococcal infection and potential vaccine 
implications: United States, 2000-2004. Clin Infect Dis 45: 853-862. 
3. Randall J. Olsen SASJMM (2009) Molecular mechanisms underlying group A streptococcal 
pathogenesis. Cellular Microbiology 11: 1-12. 
4. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, et al. (2009) Clinical and 
Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe. J 
Clin Microbiol. 
5. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, et al. (2002) An 
immunogenetic and molecular basis for differences in outcomes of invasive group A 
streptococcal infections. Nat Med 8: 1398-1404. 
6. Kotb M, Norrby-Teglund A, McGeer A, Green K, Low DE (2003) Association of human 
leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. 
Scand J Infect Dis 35: 665-669. 
7. Goldmann O, Lengeling A, Bose J, Bloecker H, Geffers R, et al. (2005) The role of the MHC 
on resistance to group a streptococci in mice. J Immunol 175: 3862-3872. 
8. Goldmann O, Rohde M, Chhatwal GS, Medina E (2004) Role of macrophages in host 
resistance to group A streptococci. Infect Immun 72: 2956-2963. 
9. Loof TG, Rohde M, Chhatwal GS, Jung S, Medina E (2007) The contribution of dendritic cells 
to host defenses against Streptococcus pyogenes. J Infect Dis 196: 1794-1803. 
10. Kawai T, Akira S The role of pattern-recognition receptors in innate immunity: update on Toll-
like receptors. (2010) Nat Immunol 11: 373-384. 
17 
 
11. O'Neill LA (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of 
progress. Immunol Rev 226: 10-18. 
12. McGettrick AF, O'Neill LA (2010) Localisation and trafficking of Toll-like receptors: an 
important mode of regulation. Curr Opin Immunol 22: 20-27. 
13. Kagan JC, Su T, Horng T, Chow A, Akira S, et al. (2008) TRAM couples endocytosis of Toll-
like receptor 4 to the induction of interferon-beta. Nat Immunol. 
14. Barbalat R, Lau L, Locksley RM, Barton GM (2009) Toll-like receptor 2 on inflammatory 
monocytes induces type I interferon in response to viral but not bacterial ligands. Nat 
Immunol 10: 1200-1207. 
15. Yang P, An H, Liu X, Wen M, Zheng Y, et al. (2010) The cytosolic nucleic acid sensor 
LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent 
pathway. Nat Immunol 11: 487-494. 
16. Ting JP, Duncan JA, Lei Y (2010) How the noninflammasome NLRs function in the innate 
immune system. Science 327: 286-290. 
17. Gratz N, Siller M, Schaljo B, Pirzada ZA, Gattermeier I, et al. (2008) Group A Streptococcus 
Activates Type I Interferon Production and MyD88-dependent Signaling without 
Involvement of TLR2, TLR4, and TLR9. J Biol Chem 283: 19879-19887. 
18. Loof TG, Goldmann O, Medina E (2008) Immune recognition of Streptococcus pyogenes by 
dendritic cells. Infect Immun. 
19. Courtney HS, Ofek I, Penfound T, Nizet V, Pence MA, et al. (2009) Relationship between 
expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm 
formation in Streptococcus pyogenes. PLoS ONE 4: e4166. 
20. Loof TG, Goldmann O, Gessner A, Herwald H, Medina E (2009) Aberrant Inflammatory 
Response to Streptococcus pyogenes in Mice Lacking Myeloid Differentiation Factor 88. 
Am J Pathol. 
21. Charrel-Dennis M, Latz E, Halmen KA, Trieu-Cuot P, Fitzgerald KA, et al. (2008) TLR-
independent type I interferon induction in response to an extracellular bacterial pathogen 
via intracellular recognition of its DNA. Cell Host Microbe 4: 543-554. 
22. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, et al. (2009) Bacterial 
recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol. 
23. Decker T, Muller M, Stockinger S (2005) The yin and yang of type I interferon activity in 
bacterial infection. Nat Rev Immunol 5: 675-687. 
24. Medina E Murine model of cutaneous infection with Streptococcus pyogenes. (2010) 
Methods Mol Biol 602: 395-403. 
18 
 
25. Sahay B, Patsey RL, Eggers CH, Salazar JC, Radolf JD, et al. (2009) CD14 signaling 
restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent 
tolerance. PLoS Pathog 5: e1000687. 
26. Watanabe T, Asano N, Fichtner-Feigl S, Gorelick PL, Tsuji Y, et al. (2010) NOD1 contributes 
to mouse host defense against Helicobacter pylori via induction of type I IFN and 
activation of the ISGF3 signaling pathway. J Clin Invest. 
27. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, et al. (2009) Activation of innate 
immune antiviral responses by Nod2. Nat Immunol 10: 1073-1080. 
28. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, et al. (2004) Autophagy 
defends cells against invading group A Streptococcus. Science 306: 1037-1040. 
29. Yamaguchi H, Nakagawa I, Yamamoto A, Amano A, Noda T, et al. (2009) An initial step of 
GAS-containing autophagosome-like vacuoles formation requires Rab7. PLoS Pathog 5: 
e1000670. 
30. Harder J, Franchi L, Munoz-Planillo R, Park JH, Reimer T, et al. (2009) Activation of the 
Nlrp3 Inflammasome by Streptococcus pyogenes Requires Streptolysin O and NF-
{kappa}B Activation but Proceeds Independently of TLR Signaling and P2X7 Receptor. J 
Immunol. 
31. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ (1995) Cellular and 
molecular barriers to gene transfer by a cationic lipid. J Biol Chem 270: 18997-19007. 
32. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, et al. (2007) DAI (DLM-1/ZBP1) is a 
cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505. 
33. Yoneyama M, Fujita T (2008) Structural mechanism of RNA recognition by the RIG-I-like 
receptors. Immunity 29: 178-181. 
34. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a cell-
permeable inhibitor of dynamin. Dev Cell 10: 839-850. 
35. Stetson DB, Medzhitov R (2006) Recognition of Cytosolic DNA Activates an IRF3-
Dependent Innate Immune Response. Immunity 24: 93-103. 
36. Kanzler H, Barrat FJ, Hessel EM, Coffman RL (2007) Therapeutic targeting of innate 
immunity with Toll-like receptor agonists and antagonists. Nat Med 13: 552-559. 
37. Draing C, Sigel S, Deininger S, Traub S, Munke R, et al. (2008) Cytokine induction by Gram-
positive bacteria. Immunobiology 213: 285-296. 
38. Henneke P, Takeuchi O, Malley R, Lien E, Ingalls RR, et al. (2002) Cellular activation, 
phagocytosis, and bactericidal activity against group B streptococcus involve parallel 
myeloid differentiation factor 88-dependent and independent signaling pathways. J 
Immunol 169: 3970-3977. 
19 
 
39. Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, et al. (2008) Lipoproteins are 
critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180: 6149-
6158. 
40. Mitchell TJ (2003) The pathogenesis of streptococcal infections: from tooth decay to 
meningitis. Nat Rev Microbiol 1: 219-230. 
41. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in 
immunity and autoimmunity. Annu Rev Immunol 23: 307-336. 
42. Kelly-Scumpia KM, Scumpia PO, Delano MJ, Weinstein JS, Cuenca AG, et al. (2010) Type I 
interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial 
sepsis by regulating CXCL10. J Exp Med. 
43. Stockinger S, Kastner R, Kernbauer E, Pilz A, Westermayer S, et al. (2009) Characterization 
of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS 
Pathog 5: e1000355. 
44. Levy DE, Marie I, Prakash A (2003) Ringing the interferon alarm: differential regulation of 
gene expression at the interface between innate and adaptive immunity. Curr Opin 
Immunol 15: 52-58. 
45. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, et al. (2002) Small anti-viral compounds 
activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 
3: 196-200. 
46. Boneca IG (2005) The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 8: 46-53. 
47. Mora M, Bensi G, Capo S, Falugi F, Zingaretti C, et al. (2005) Group A Streptococcus 
produce pilus-like structures containing protective antigens and Lancefield T antigens. 
Proc Natl Acad Sci U S A 102: 15641-15646. 
48. Reutterer B, Stockinger S, Pilz A, Soulat D, Kastner R, et al. (2008) Type I IFN are host 
modulators of strain-specific Listeria monocytogenes virulence. Cell Microbiol 10: 1116-
1129. 
49. Kovarik P, Stoiber D, Novy M, Decker T (1998) Stat1 combines signals derived from IFN-
gamma and LPS receptors during macrophage activation [published erratum appears in 
EMBO J 1998 Jul 15;17(14):4210]. Embo J 17: 3660-3668. 
50. Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of low-copy transcripts by 
continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-958, 
960, 962. 
 
 
 
20 
 
Figure Legends 
 
Figure 1. Type I IFNs are required for efficient host immune response against S. pyogenes 
and MyD88 plays a key role in type I IFN production.  
(A) Kaplan-Meier survival curves of C57BL/6 and IFNAR1-/- mice (15 mice per genotype) after 
subcutaneous infection with 3x108 CFU of S. pyogenes. Survival was monitored for 6 days. 
Significance: ** = P value < 0.01. (B, C) IFN-β production is in BMDMs partially (B) and cDCs 
completely (C) dependent on MyD88. Cells from wild-type (WT) and MyD88-/- mice were infected 
with S. pyogenes (MOI100) or left untreated. After indicated periods, supernatants were 
collected and IFN-β release was measured by ELISA. Values represent mean ± SD; n = 3. (D, 
E) MyD88 deficiency results in stronger Stat1 activation and reduced SOCS1 expression in 
response to S. pyogenes. Control (WT) and MyD88-/- BMDMs were infected with S. pyogenes 
(MOI100) or left untreated. At indicated time-points, either whole cell extracts were prepared or 
total mRNA was extracted. In (D), Stat1 activation was determined by Western blotting using 
antibody to phosphorylated Stat1 (pY-S1). For loading control the membrane was reprobed 
using antibodies to total Stat1 (Stat1) and p38MAPK (p38). Note the double band on the pY-S1 
blot represents the phosphorylated forms of both Stat1 splicing isoforms Stat1-α and Stat1-β. 
Loading control (Stat1) was performed with an antibody directed to the C-terminus of Stat1, 
which is absent in the Stat1-β isoform. In (E), total RNA was reverse-transcribed and analyzed 
by qRT-PCR for SOCS1 expression. For normalization expression of the house-keeping gene 
HPRT was measured. These data represent one of at least three independent infection 
experiments with different mice from each genotype. 
 
Figure 2. BMDMs and cDCs differ in their requirements for IRF1 and IRF3 in S. pyogenes-
induced IFN-β production.  
BMDMs from IRF1-/- (A) and IRF3-/- (C) mice or cDCs derived from IRF1-/- (B) and IRF3-/- (D) (as 
well as control mice (WT) were infected with S. pyogenes (MOI100) or left untreated. At 
indicated time-points, supernatants were collected and IFN-β release was measured by ELISA. 
The data represent at least three independent infection experiments. SDs (n ≥ 3) are shown. 
 
Figure 3. S. pyogenes-mediated induction of IFN-β occurs independently of TLR3, TLR7 
or TRIF and in BMDMs requires TBK1.  
BMDMs (A) and cDCs (B) and from control (WT) and TLR7-/- mice or BMDMs from control (WT), 
TLR3-/- (C) and TRIF-/- (D) mice were infected with S. pyogenes (MOI100) for the indicated 
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periods or left untreated. Supernatants were collected and IFN-β release was measured by 
ELISA. The data represent at least three independent infection experiments. SDs (n ≥ 3) are 
shown. (E, F) BMDMs were transfected with siRNA specific for TBK1 or non-target control 
siRNA. siRNA-treated cells were then infected with S. pyogenes (MOI 100) or left uninfected. At 
indicated time-points, whole-cell extracts were prepared and supernatants were collected. In (E), 
silencing of TBK1 was controlled by Western Blot using an antibody against TBK1. Equal 
loading was determined by re-probing the membrane with an antibody to p38 MAPK. In (F), IFN-
β production was measured using ELISA. The data represent one of at least three independent 
experiments. 
 
Figure 4. S. pyogenes-derived RNA and DNA delivered to endosomes induce IFN-β in 
cDCs and BMDMs, respectively.  
S. pyogenes cells were sonicated and treated with either DNase I, RNase A, Proteinase K or left 
untreated (control extract). These extracts and a reagent control were delivered into cDCs 
derived from control (WT), TLR7-/- (A), IRF1-/- (B) or MyD88-/- (C) mice using DOTAP. After 
stimulation for 6 h supernatants were collected and IFN-β release was measured using ELISA. 
(D) S. pyogenes extracts were delivered into BMDMs pretreated (for 45 min) or untreated with 
dynasore. After stimulation for 8 h supernatants were collected and IFN-β production was 
measured using ELISA. Values represent mean ± SD; n = 3. (E) BMDMs from control (WT) and 
TLR9-/- mice were transfected with streptococcal extracts using DOTAP and after 8 h 
supernatants were collected for IFN-β measurements by ELISA. Values represent mean ± SD; n 
= 3. 
 
Supporting Information  
 
Figure legends 
 
Figure S1. NOD1 and NOD2 are not required for IFN-β induction by S. pyogenes.  
BMDMs from control (WT), NOD1-/- or NOD2-/- mice were infected with S. pyogenes (MOI100) 
and after indicated time-points whole cell extracts were prepared and supernatants were 
collected. In (A), Stat1 activation was determined by Western blotting using an antibody to 
phosphorylated Stat1 (pY-S1) and total Stat1 (Stat1). In (B), IFN-β release after 6 h of infection 
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was measured in three independent infection experiments using ELISA. Values represent mean 
± SD; n = 3. 
 
Figure S2. Heat-killed S. pyogenes causes induction of IFN-β in BMDMs. 
BMDMs were infected with equal amounts of live and heat-killed S. pyogenes (MOI100) or left 
untreated. After 4 and 6 h, supernatants were collected and IFN-β release was measured using 
ELISA. Mean ± SD; n = 3.  
 
Supporting information Figures  
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5.3. Unpublished Data 
 
5.3.1. NOD-Proteins are not involved in the Recognition of S. pyogenes by 
BMDMs 
Besides Toll-like receptors (TLRs), nucleotide-binding oligomerization domain (NOD)-like receptors 
(NLRs) are known to be important pattern recognition receptors (PRRs). Among them, NOD1 and 
NOD2 are the best understood members of this family and have been shown to be important sensors 
of bacterial infection in the cytoplasm. 
To assess the role of these two proteins during streptococcal infection, bone marrow derived-
macrophages (BMDMs) from wild-type mice and mice deficient for NOD1 or NOD2 were infected 
with S. pyogenes with a multiplicity of infection (MOI) of 100.  
After indicated time-points, whole cell extracts for Western blot were prepared and supernatants 
were taken for subsequent ELISA analysis. The activation of p38 and Stat1 as well as the production 
of TNF-α and interferon-β (IFN-β) served as read-out for the induction of an inflammatory response 
against S. pyogenes in these macrophages. 
 
 
 
Figure 5: BMDMs from NOD1 and NOD2-deficient mice display normal response to infection with S. 
pyogenes BMDMs derived from NOD1-and NOD2-deficient and wild-type (WT) mice were infected with S. 
pyogenes (EC700, MOI 100) or left untreated. At indicated time-points, supernatants were collected and whole 
cell extracts were prepared. (A) Activation of p38 MAPK (p-p38) and (C) activation of Stat1 (S1-pY) were 
analyzed by Western Blot. Equal loading was determined by re-probing the membrane with an antibody 
specific for (A) total p38 or (C) to the C-terminus of Stat1. TNF-α (B) and interferon-β (D) production was 
measured by ELISA. 
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Infection of NOD1-, NOD2- deficient BMDMs with S. pyogenes led to the activation of p38 (p-p38) 
similar to wild-type macrophages. TNF-α production was also observed in both, NOD1- and NOD2-
deficient macrophages as well as in wild-type macrophages.  
IFN-β production after 6 hours of infection with S. pyogenes was detectable in wild-type, NOD1- and 
NOD2- deficient macrophages. The levels of IFN-β were higher in the NOD1- and NOD2-deficient 
macrophages compared to the wild-type ones. 
These results indicate that NOD1 and NOD2, which are known to be important bacterial sensors 
within the cytoplasm, are not involved in the sensing and the induction of an immune response 
against S. pyogenes. 
 
 
5.3.2. Streptococcal RNA induces TNF-α Production 
The receptor molecule(s), which are inducing the inflammatory response against S. pyogenes, are not 
known yet. We wanted to address the question for the receptor of S. pyogenes not only by analyzing 
the host side, but also the pathogen site.  
Therefore it was decided to use bacterial fractions in order to elucidate possible ligands recognized 
by macrophages. For this purpose, Streptococci grown to mid-log phase were sonicated and 
subsequently treated with DNase I, Proteinase K, RNase A or the combination of them. These 
fractions were then transfected into wild-type BMDMs using the transfection reagent DOTAP. This 
reagent is used for the transfer of negatively charged molecules (e.g. RNA, oligonucleotides, proteins) 
into cells by the engagement of the endosome/lysosome system (137) (138). DOTAP-mediated 
transfection of the control extract (i.e. sonicated S. pyogenes), the DNase I-, the Proteinase K- and a 
double-treated extract (DNase I and Proteinase K) led to the production of TNF-α, whereas 
macrophages transfected with RNase A-treated extracts did not show any TNF-α production. This 
was also observed when double-treated extracts (i.e. DNase I and RNase A or RNase A and Proteinase 
K) were used for transfection. Stimulation with heat-killed streptococci led to induction of TNF-α, 
which was higher than TNF-α levels obtained with transfection. Contamination of the buffers or 
DOTAP was excluded, since the reagent control did not induce any observable TNF-α production. 
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Figure 6: TNF-alpha production requires the presence of streptococcal RNA in the bacterial extracts 
Streptococcal fractions were treated with either RNase A, DNase I, Proteinase K or combinations of them or left 
untreated (control extract). The fractions and a reagent control were transfected into wild-type BMDMs using 
DOTAP. Heat-killed bacteria served also as a control and were applied directly to the BMDMs. After 8 hours, 
supernatants were collected and TNF-α secretion was measured using ELISA. 
 
 
These data suggest that streptococcal RNA is the ligand for a yet unknown receptor which is inducing 
an inflammatory response against S. pyogenes. Since this finding is only observable for extracts 
complexed with DOTAP that is known to deliver complexed material mainly into the 
endosome/lysosome system, and not when the extracts are directly added to the cells (data not 
shown), it is very likely that the streptococcal RNA is recognized by a pattern recognition receptor 
(PRR) within the endosome. However, using this method, one cannot exclude the possibility that 
parts of the bacterium enter compartments of the cells which cannot be reached during normal 
infection. Further, sonication of bacteria may also expose parts of the bacteria normally not 
accessible for recognition by cells of the innate immune system. 
 
 
5.3.3. Strain Comparison 
During in vivo challenges of mice with S. pyogenes, we realized that the ATCC 700294 strain (for 
simplicity EC700) was inducing lesions at the site of infection, but was not able to cause a lethal 
infection. The ISS 3348 strain (3348), which is like EC700 a streptococcal M1-serotype, was shown to 
be more virulent and was therefore chosen for the subsequent experiments (81). 
Pilot-experiments revealed that the 3348 strain had a higher capacity to kill mice compared to EC700 
(data not shown). Both strains share the same streptococcal M-type, namely M1, which is among the 
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most prevalent ones in terms of involvement in severe invasive diseases in humans (139). This finding 
raised the question, why the 3348-strain is more efficient in killing infected mice. 
On that account, we wanted to compare these two strains for their ability to induce proinflammatory 
responses in BMDMs. 
 
 
Figure 7: Two Streptococcal strains of the same M1-serotype induce different levels of inflammatory 
cytokines BMDMs were infected with either the S. pyogenes EC700 or the 3348 strain. At indicated time-
points, whole cell extracts for Western Blot analysis were prepared and cell-culture supernatants were 
collected. (A) Activation of p38 MAPK (p-p38) and (B) activation of Stat1 (S1-pY) were analyzed using Western 
Blot. Equal loading was determined by re-probing the membrane with an antibody specific for (A) total p38 or 
to (B) the C-terminus of Stat1. TNF-α (C) and IFN-β (D) secretion was measured using ELISA. 
 
 
Analysis of activation of the p38 MAPK using an antibody specific for the phosphorylated and 
therefore activated form of p38 revealed that both strains (EC700 and 3348) were able to induce 
similar activation of p38 MAPK in infected macrophages (Fig. 7, A). 
The Stat1 phosphorylation at tyrosine 701, which serves as a read-out for activation of the JAK/STAT 
signaling pathway, was also observable, but in response to 3348, the phosphorylation was strongly 
reduced compared to the EC700 strain (Fig.7, B).The production of TNF-α and IFN-β induced by 3348 
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was much lower compared to EC700 (Fig. 7, C and D). The lower IFN-β production is consistent with 
the reduced Stat1 activation in 3348-infected BMDMs. 
We thus conclude that the EC700 strain is a more potent activator of inflammatory responses in 
macrophages than the 3348 strain. The molecular reasons why these two strains differ in regard to 
the induction of proinflammatory cytokines and type I IFNs are not known yet. Therefore, it would be 
valuable to gain further information about the microbial features of these two streptococcal strains. 
For example, analysis of differences in the expression of virulence factors such as capsule, 
Streptolysins or analysis of cell wall composition would be important. 
 
 
5.3.4. Heat-killed Streptococci 
In this part we wanted to investigate, if induction of innate immune responses by S. pyogenes is 
dependent on living bacteria, which would suggest that the streptococcal ligand sensed by 
macrophages has to be actively secreted by the bacterium. Therefore heat-killed with living 
Streptococci were compared for their ability to induce TNF-α and IFN-β production, since these are 
the two major cytokines that have been shown to be produced in response to by S. pyogenes.  
Bacteria were grown to mid-log phase, washed with PBS and were then heat-inactivated for 20 
minutes at 70 °C. Equal amounts of living and heat-killed bacteria were then applied to macrophages 
(MOI 100). We analyzed the induction of immune responses in macrophages by heat-killed bacteria 
from both, the EC700 and the 3348 strain, since we were able to observe differences in the potential 
to activate inflammatory responses by living EC700 and 3348 (see results 5.3.3.).  
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Figure 8: Heat-killed Streptococci induce production of TNF-α  
BMDMs were infected with equal amounts (MOI 100) of living or heat-killed (HK) EC700 and 3348 strains. After 
indicated time-points, cell culture supernatants were collected and TNF-α release by BMDMs was measured 
using ELISA. TNF-α production induced by (A) the living EC700 strain was compared to heat-killed (HK) EC700, 
in (B) the living 3348 strain with HK-3348 and in (C) HK-EC700 with HK-3348. 
 
 
Infection of macrophages with both, the streptococcal EC700 strain and heat-killed (HK) EC700 led to 
the production of TNF-α, although TNF-α levels were lower in macrophages treated with heat-
inactivated bacteria (Fig. 8, A).  
Surprisingly, comparison of the living and heat-killed 3348 strain revealed that TNF-α production in 
response to the heat-killed bacteria was higher than after infection with living bacteria (Fig. 8, B). 
Direct comparison of the heat-killed strains revealed that induced TNF-α levels in macrophages 
appeared quite similar (Fig. 8, C).  
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Figure 9: Heat-killed Streptococci cause type I IFN production, although less than live bacteria, and the 
activation of Stat1  
BMDMs were infected with equal amounts (MOI 100) of living or heat-killed (HK) EC700 and 3348 strains. After 
indicated time-points, cell culture supernatants were collected and IFN-β release by BMDMs was measured 
using ELISA. TNF-α secretion from (A) the living EC700 strain was compared to heat-killed (HK) EC700, in (B) the 
living 3348 strain was compared with HK-3348 and in (C) HK-EC700 was compared with HK-3348. (D) Stat1 
activation in response to living and HK-EC700 as well as to (E) living and HK-3348 in BMDMs was analyzed using 
Western Blot with a specific antibody for Tyrosine701-phosphorylated Stat1. Equal loading was checked by re-
probing the membrane with an antibody specific for (D) the C-terminus or (E) the N-terminus of Stat1.  
 
Infection with heat-killed Streptococci also led, as during infection with living bacteria, to the 
production of type I IFNs. The IFN-β production was lower in macrophages treated with HK-EC700 
(see Fig. 9, A) or HK-3348 (B) than with the respective living streptococcal strains. Direct comparison 
of IFN-β secretion induced by the HK-strains revealed that after 4 hours of infection both strains 
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produced nearly the same amount of IFN-β whereas after 6 hours, the HK-EC700 strain was more 
efficient in IFN-β induction (Fig. 9, D and E).  
Further, the capacity of living or heat-killed bacteria of both strains to activate the Jak/Stat signaling 
pathway was assessed. Therefore the activation of the Stat1 protein was determined by Western 
blotting with an antibody specific for the phosphorylated form of Stat1. Analysis of Stat1 activation in 
macrophages infected with living and heat-killed bacteria from the EC700 strain revealed that Stat1-
phosphorylation appeared similar (Fig. 9, D). This was also the case when macrophages were infected 
with either living or the HK-3348 streptococci (Fig. 9, E).  
Given these results, we conclude that TNF-α and IFN-β secretion occurs also in response to HK 
bacteria derived from both strains. The fact that HK-streptococci from the 3348 strain are able to 
induce a higher TNF-α secretion than living bacteria was an unexpected finding. A possible 
explanation for this phenomenon could be that during the heat-killing process, specific parts of the 
bacteria present in the 3348 strain only get exposed, which are not accessible under normal 
conditions. 
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6. Final Discussion 
 
6.1. Production of TNF-α and IL-6 in Response to S. pyogenes 
Recognition of an invading pathogen by a pattern-recognition receptor (PRR) expressed by the host 
and the subsequent activation of an effective immune response in order to eradicate the unwanted 
intruder is a fundamental process in innate immunity.  
In the case of the human pathogen S. pyogenes, the molecules responsible for its recognition by cells 
of the innate immune system have still to be identified.  
Thus, the main aim of this thesis was the analysis of the involvement of the known PRRs in S. 
pyogenes recognition and the investigation of the signaling pathways that are initiated after 
recognition. 
For this purpose, it was decided to use bone marrow-derived macrophages (BMDMs) for 
investigations, since these cells constitute the first line of defense against invading pathogens.  
Macrophages are important mediators of innate immunity. Once activated, they kill pathogens by 
phagocytosis, become efficient antigen-presenting cells (APCs) and are known to produce 
inflammatory cytokines and growth factors that trigger a strong inflammatory response. 
It is very likely that during an infection with S. pyogenes this cell type is among the first encountered 
by the bacterium.  Further, it has been shown using an experimental mouse model of streptococcal 
infection that macrophages play an important role during the early immune responses against S. 
pyogenes (128). Dendritic cells have also been shown to contribute to host defenses against S. 
pyogenes by preventing bacterial dissemination and production of IL-12 (129).In contrast, natural 
killer (NK)-cells are participating in the progression of septic shock in S. pyogenes-infected mice by 
amplification of the immune response (140). 
 
We were able to show that infection of BMDMs with S. pyogenes leads to the activation of p38 
mitogen-activated protein kinase (MAPK), NF-κB and the production of proinflammatory cytokines 
such as tumor necrosis factor- α (TNF-α) and interleukin (IL)-6 (130). These proteins are well known 
for being activated during the inflammatory response after the recognition of microbial pathogens. 
Activation of p38 MAPK and NF-κB in response to S. pyogenes has also been observed in human 
respiratory epithelial HEp-2 cells (141). Since both pathways are activated after Toll-like receptor 
(TLR) engagement, we decided to analyze murine macrophages deficient for the prototype bacterial 
receptors TLR2, TLR4 and TLR9. Infection of these macrophages led to a normal activation of p38 
MAPK and NF-κB and an undisturbed production of TNF-α and IL-6 in response to S. pyogenes (130). 
Redundancy of these three receptors was excluded by analysis of TLR2/4/9-deficient BMDMs. These 
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results led to the assumption that the main bacterial TLRs are not involved in the recognition of S. 
pyogenes and are dispensable for the induction of an inflammatory response against this bacterium. 
It is therefore elusive why TLR2, known to sense peptidoglycan (PGN) from Gram-positive bacteria, is 
not involved in the detection of the Gram-positive bacterium S. pyogenes (142). 
Moreover, the involvement of the important TLR-adaptor protein myeloid differentiation primary 
response gene 88 (MyD88) in S. pyogenes-induced inflammatory signaling was analyzed 
This protein is used for initiation of downstream signaling by almost all TLRs, except TLR3 (21). We 
found that initiation of inflammatory signaling during streptococcal infection fully depends on this 
adaptor protein, since MyD88-deficient BMDMs neither activate p38 MAPK and NF-κB nor they 
produce TNF-α and IL-6 in response to S. pyogenes infection.  
These findings were supported by a recent in vivo study, where MyD88-deficient mice were infected 
with S. pyogenes. The MyD88-deficient mice showed diminished levels of proinflammatory cytokines 
such as TNF-α, IL-12 and IFN-γ in response to infection with S. pyogenes and succumbed much earlier 
to infection as wild-type control mice (143) . 
Members of the IL-1R family (IL-1RI, IL-18R and ST2) also have been described to signal via MyD88 
leading to the activation of NF-κB, p38 MAPK and JUN amino-terminal kinase (JNK) (144). To exclude 
the involvement of IL-1 in the induction of the inflammatory signaling during streptococcal infection, 
BMDMs from IL-1R-deficient mice were analyzed. Since we were not able to observe any differences 
in the activation of proinflammatory signaling in the IL-1RI-deficient BMDMs, we came to the 
conclusion that the signaling events induced by S. pyogenes are also not dependent on the IL-1 
receptor (130). 
 
NOD1 and NOD2, both members of the nucleotide-binding and oligomerization domain (NOD)-like 
receptor (NLR) family, have been reported to be important cytosolic sensors of muropeptides from 
bacterial cell walls (18). Upon recognition of an intracellular pathogen, NOD1 and NOD2 get activated 
thus leading to the activation of NF-κB, MAPKs such as p38 MAPK, JNK and extracellular-signal-
regulated kinase (ERK) (30). 
Although S. pyogenes is an extracellular bacterium and is therefore not able to replicate within the 
cytosol, there is evidence that S. pyogenes is able to evade lysosomal killing in epithelial cells with the 
help of Streptolysin O (SLO) (111). Studies using nonphagocytic cells showed that S. pyogenes 
escapes from the endosomes into the cytoplasm where it is trapped in autophagosome-like 
compartments and degraded upon fusion with lysosomes (145) (146).  
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Further, it has also been shown that S. pyogenes is able to survive within the cytoplasm of phagocytic 
cells by escaping from the phagosome by a yet unknown mechanism (147). However, it is very likely 
that also in this case Streptolysin O might be involved in evasion. 
 
To investigate the involvement of NOD1 and NOD2 in sensing of S. pyogenes, NOD1-and NOD2-
deficient BMDMs were infected with S. pyogenes and induction of proinflammatory signaling was 
monitored. Our experiments revealed that the two NOD-proteins are dispensable for the induction of 
an inflammatory response against S. pyogenes, since NOD1-and NOD2-deficient macrophages show a 
similar activation of p38 MAPK as well as production of TNF-α and IL-6 as wild-type BMDMs (see 
figure 5).The fact that initiation of signaling in response to S. pyogenes absolutely requires the 
adaptor protein MyD88 also strengthens the assumption that NOD proteins are not involved in 
sensing this bacterium, since it is known that MyD88 is not required for NOD-induced signaling. The 
dependency on MyD88 leads to the further assumption that a member of the TLR-family could be 
involved in sensing of S. pyogenes. 
  
It is also of general interest, whether the ligands of the PRRs are produced by the bacterial cells upon 
infection. To analyze this question, Streptococci were grown to mid-log phase and then heat-
inactivated for 20 min at 70° C. Living and heat-killed (HK) bacteria were then used to infect BMDMs 
at equal ratios (MOI 100) and production of TNF-α by BMDMs was measured.  
It turned out that HK bacteria were also able to induce an inflammatory response in BMDMs.  
When the EC700 strain was used, TNF-α levels in response to HK bacteria were lower than with living 
bacteria. Surprisingly, we observed the opposite after infection with HK-3348 bacteria, since TNF-α 
levels were higher compared to the production initiated by the living 3348 strain. Additional 
experiments will be needed to find out the reason for this observation. One possible explanation for 
this observed phenomenon is that the 3348 strain somehow might be able to actively prevent the 
production of TNF-α.  
The fact that heat-killed bacteria from both strains trigger an inflammatory response in BMDMs leads 
to the assumption that recognition of bacteria does not depend on the active secretion of the 
potential ligand. So the recognition of a secreted streptococcal virulence factor serving as ligand for 
the unknown receptor can be excluded.  
 
The analysis of the receptor molecules responsible for the recognition of S. pyogenes can be 
addressed from two sites. In the first part of my thesis we aimed to identify the host receptor sensing 
S. pyogenes. However, we were also interested in the bacterial ligand that elicits the host response. 
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Since it is known that Toll-like receptors recognize various different molecules including nucleic acids, 
sugars and lipoproteins, we decided to perform experiments using streptococcal fractions. 
Streptococci were grown to mid-log phase, were sonicated and afterwards treated with DNase I, 
Proteinase K, RNase A or the combination of them.  
Stimulation of BMDMs with these extracts did not lead to a detectable production of TNF-α (data not 
shown). Therefore it was decided to transfect the streptococcal extracts into the BMDMs using 
DOTAP. DOTAP is a liposomal transfection reagent which delivers the associated complexes mainly to 
endosomes. BMDMs transfected with extracts enzymatically treated with RNase A did not secrete 
TNF-α, whereas extracts treated with DNase I, Proteinase K as well as an untreated control extract, 
led to production of TNF-α (Fig. 6).  
These results lead to the conclusion that streptococcal RNA is the ligand that is recognized by a yet 
unknown receptor probably located in the endosomes of BMDMs.  
Recognition of streptococcal RNA then leads to a proinflammatory response as indicated by the 
production of TNF-α. Four TLRs have been reported to be located within endosomes: TLR3, TLR7, 
TLR8 and TLR9 (18). All of them have been described to recognize nucleic acids derived from viruses 
and bacteria. TLR3 is known to recognize double-stranded RNA derived from viruses. TLR7 recognizes 
synthetic imidazoquinoline-like molecules, guanosine analogs such as loxoribine, single stranded RNA 
(ssRNA) derived from various viruses and small interfering RNA. Human TLR8 shares a high homology 
to TLR7 and has been shown to sense ssRNA and imidazoquinoline. However, ligands and function of 
murine TLR8 still have to be determined. CpG DNA motifs present in bacterial and viral genomes are 
detected by TLR9 (27).  
We were able to exclude the involvement of TLR9 (130) and TLR7 (preliminary data, not shown) in 
the detection of S. pyogenes by BMDMs under normal infection conditions. Recognition of S. 
pyogenes by TLR3 can also be excluded, since this receptor uses the adaptor protein TRIF for 
downstream signaling upon activation, whereas our data show that induction of inflammatory 
signaling is fully dependent on MyD88.  
The treatment of BMDMs with enzymatically modified streptococcal extracts and the use of DOTAP 
are not comparable to a normal infection experiment for following reasons: (i) sonication of 
Streptococci can expose PAMPs which are not accessible for PRRs under normal conditions; (ii) 
transfection using DOTAP might deliver the extracts not only to the endosomes but also to the 
cytoplasm, where other receptors than TLRs are recognizing them; (iii) DOTAP is known to form large 
complexes. Therefore, DOTAP could complex large amounts of ligand leading to an artificial receptor 
clustering. 
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Taken together, our results suggest that streptococcal RNA is recognized by BMDMs leading to 
induction of a proinflammatory response. As this response is fully dependent on the TLR-adaptor 
protein MyD88, the involvement of a RNA-recognizing TLR in detection of S. pyogenes is likely.  
During this thesis, we were able to exclude all RNA-sensing TLRs (TLR3, TLR7) with exception of TLR8.  
This receptor has been shown to respond to the TLR7 ligand imidazoquinoline resiquimod (R848) in 
the human system, but is believed to be non-functional in mice, since HEK293 cells transiently 
transfected with murine TLR8 did not respond to R848 (148). A further proof for the lacking 
functionality of TLR8 in mice is the finding that TLR7-deficient mice did not respond to R848, 
although TLR8 was present (149). A more recent study suggests that murine TLR8 is indeed 
functional, since imidazoquinoline immune response modifiers (IRMs) in combination with 
oligodeoxynucleotides (ODNs) led to a NF-κB response in HEK293 cells transfected with murine TLR8. 
In addition, stimulation of cells derived from TLR7-and TLR9-deficient mice responded to the 
IRM/ODN combination, whereas MyD88-deficient cells did not (150). However, there is no data 
available showing the involvement of murine TLR8 in host responses against pathogens. 
Although it cannot excluded that this receptor is sensing S. pyogenes in BMDMs, it is rather likely that 
this bacterium is recognized by a yet unidentified receptor molecule.  
 
 
6.2. Mechanisms of Induction of Type I Interferon Signaling by S. pyogenes 
The production of interferons is a mechanism of the innate immune system to control infections 
caused by intracellular pathogens. Although initially described to be produced in response to viral 
infection, an increasing body of evidence shows that these cytokines play also an important role in 
the host response against bacterial infection (151). 
Type I IFNs are produced in response to both, Gram-positive and Gram-negative bacteria, such as 
Chlamydia spp., Salmonella typhimurium, Shigella flexneri and Escherichia spp. (44). Type I IFN 
production in response to Gram-positive bacteria, is best studied in Listeria monocytogenes. This 
pathogen has a predominantly intracellular lifestyle, which is achieved by the escape from phagocytic 
vacuoles into the cytoplasm using Listeriolysin O (LLO), a pore-forming cytolysin. Once in the 
cytoplasm, the bacterium is recognized by a yet unknown receptor, leading to the induction of the 
IFN-β gene and also initiation of JAK/STAT signaling depending on TBK1 and IRF3 in BMDMs (152). 
 
We were able to show that the extracellular, Gram-positive bacterium S. pyogenes also induces the 
activation of Stat1 in murine BMDMs and that this event occurs without the involvement of the two 
streptococcal cytolysins Streptolysin O (SLO) and Streptolysin S (SLS)(130). Further, preliminary data 
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generated by us suggest that IFN-β production in response to S. pyogenes also occurs in the absence 
of SLS and SLO, albeit to a lesser extent. The finding that stimulation of BMDMs with heat-killed 
streptococci also leads to an IFN-β production, albeit to a lesser extent, supports the fact that these 
cytolysins, which are secreted by living cells only, are not needed for IFN-production (Fig. 9). The 
reason why heat-killed streptococci induce a reduced IFN-β production compared to living bacteria 
cannot be explained by us yet and was not expected, since Stat1 activation in response to heat-killed 
S. pyogenes was similar to the activation induced by living bacteria (see Fig. 9).  
Further we could demonstrate that in BMDMs, type I IFN production is absolutely dependent on IRF3 
and TBK1. Interestingly, we did not observe this IRF3-dependency in S. pyogenes-infected 
conventional dendritic cells (cDCs). This goes in line with a study that shows that in cDCs, infected 
either with S. pyogenes or Group B Streptococcus (GBS), production of IFN-β does not depend on 
IRF3 (134). Further we were able to show that in cDCs infected with S. pyogenes, IFN-β production is 
partially dependent on IRF1, whereas infection of IRF1-deficient BMDMs does not lead to any 
observable differences in the production of IFN-β (see manuscript, Fig. 2A,B). 
In addition, we found that the presence of the adaptor protein MyD88 is crucial for the production of 
IFN-β in S. pyogenes-infected cDCs, but not in BMDMs, where just a partial dependency is 
observable. Similar results were obtained when GBS was used to infect these two cell types (134). 
TRIF, the second major adaptor protein involved in TLR signaling was found to be dispensable for 
production of IFN-β in BMDMs (see manuscript, Fig. 3D) and as well in cDCs, as shown by a recent 
report (134). 
 
Obviously, the TBK1/IRF3 axis plays an important role in the transcriptional regulation of type I IFN 
production upon bacterial infection in S. pyogenes-infected macrophages. However, little is known 
about the receptor upstream of TBK1. 
We wanted to obtain more information about the nature of the ligand that is inducing the IFN 
production in response to S. pyogenes, therefore streptococcal extracts either depleted for DNA, 
RNA or Proteins were transfected into BMDMs and cDCs with DOTAP.  
Our experiments revealed that streptococcal DNA is launching an IFN-β response in BMDMs, 
whereas in conventional DCs (cDCs) streptococcal RNA seems to trigger IFN-β production (see 
manuscript, Fig. 4A). These results are consistent with the finding that IFN-β production in response 
to GBS appears to be induced in DC by bacterial RNA, whereas in macrophages bacterial DNA is the 
IFN inducer (135) (134). DOTAP employs the endosomal pathway for the delivery of molecules into 
the cell. To investigate if TLR9, one of the TLRs located in the endosomes and known to recognize 
bacterial DNA, is involved in the recognition of streptococcal DNA, experiments using TLR9-deficient 
BMDMs were performed. It turned out that recognition of streptococcal DNA occurs without the 
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involvement of TLR9, since TLR9-deficient BMDMs showed an undisturbed IFN production in 
response to streptococcal DNA (see manuscript, Fig. 4E). 
 
Since we were able to exclude TLR9, the only DNA-sensing receptor within the endosomes, as 
possible receptor inducing an IFN-response in BMDMs, other DNA-sensing PRR might be involved in 
the recognition of S. pyogenes.  
One possibility is that streptococcal DNA is recognized by DNA-dependent activator of IFN-regulatory 
factors (DAI), which has been shown to recognize various DNAs, including synthetic B- or Z-form DNA, 
or bacterial, viral or mammalian DNA, albeit with different efficiencies(33). Binding of DNA to DAI 
results in an increased interaction of DAI with IRF3 and TBK1, leading to type I IFN and 
proinflammatory cytokine production. However, studies using DAI-deficient cells revealed that those 
cells responded normally to poly(dA:dT) and plasmid DNA and they also showed  an unimpaired 
response to a DNA virus. These findings lead to the conclusion that DAI has just a redundant role in 
sensing of DNA (153).  
Recently, a new DNA-sensing pathway has been identified, in which RNA polymerase III efficiently 
triggers the production of type I IFN by transcribing microbial DNA templates into dsRNA containing 
5'-triphosphate, which is a potent activator of RIG-I (154) (155). It has been shown that RNA Pol III 
converts the DNA within the cytoplasm, making it a true cytoplasmic pathway (155). The authors 
applied the RNA Pol III inhibitor ML-60218 to test, if infection with several pathogens is still inducing 
IFN-β production. They observed that Pol-III inhibition leads to a reduced induction of IFN-β by 
Legionella pneumophila, DNA viruses such adenovirus, HSV-1 and EBV, but not with RNA viruses 
(Sendai virus) (155). Experiments using the ML-60218 inhibitor might also provide new insights into 
the recognition of S. pyogenes. Previously, stimulator of IFN genes (STING) has been described to be 
a potent activator of IRF3 and seems to function downstream of both, the RNA and DNA recognition 
pathways, since STING-deficient cells lose their ability to mount an efficient immune response 
against intracellular B-DNA and IFN-stimulatory DNA (ISD, a synthetic 45-mer dsDNA of random 
sequence lacking contiguous CpG motifs) or to infection with L. monocytogenes and herpes simplex 
virus type 1 (HSV-1) (153). It is possible, that one of these three cytoplasmic DNA-receptors (STING, 
DAI, RIG-I) are involved in the sensing of streptococcal DNA in BMDMs. Thus, further experiments 
might reveal the mechanism by which the S. pyogenes-induced IFN response is induced in BMDMs. 
In the case of cDCs, where RNA seems to be the ligand responsible for the induction of IFN-β 
production, TLR7-deficient cells were analyzed. TLR7 is also located within endosomes and known to 
recognize RNA. Our experiments revealed that TLR7 is dispensable for the recognition of 
streptococcal RNA in cDCs. In addition TLR3, a sensor for double-stranded RNA located in the 
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endosomes, was shown in this thesis to be not relevant for IFN-β production in S. pyogenes infected 
BMDMs and also in cDCs, being in accordance with other studies (134).  
In cDCs, other RNA-sensing PRRs can serve as possible candidates, such as the family of RIG-like 
receptors (RLRs) consisting of RIG-I, MDA5 and LGP2. They have been described to sense intracellular 
RNA species leading to an IFN-response. But these molecules can be ruled out as receptors for S. 
pyogenes in cDCs, since they do not rely on the MyD88 adaptor protein for their signaling.  
As already discussed in the previous section, the experiments using DOTAP-transfected streptococcal 
fractions may not resemble a normal infection experiment. Sonication might produce PAMPs that 
would not be recognized during normal infection and DOTAP might delivers PAMPs not only into 
endosomal compartments but also into the cytosol where other receptors might recognize the 
ligand. However, the DOTAP experiments are in good agreement with results obtained with HK so 
that all in all, these experiments provide a good hint in the search for possible receptors and 
molecules that might serve as ligands.  
 
 
6.3. The Role of Type I Interferons during Streptococcal Infection 
Interferon production during viral infection has been shown to be protective for the host but the role 
of type I interferons during bacterial infection is more complex as documented in extensive studies 
during the last years.  
Upon infection of mice with Salmonella typhimurium for example, production of type I IFNs has been 
shown to be beneficial for survival of infected mice (156), whereas in the case of Listeria 
monocytogenes, type-I IFN production is detrimental (157) (158, 159). Both bacteria have an 
intracellular lifestyle and are able to replicate within the host cell which is known to be important for 
IFN-β production.  
However, an increasing body of evidence suggests that type I IFN production is also induced in 
response to bacteria with an extracellular lifestyle (i.e. bacteria that are not able to replicate within 
the host cell). Our group was able to demonstrate that mouse innate immune cells produce IFN-β in 
response to an extracellular Gram-positive bacterium (S. pyogenes)(130). Subsequently, it has been 
shown that group B streptococcus (GBS) is able to induce IFN-β production in BMDMs and cDCs, and 
that IFN-β is critical for host defense against these bacteria in vivo (133) (135).  
To investigate the role of type I IFN-production during S. pyogenes infection, it was decided to 
establish a mouse in vivo model. The subcutaneous infection route was chosen since it is the most 
physiologically relevant model for invasive streptococcal infections (160) (161) (105) (108). To study 
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the contribution of the innate immune response in this infection model, the survival of mice was 
monitored not longer than day 6 after infection. 
S. pyogenes is a strictly human pathogen and only few strains can establish an infection in mice (105), 
therefore a murine model does not reflect natural infection by this bacterium. This limited host 
specificity is explained by the existence of several virulence factors which were shown to function 
only in human cells. To circumvent this problem, a human CD46 transgenic (Tg) mouse model of skin 
and soft-tissue infection with S. pyogenes has been established recently. This model closely 
resembles human infection, since the complement regulatory protein CD46 is implicated as receptor 
for several pathogens including S. pyogenes. Human CD46-expressing Tg mice are more susceptible 
to S. pyogenes infection as non-Tg ones (162).  
Another transgenic mouse model has been established by inducing human plasminogen into mice in 
order to bypass the restricted host specificity of S. pyogenes. Plasminogen is a human blood-clot 
dissolving protein, which can be activated by the S. pyogenes-derived virulence factor streptokinase. 
Streptokinase is highly specific for human plasminogen, exhibiting little or no activity against other 
mammalian species, including mouse. These Tg mice showed an increased mortality when infected 
with S. pyogenes and this susceptibility was dependent on bacterial streptokinase expression (163). 
The genetic background of mice can also influence the susceptibility to infection with S. pyogenes. A 
study where different genetic backgrounds were analyzed for the ability to control streptococcal 
infection revealed that BALB/c and C57BL/10 mouse strains are more resistant to infection with S. 
pyogenes as for example C3H/HeN and CBA/J mice (164). Further the age of the mice used for the 
experiments might influence the susceptibility to streptococcal infection, since it has been shown 
that aged-mice (20 months and older) show a faster progression of disease than young mice (2-3 
months)(165). 
We observed the ATCC 700294 strain (for simplicity: EC700) did not have the capacity to kill wild-type 
mice, although they developed lesions at the site of injection. Therefore, the ISS 3348 strain was used 
in further experiments, since this one is also able to kill infected mice. 
Comparing these two strains, by monitoring the capacity to induce an inflammatory response, led to 
the conclusion that the 3348 strain is inducing a lower inflammatory response than the EC700 strain 
(see results 5.3.3.). One possible explanation for the observed differences could be that during 
infection of mice, the 3348 strain-induced immune response is lower. Lower amounts of cytokines 
are produced and so less cells of the innate immune system get attracted to the site of infection. This 
might be of advantage for the bacterium since it can proliferate and invade tissues more easily 
leading to a more severe systemic infection which is subsequently lethal. 
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The role of type I IFNs during in vivo infection of mice with S. pyogenes was studied by subcutaneous 
infection of wild-type and IFNAR1-deficient mice with the 3348 strain. The IFNAR1-deficient mice 
succumbed earlier to infection and also died at higher numbers than control mice. This finding led to 
the conclusion that defective type I IFN signaling results in impaired host responses against the 
extracellular bacterium S. pyogenes. Therefore, production of IFN-β is essential for an effective host 
response against S. pyogenes. This is in accordance to a study provided by Mancuso et al. where it 
has been shown that the production of IFN-β in response to other extracellular Gram-positive 
bacteria, such as GBS and S. pneumoniae, is critical for the clearance of infection by the host (133). 
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Tristetraprolin Is Required for Full Anti-Inflammatory
Response of Murine Macrophages to IL-101
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Michael Hammer,# Claus Vogl,† Birgit Strobl,†‡ Mathias Mu¨ller,†‡ Perry J. Blackshear,§
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IL-10 is essential for inhibiting chronic and acute inflammation by decreasing the amounts of proinflammatory cytokines made
by activated macrophages. IL-10 controls proinflammatory cytokine and chemokine production indirectly via the transcription
factor Stat3. One of the most physiologically significant IL-10 targets is TNF-, a potent proinflammatory mediator that is the
target for multiple anti-TNF- clinical strategies in Crohn’s disease and rheumatoid arthritis. The anti-inflammatory effects of
IL-10 seem to be mediated by several incompletely understood transcriptional and posttranscriptional mechanisms. In this study,
we show that in LPS-activated bone marrow-derived murine macrophages, IL-10 reduces the mRNA and protein levels of TNF-
and IL-1 in part through the RNA destabilizing factor tristetraprolin (TTP). TTP is known for its central role in destabilizing
mRNA molecules containing class II AU-rich elements in 3 untranslated regions. We found that IL-10 initiates a Stat3-dependent
increase of TTP expression accompanied by a delayed decrease of p38 MAPK activity. The reduction of p38 MAPK activity
releases TTP from the p38 MAPK-mediated inhibition, thereby resulting in diminished mRNA and protein levels of proinflam-
matory cytokines. These findings establish that TTP is required for full responses of bone marrow-derived murine macrophages
to IL-10. The Journal of Immunology, 2009, 183: 1197–1206.
O ne of the key players in immune homeostasis is IL-10, acytokine that was discovered 18 years ago as a T cell-secreted factor that inhibited cytokine production by Th1
cells (1). Over the years, it became clear that IL-10 is produced by
many cell types including T and B cells, macrophages, dendritic
cells, mast cells, keratinocytes, or epithelial cells (2). It is generally
considered that the main biological function of IL-10 is to limit or
shut down inflammatory responses. This notion is supported by the
phenotype of IL-10-deficient mice that develop severe inflamma-
tory bowel disease due to spontaneous chronic inflammation and
are susceptible to endotoxin treatment because of acute overpro-
duction of proinflammatory cytokines (3, 4). Many of these phe-
notypes can be recapitulated by T cell-specific deletion of the
IL-10 gene, indicating that T cell-derived IL-10 is primarily re-
sponsible for chronic inflammation (5). Under conditions of acute
inflammation, the main source of IL-10 are macrophages and den-
dritic cells (6). On the cellular level, IL-10 inhibits production of
proinflammatory cytokines and regulates differentiation and pro-
liferation of various immune cells. These effects depend entirely
on the activation of the transcription factor Stat3 by IL-10 (7–11).
The events downstream of Stat3 activation that mediate the anti-
inflammatory functions of IL-10 remain an area of active research.
It is becoming increasingly clear that multiple mechanisms medi-
ate the IL-10 function. On the one hand, IL-10 inhibits transcrip-
tion of a subset of proinflammatory genes (12, 13). In a mouse
model lacking 3 untranslated regions (UTR)4 in the Tnf gene, the
transcriptional mechanism was found to play a major role in IL-10
responses (13). On the other hand, IL-10 was also reported to act
posttranscriptionally by increasing the rate of mRNA decay of in-
flammatory cytokines such as TNF- or by inhibiting translation
(12, 14, 15). The posttranscriptional regulation depends on 3 UTR
containing AU-rich elements (AREs) (16). However, far less is
known about the IL-10-regulated effector genes that control the
anti-inflammatory response. Several candidates have been de-
scribed, but so far none have been shown to account for the ma-
jority of the anti-inflammatory effects (17). IL-10 was also dem-
onstrated to up-regulate the dual-specificity phosphatase 1
(DUSP1) in LPS-stimulated macrophages. causing a more rapid
inactivation of p38 MAPK (18). The reduction of p38 MAPK ac-
tivity may lead to a decreased stability of ARE-containing mRNAs
and/or reduced transcription by transcription factors that depend
on p38 MAPK. Recently, the transcriptional repressor ETV3 and
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the corepressor SBNO2 were characterized as IL-10/Stat3-induced
genes that may contribute to the anti-inflammatory IL-10 effects
(19). An important aspect of the above-mentioned studies that re-
mains to be resolved is how IL-10 inhibits specifically only a sub-
set of inflammatory genes. These studies indicate that yet unknown
IL-10/Stat3 target genes need to be discovered to complement the
current knowledge about the anti-inflammatory effects of IL-10.
In this study, we demonstrate that IL-10-mediated reduction of
TNF- and IL-1 production by LPS-treated mouse bone marrow-
derived macrophages (BMDMs) is less efficient in cells lacking the
RNA-destabilizing factor tristetraprolin (TTP). TTP is known to
bind and destabilize mRNAs of several proinflammatory cytokines
(e.g., TNF-) containing class II AREs in their 3 UTRs (20). TTP
facilitates degradation of the bound mRNA by initiating the as-
sembly of RNA decay machinery (21, 22). The RNA degradation
activity of TTP is negatively regulated by p38 MAPK-dependent
signaling (23–25). Mice lacking TTP (encoded by the Zfp36 gene)
develop multiple chronic inflammatory syndromes ranging from
arthritis to cachexia to dermatitis that can all be relieved by re-
duction of TNF- levels (26). By comparing LPS-treated wild-
type and TTP-deficient BMDMs, we show that IL-10 accelerates,
in a TTP-dependent way, the decay of TNF- mRNA, resulting in
a reduction of secreted TNF-. Furthermore, IL-10 increases TTP
expression in LPS-treated wild-type (WT) but not Stat3-deficient
BMDMs. However, we show that the increased TTP levels are not
sufficient to mediate the IL-10 effects. Instead, the IL-10- me-
diated reduction of p38 MAPK activity in LPS-treated BMDMs
that is known to be caused by up-regulation of the p38 MAPK
phosphatase DUSP1 (18) is required to act in concert with TTP
to reduce mRNA levels of proinflammatory cytokines such as
TNF- and IL-1. We propose that the sustained activation of
Stat3 by IL-10 causes both an increased TTP expression and a
reduction in p38 MAPK activity. The combination of these ef-
fects results in a reduction of mRNA stability and attenuation of
cytokine production.
Materials and Methods
Reagents
Stat3, p38 MAPK, and DUSP1 (sc-1102) Abs were from Santa Cruz Bio-
technology, the ERK Ab was from BD Transduction Laboratories, and the
phosphotyrosine-Stat3 Ab (pY-Stat3) was from Cell Signaling and New
England Biolabs. Rabbit Ab to TTP was obtained by immunizing rabbits
with 44 C-terminal amino acids of TTP fused to GST. IL-10 and IL-6
(Sigma-Aldrich) were used at a concentration of 10 ng/ml, LPS from Sal-
monella minnesota (Alexis) was used at a concentration of 5–10 ng/ml, and
anisomycin and actinomycin D (both Sigma-Aldrich) were used at a con-
centration of 100 ng/ml and 5 g/ml, respectively. SB203580 (SB; Sigma-
Aldrich) was dissolved in DMSO and used at final concentration 4 M.
ATP (1 M; Sigma-Aldrich) was added 1 h before collecting the samples.
Cell culture
Primary macrophages were grown in L cell-derived CSF-1 as previously
described (27). Zfp36/ and Dusp1/ mice (26) were on the C57BL/6
background. The Zfp36 gene encodes TTP, which is the better known name
and therefore is used throughout. For experiments with cells derived from
TTP/ and TTP/ mice, littermates originating from the TTP/ colony
were used. The LysMcre-Stat3fl/fl mice were obtained by crossing Stat3fl/fl
mice (28) with LysMcre, strain B6.129P2-Lyzstml(cre)Ifo (The Jackson Lab-
oratory), all on the C57BL/6 background. Mice, 8–12 wk old at the time
of bone marrow collection, were housed under specific pathogen-free con-
ditions. Mouse experiments were conducted in compliance with national
laws. Mouse macrophage line RAW 264.7 was grown in DMEM supple-
mented with 10% FCS.
Inducible expression of TTP
The open reading frame of the mouse TTP was PCR-amplified from
cDNA. The PCR was used to add Flag tag DYKDDDDK at the C terminus.
The TTP-Flag fragment was cloned into the pGL2-basic (Promega) con-
taining a tetracycline-responsive element (TRE) in the promoter. The re-
sulting plasmid pTRE-TTPfl was transfected into HeLa-Tet-off cells (BD
Clontech) using nucleofection (Amaxa). After transfection, the cells were
incubated overnight in medium with (no TTP expression) or without (TTP
expression) tetracycline (1 g/ml).
ELISA
For ELISA, BMDMs were seeded the day before use at 2  105 cells/well
in a 24-well plate. Supernatants were diluted 1/8 in DMEM (for TNF-) or
1/2 (for IL-1) and cytokines were assayed using ELISA kits (R&D Sys-
tems) according to the manufacturer’s instructions.
Quantitative Western blot
After treatment, whole cell extracts were prepared and assayed by Western
blotting as described elsewhere (29). Detection and quantitation of signals
were performed using the infrared imaging system Odyssey (LI-COR
Biosciences).
Quantitation of gene expression by quantitative RT-PCR
(qRT-PCR)
Total RNA was isolated using TRIzol reagent (Invitrogen). Reverse tran-
scription was performed with Moloney murine leukemia virus reverse tran-
scriptase (Fermentas). The following primers were used: for HPRT, the
housekeeping gene used for normalization, HPRT forward (fwd) 5-GG
ATTTGAATCACGTTTGTGTCAT-3 and HPRT reverse (rev) 5-ACAC
CTGCTAATTTTACTGGCAA-3; for TTP, TTP fwd 5-CTCTGCCATC
TACGAGAGCC-3 and TTP rev 5-GATGGAGTCCGAGTTTATGTTC
C-3; for TNF-, TNF- fwd 5-CAAAATTCGAGTGACAAGCCTG-3
and TNF- rev 5-GAGATCCATGCCGTTGGC-3; for suppressor of cy-
tokine signaling (SOCS) 3, SOCS3 fwd 5-GCTCCAAAAGCGAGTACC
AGC-3 and SOCS3 rev 5-AGTAGAATCCGCTCTCCTGCAG-3; and
for TTP primary transcript, TTPpt fwd 5-GACTGGCAAGCTCGTGAA
GT-3, pt-TTP-rev 5-CAGTCAGGCGAGAGGTGA-3. For determina-
tion of mRNA decay by qRT-PCR, the primers TNF- fwd 5-TTCTGT
CTACTGAACTTCGGGGTGATCGGTCC-3 and TNF- rev 5-GTAT
GAGATAGCAAATCGGCTGACGGTGTGGG-3 and for IL-1, the
primer set QT00113505 from Qiagen was used. Amplification of DNA was
monitored by SYBR Green (Molecular Probes (30).
RNA EMSA
To prepare extracts, cells were washed with cold PBS and lysed in buffer
containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 30 mM NaPPi, 50 mM
NaF, 2 mM EDTA, 1% Triton X-100, and a protease inhibitor mixture
(Roche). Extracts were cleared by centrifugation at 15,000 rpm. Twelve-
microliter cell extracts (30 g of protein) from RAW 264.7 cells or 5-l
cell extracts (15 g of protein) from pTRE-TTPfl-transfected HeLa-Tet-off
cells were incubated with 0.5 l of poly(U) RNA (100 ng/l), 0.5 l of
Cy5.5-labeled TNF- ARE (1 pmol/l), 1 l of RiboLock RNase Inhibitor
(Fermentas), and 2.5 l of 5 Gelshift buffer (200 mM KCl, 5 mM MgCl2,
0.5 mM EGTA, 2.5 mM DTT, 100 mM HEPES-KOH (pH 7.9), and glyc-
erin 50% (v/v)) for 20 min at room temperature. For supershift assays, 0.5
l of TTP antiserum was added. Samples were then separated on a 6%
polyacrylamide gel. The Cy5.5 signal was detected and quantified using the
infrared imaging system Odyssey (LI-COR Biosciences). Poly(U) RNA
and Cy5.5-labeled TNF- ARE RNA were purchased from Microsynth.
The sequence for Cy5.5-labeled TNF- ARE was as follows:
5-AUUAUUUAUUAUUUAUUUAUUAUUUA-3.
Statistical analysis
Data from independent experiments were analyzed using univariate linear
regression models and the SPSS program. For qRT-PCR normalized copy
numbers and for ELISA pg/ml were log-transformed. Residuals were plot-
ted, visually inspected, and tested for normality. Design matrices were
specified such that the coefficients for the relevant comparisons could be
calculated, e.g., between the baseline and induced states and between ge-
notypes. Only the significance levels are reported.
Results
IL-10 increases TTP expression in LPS-treated macrophages in
a Stat3-dependent manner
TTP expression has been reported to be controlled by the tran-
scription factors Stat1 (in response to IFNs) and Stat6 (in response
to IL-4) (27, 31). Affymetrix analysis revealed that LPS-induced
TTP expression is further enhanced by IL-10 (data not shown) at
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30 min after treatment of Il10/ BMDMs with IL-10 and LPS,
suggesting that TTP may represent a Stat3 target gene involved in
the anti-inflammatory responses to IL-10. To examine the effect of
IL-10 on TTP expression in more detail, we investigated TTP gene
expression in BMDMs conditionally deleted for Stat3 (LysMcre-
Stat3fl/fl) and control LysMcre-Stat3 cells. LysMcre is known to
delete loxP-flanked alleles in macrophage and neutrophil lineages
with 90% efficiency (7). Treatment of BMDMs with IL-10 and
LPS caused a 2- to 3-fold increase in TTP mRNA (Fig. 1A) and
protein levels (Fig. 1B) compared with LPS treatment alone. The
IL-10-mediated increase in TTP expression required Stat3 since in
LysMcre-Stat3fl/fl cells the TTP levels remained unchanged upon
IL-10 treatment. The expression of Stat3 was reduced by 90%
in LysMcre-Stat3fl/fl cells (Fig. 1B), thereby confirming the dele-
tion efficiency by LysMcre. Analysis of TTP primary transcripts
by PCR (Fig. 1C) and nuclear run-on assays (data not shown)
revealed that the IL-10-mediated induction of TTP was caused by
increased transcription.
These findings document that IL-10-activated Stat3 increases
expression of TTP in LPS-stimulated macrophages. IL-10 alone
only weakly increased TTP transcription, and this induction was
not sufficient to generate detectable levels of TTP protein. This
way of regulation resembles that of IFN-induced TTP expression,
which was shown to be activated by IFNs and the IFN-activated
Stat1 only if p38 MAPK signaling (by e.g., LPS) is stimulated in
parallel (27). p38 MAPK is known to increase by yet unclear
mechanisms the transcriptional activity of several Stat members
(32–34).
TTP is required for full inhibitory effect of IL-10 on TNF- and
IL-1 production
To test whether TTP was an effector of the IL-10 anti-
inflammatory responses, we measured the amount of secreted
TNF- by ELISA in BMDMs from TTP/ and control WT lit-
termates that were treated with LPS with or without pretreatment
with IL-10. We measured TNF- production at 6, 8, and 10 h after
LPS stimulation. After 10 h, TNF- was diminished by IL-10 to
20% in control cells, whereas in TTP/ cells only a reduction
to 60% was achieved (Fig. 2A). Similar results were obtained if
cells were treated simultaneously with LPS and IL-10 (Fig. 2B),
although the contribution of TTP to the IL-10 response was higher
in the pretreatment protocol (Fig. 2). These data show that TTP
contributes to IL-10-mediated inhibition of TNF- cytokine
production.
To investigate whether the incomplete IL-10-mediated inhibi-
tion of TNF- production in TTP/ BMDMs resulted from dif-
ferences in mRNA amounts or in mRNA decay, we analyzed the
amounts of TNF- mRNA in LPS-stimulated TTP/ and control
BMDMs with or without pretreatment with IL-10. In WT cells,
IL-10 caused a reduction of TNF- mRNA to 40% of the amount
present in cells treated with LPS alone, whereas in TTP/ cells
IL-10 caused a reduction to only 80% of the level in cells treated
with LPS alone (Fig. 2C). In these experiments, TNF- mRNA
was measured after 2 h of LPS treatment since the amount of
TNF- mRNA peaks at this time point (Ref. 13 and data not
shown). To further illustrate the role of TTP in IL-10-mediated
decrease of TNF- mRNA, we analyzed the rate of TNF- mRNA
decay in LPS-stimulated TTP/ and WT BMDMs with or with-
out IL-10 pretreatment. Transcription was stopped after 3 h of LPS
stimulation by addition of actinomycin D, and the degradation of
TNF- mRNA was followed in 15- min intervals for a total of 45
min after imposing the transcriptional stop (Fig. 3A). In LPS-
treated control BMDMs, the decay rate of TNF- mRNA was
increased 2.5-fold by IL-10 treatment (half-life t1⁄2 without IL-10
32 min; t1⁄2 with IL-10  13 min). In LPS-treated TTP/ BM-
DMs, the residual TNF- mRNA decayed with a 2.5-fold longer
half-life (t[1/2]  82 min) compared with WT. This difference is
similar to the one reported previously (35). Importantly, IL-10
treatment of LPS-stimulated TTP/ cells did not increase the
decay rate and the remnant mRNA levels were comparable to
those in cells treated with LPS alone. LPS-stimulated macrophages
produced endogenous IL-10 that is known to mask to some extent
the effect of added IL-10 (see Ref. 18). Since TTP was recently
FIGURE 1. IL-10-mediated increase of TTP expression in LPS-treated
macrophages depends on Stat3. A, BMDMs from LysMcre-Stat3 (LysM-
Stat3) and LysMcre-Stat3fl/fl (LysM-Stat3fl/fl) mice were treated for 1 h
with LPS (L), IL-10, or both (IL-10/L). Induction of TTP mRNA was
quantified using qRT-PCR. Bars indicate SDs, n  3. B, BMDMs from
LysMcre-Stat3 (LysM-Stat3) and LysMcre-Stat3fl/fl (LysM-Stat3fl/fl) ani-
mals were left untreated or treated with IL-10 (IL), LPS (L), or both (IL/L)
for 3 h. TTP protein levels were analyzed by Western blotting of cell
extracts using TTP Ab. TTP appears in multiple bands representing phos-
phorylated forms. Blot was reprobed with Stat3 Ab to control for Stat3
deletion in LysMcre-Stat3fl/fl cells and panERK Ab for loading control.
Differences in TTP levels (normalized to panERK and quantitated using
infrared imaging system Odyssey) in cells treated with IL-10/LPS com-
pared with LPS alone are indicated. C, BMDM (WT) were stimulated for
30 min with LPS (L), IL-10, or both (IL-10/L), total RNA was isolated,
DNase treated, and the amount of primary transcript was determined by
qRT-PCR. Bars indicate SDs, n  3.
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shown to target IL-10 mRNA for degradation (36), we asked
whether TTP/ BMDMs produce more IL-10 after stimulation
with LPS. Cytokine measurement revealed that TTP-deficient cells
secrete 2- to 3-fold more IL-10 than the WT cells (supplemental
Fig. S15). To assess the contribution of endogenous IL-10 to the
IL-10-mediated TNF- mRNA decay, we compared the TNF-
mRNA levels and decay rates in IL-10/ and WT cells. IL-10/
BMDMs expressed 2-fold more TNF- than WT cells (Fig. 3B).
Importantly, the reduction of TNF- mRNA by exogenous IL-10
was more pronounced in IL-10/ cells compared with WT cells.
The decay rate of TNF- mRNA was not affected by IL-10 treat-
ment of WT cells stimulated for 1 or 2 h with LPS (Fig. 3C).
However, IL-10 accelerated the decay rate in IL-10/ cells
treated for 2 h with LPS, but not for 1 h (Fig. 3D). Therefore,
endogenous IL-10 can mask to a certain extent the effect of exog-
enous IL-10 on the mRNA decay. In addition, the IL-10-mediated
increase in mRNA decay rate becomes more apparent at later time
points of LPS treatment, consistent with the need for new protein
synthesis (e.g., TTP). Note that the duration of LPS treatment in
Fig. 3A was 3 h and that the differences in IL-10-imposed inhibi-
tion of TNF- production in TTP/ vs WT cells increased with
time of LPS treatment (Fig. 2, A and B).
To further substantiate the role of TTP in the anti-inflammatory
effects of IL-10, we measured the IL-10-mediated reduction of
IL-1 protein and mRNA in TTP/ and WT cells (Fig. 3, E and
F). Efficient LPS-stimulated production of IL-1, a known IL-10
target (13), depends on a second stimulus, such as ATP, that ac-
tivates the IL-1-processing function of the inflammasome (37). Al-
though IL-1 is not a direct substrate of caspase 1, production of
mature IL-1 has been shown to be inflammasome/caspase 1 de-
pendent (37). BMDMs from WT and TTP/ animals were stim-
ulated with LPS (10 h) and ATP (1 h before the collection of
supernatants) in the presence or absence of IL-10. IL-10 caused a
decrease of IL-1 protein to 20% of LPS plus ATP-treated WT
cells, whereas in TTP/ cells the IL-1 production was reduced
only to 60% of the LPS plus ATP-treated samples (Fig. 3E). Sim-
ilar differences between WT and TTP/ cells were determined
also for the IL-10-mediated decrease in IL-1 mRNA (Fig. 3F).
To rule out that the absence of TTP affected activation of Stat3
by IL-10 that might result in reduced IL-10 responsiveness of
TTP/ cells, the IL-10-induced tyrosine phosphorylation of Stat3
was determined in LPS-stimulated TTP/ and WT BMDMs in
the presence or absence of IL-10. The level of tyrosine-phospho-
rylated Stat3 was under all conditions comparable in both geno-
types (supplemental Fig. S2A). In addition, the stimulatory effect
of LPS was similar in TTP/ and WT cells as judged by the
activation of p38 MAPK (supplemental Fig. S2B). Thus, a differ-
ent activation of the critical proinflammatory (p38 MAPK) and
anti-inflammatory (Stat3) components in the WT and TTP/ cells
could be excluded as a reason for the observed differences in IL-10
responses.
These data establish that TTP plays an important role in IL-10-
mediated down-regulation of two critical inflammatory cytokines
(TNF- and IL-1).
TTP function in IL-10 responses depends on IL-10-mediated
reduction of p38 MAPK activity at later phase of inflammation
IL-10 and IL-6 are both known to activate Stat3 yet only IL-10
exhibits anti-inflammatory properties (38–40). To examine
whether and to what extent IL-6 was able to stimulate TTP ex-
pression, BMDMs were treated with LPS with or without IL-6.
5 The online version of this article contains supplemental material.
FIGURE 2. TTP is required for full IL-10-mediated inhibition of TNF-
production. A, Reduction of LPS-induced TNF- cytokine production in cells
pretreated with IL-10. BMDMs from WT and TTP/ mice were treated with
LPS or pretreated overnight (o/n) with IL-10 followed by stimulation with LPS
(ILon/LPS) for indicated time points. Supernatants were collected and ana-
lyzed for TNF- cytokine levels by ELISA. Reduction of TNF- cytokine
levels by IL-10 pretreatment (IL-10 o/n) relative (in percent) to LPS-alone
treatment (100%) is depicted. SDs (n  4) are indicated. B, Effect of simul-
taneous treatment with IL-10 and LPS on TNF- cytokine production per-
formed as described in A. Relative amounts of TNF- cytokine secreted by
LPS-treated WT and TTP/ BMDMs compared with cells simultaneously
treated with IL-10/LPS are shown. SDs (n 3) are indicated. C, Reduction of
LPS-induced TNF- mRNA in cells pretreated with IL-10. WT-BMDMs and
TTP-deficient BMDMs (TTP/) were treated 2 h with LPS or pretreated
overnight with IL-10 followed by LPS addition (IL-10/L) and analyzed for
expression of TNF- by qRT-PCR, normalized to HPRT mRNA. Shown is the
reduction of TNF- mRNA levels after IL-10/LPS treatment in relation to the
sample treated with LPS alone. SDs (n  3) are indicated.
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Interestingly, IL-6 was able to increase TTP expression in LPS-
treated macrophages almost to the same extent as IL-10 (Fig. 4A).
Yet, consistent with the known properties of IL-6, IL-6 was not
able to inhibit TNF- (Fig. 4B) and IL-1 (Fig. 4C) in either WT
or TTP/ BMDMs. These data also implicate that the up-regu-
lation of TTP expression by IL-10 cannot solely explain the role of
TTP in the anti-inflammatory effects of this cytokine. We specu-
lated that the role of TTP in IL-10 responses might be explained by
an IL-10-dependent increase in TTP activity. TTP function is
known to be negatively regulated by p38 MAPK and its down-
stream kinase MK2 (41). IL-10 has been reported to modestly
inhibit p38 MAPK in the later phases of LPS treatment (18). The
reduction of p38 MAPK activity is caused by the IL-10-mediated
up-regulation of the dual-specificity phosphatase DUSP1 (Ref. 18
and Fig. 4F). We reasoned that such a reduction in p38 MAPK
could relieve the p38 MAPK-dependent inhibition of TTP, thereby
increasing the ability of TTP to down-regulate its target mRNAs.
To investigate whether IL-6 was also able to reduce p38 MAPK
activity, BMDMs were stimulated with LPS alone or along with
either IL-10 or IL-6 and p38 MAPK activity was monitored after
2, 4, and 6 h. Treatment of LPS-stimulated cells with IL-10 caused
a modest (3-fold) but consistent inhibition of p38 MAPK at 2, 4,
and 6 h compared with the samples treated with LPS alone (Fig.
4D). To better document the IL-10 effect on p38 MAPK phos-
phorylation, the complete time course of IL-6- and IL-10-treated
samples was run on a single gel (supplemental Fig. S3A). The
LPS-induced activation of p38 MAPK at an early time point (30
min) was not affected by IL-10 cotreatment (Fig. 4E). Importantly,
FIGURE 3. TTP is required for IL-10-mediated acceleration of TNF- mRNA decay and for full IL-10-dependent reduction of IL-1. A, IL-10-induced
changes in decay of TNF- mRNA. WT-BMDMs and TTP-deficient BMDMs (TTP/) were pretreated with IL-10 overnight and stimulated for 3 h with
LPS followed by addition of actinomycin D (act D; 5 g/ml) to stop transcription. After the indicated time points, TNF- mRNA was quantified using
qRT-PCR. Values were normalized against the housekeeping gene HPRT. Remnant TNF- mRNA in percentage of the amount at the time point 0 of
actinomycin D treatment is depicted. SDs (n  3) are indicated. B, Effects of endogenous IL-10 on TNF- mRNA induction in LPS- or LPS/IL-10-treated
BMDMs. BMDMs derived from WT or IL-10/ animals were treated for 1 or 2 h with LPS in the presence or absence of IL-10. The amount of TNF-
mRNA in these cells was determined by qRT-PCR. C and D, TNF- mRNA decay in WT (C) and IL-10/ (D) BMDMs. BMDMs were treated for 1 or
2 h with LPS in the presence or absence of IL-10. Thereafter, the transcription was stopped by actinomycin D and the remaining TNF- mRNA was
determined at the indicated times by qRT-PCR. Remnant TNF- mRNA in percentage of the amount at the time point 0 of actinomycin D treatment is
depicted. E, Reduction of IL-1 cytokine by IL-10. BMDMs from WT and TTP/ mice were treated with LPS for 10 h in the presence or absence of
IL-10. ATP was added 1 h before the collection of supernatants. Supernatants were collected and analyzed for IL-1 cytokine levels by ELISA. Reduction
of IL-1 cytokine levels by IL-10 pretreatment relative (in percent) to LPS alone treatment (100%) is depicted. SDs are indicated, n  3. F, Reduction
of IL-1 mRNA by IL-10. BMDMs from WT and TTP/ mice were treated with LPS for 2 h in the presence or absence of IL-10. IL-1 expression was
analyzed by qRT-PCR. Reduction of IL-1 mRNA by IL-10 treatment relative (in percent) to LPS alone treatment (100%) is depicted.
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p38 MAPK activity was not reduced by treatment with IL-6 at any
time point examined (Fig. 4, D and E, and supplemental Fig. S3A).
These findings are in agreement with the induction of mRNA for
the MAPK phosphatase DUSP1 by IL-10 but not IL-6 in LPS-
treated macrophages (18). To further support the role of DUSP1 in
the IL-10-mediated effect on p38 MAPK activity, we examined
p38 MAPK phosphorylation in DUSP1/ BMDMs treated with
LPS alone or along with either IL-10 or IL-6 for 4 h. In DUSP1/
cells, IL-10 was no longer able to reduce p38 MAPK phosphory-
lation after treatment (Fig. 4F). Consistent with the IL-10-medi-
ated decrease in p38 MAPK phosphorylation, at the 4 h-time point,
the induction of DUSP1 by IL-10 plus LPS compared with LPS
alone was more apparent than after a shorter treatment (1 h; sup-
plemental Fig. S3B). The different effect of IL-10 and IL-6 on p38
MAPK is in agreement with the anti-inflammatory properties that
are exhibited by IL-10 but not IL-6. The difference between IL-10
and IL-6 with regard to their anti-inflammatory properties has been
attributed to SOCS3 that, as part of the negative feedback loop,
binds to the gp130 subunit of the IL-6 receptor but not to the IL-10
receptor (38–40). Thus, SOCS3, a Stat3 target gene, is able to
inhibit signaling elicited by IL-6 but not by IL-10. Consequently,
IL-10 induces a prolonged Stat3 activation, whereas IL-6-mediated
Stat3 activation is rapidly shut down. Consistently, in LPS-treated
BMDMs IL-10 and IL-6 caused a comparable Stat3 activation af-
ter 30 min of cytokine treatment, whereas after 2 h Stat3 remained
active only in cells stimulated with IL-10 but not IL-6 (supple-
mental Fig. 3C). These data suggest that a sustained Stat3 activa-
tion is needed for inhibition of p38 MAPK.
Although p38 MAPK is needed for TTP expression and protein
stability (24, 25, 42), the kinase negatively regulates TTP activity at
least at two levels. First, phosphorylation of TTP at Ser52 and Ser178
by MAPK-activated protein kinase kinase 2 (MK2), a kinase down-
stream of p38 MAPK, provides binding sites for 14-3-3 proteins that
reduce the destabilizing activity of TTP (23, 43). Second, phosphor-
ylation of TTP by MK2 was reported to negatively regulate its bind-
ing to AREs (25). To show that the IL-10-mediated decrease in p38
MAPK activity was able to change TTP properties in terms of its
phosphorylation and binding to AREs, we analyzed the mobility of
TTP in SDS-PAGE and binding of TTP to AREs in EMSA experi-
ments. TTP appears in SDS-PAGE in the form of multiple bands that
reflect various degree of predominantly p38 MAPK-dependent phos-
phorylation (24). To demonstrate p38 MAPK effects on TTP phos-
phorylation and binding to AREs, we first used an inducible expres-
sion of TTP in HeLa-Tet-off cells. This system allows manipulation of
p38 MAPK activity without affecting the transcription of the TTP
gene that is known to require p38 MAPK activity (27, 42). Stimula-
tion of HeLa-Tet-off cells expressing TTP (i.e., without tetracycline)
with anisomycin (a p38 MAPK agonist (44)) resulted in a more pro-
nounced appearance of a slower migrating hyperphosphorylated
TTP band, whereas the p38 MAPK inhibitor SB reduced the
amount of the hyperphosphorylated TTP and also the total TTP
level due to TTP protein destabilization (Fig. 5A). The analysis of
FIGURE 4. Effects of IL-6 on TTP expression, TNF- and IL-1 production, and p38 MAPK activation in LPS-treated BMDMs. A, IL-6 and
IL-10 increase TTP expression to similar levels in LPS-treated BMDMs. BMDMs were stimulated for 2 h with LPS alone or along with IL-10 or
IL-6, and whole cell extracts were prepared. Expression of TTP was analyzed by Western blotting. panERK Ab was used for loading control. B and
C, IL-6 does not reduce TNF- production (B) or IL-1 (C) production in LPS-treated TTP/ and control WT BMDMs. WT and TTP/ BMDMs
were stimulated for 10 h with LPS with or without cotreatment with IL-6. Amounts of TNF- and IL-1 in supernatants were determined by ELISA.
SDs of three representative experiments (n  3) are indicated. D, IL-10 but not IL-6 decreases p38 MAPK activity in LPS-treated BMDMs. Whole
cell extracts of BMDMs treated for 2, 4, and 6 h with LPS alone or cotreated with IL-10 or IL-6 were analyzed for activation of p38 MAPK by
Western blotting using Ab to activated p38 MAPK (pp38). Ab to total p38 MAPK (p38) was used for loading control. E, p38 MAPK is not inhibited
by IL-10 or IL-6 after 30 min of treatment. BMDMs were treated for 30 min with LPS with or without cotreatment with IL-10 or IL-6. p38 MAPK
activation was determined as in D. F, IL-10 no longer reduces p38 MAPK phosphorylation in DUSP1/ BMDMs. DUSP1/ BMDMs were treated
for 4 h with LPS alone, LPS  IL-10 or LPS  IL-6, and the activation of p38 MAPK was examined as in D. Figures are representative of at least
three experiments.
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the same extracts in a RNA EMSA experiment revealed that ani-
somycin reduced binding of TTP to the TNF- ARE by 50% (Fig.
5B), whereas inhibition of p38 MAPK resulted in a similar amount
of ARE-bound TTP as in untreated cells (Fig. 5B) despite a re-
duced TTP protein level present in that sample (compare SB-la-
beled lanes in Fig. 5A and 5B). Consistent with the IL-10-mediated
p38 MAPK inhibition, the treatment of BMDMs with LPS plus
IL-10 resulted in a shift to less phosphorylated TTP bands in SDS-
PAGE if compared with cells treated with LPS alone or with LPS
plus IL-6 (Fig. 5C). This shift to faster migrating TTP bands was
more pronounced after 6 h of treatment. To address the IL-10
effect on TTP binding to AREs, we used the murine macrophage
cell line RAW 264.7 since we were not able to detect TTP-ARE
complexes in RNA EMSA experiments if BMDMs were used.
LPS-stimulated RAW 264.7 cells express at least 3- to 5-fold more
TTP than BMDMs (data not shown). Similar to BMDMs, LPS plus
IL-10 treatment resulted in a more pronounced appearance of the
hypophosphorylated TTP if compared with treatment with LPS
alone or LPS plus IL-6 (Fig. 5D). Consistently, LPS plus IL-10
treatment caused an 50–80% increase in the formation of TTP-
ARE complexes in RNA EMSA experiments compared with LPS
alone or LPS plus IL-6 treatments (Fig. 5E). These data show that
IL-10 decreases the phosphorylation of TTP and enhances the in
vitro binding of TTP to TNF- ARE in a manner similar to the
pharmacological inhibition of p38 MAPK. These findings are in
agreement with an increased TTP activity under conditions of re-
duced p38 MAPK activation as is the case in IL-10-treated cells.
Interestingly, despite the reduced p38 MAPK activity and hence
increased proteasome-mediated TTP degradation in IL-10-treated
cells, the TTP protein levels were not diminished compared with
LPS plus IL-6-treated cells (Fig. 5, C and D). We explain this
observation by the sustained Stat3 activation and, hence, a strong
Stat3-driven transcription of the TTP gene in IL-10-treated cells
(supplemental Fig. 3C).
To test whether p38 MAPK activity protects mRNA from TTP-
mediated decay, we examined the stability of TNF- and IL-1
FIGURE 5. IL-10 reduces TTP phosphorylation and increases in vitro binding of TTP to ARE. A and B, HeLa-Tet-off cells were transiently transfected
with pTRE-TTPfl and equally split into four 6-cm dishes. In three dishes, the expression of TTP was allowed overnight in medium without tetracycline
(Tet), whereas in one dish the TTP expression was blocked by tetracycline (Tet). The (Tet) cells were treated for 60 min with anisomycin (aniso)
or SB. Whole cell extracts were prepared and split into one part for Western blot analysis (A) and a second part for RNA EMSA (B). The position of
hyperphosphorylated (hyper-p.) and hypophosphorylated (hypo-p.) TTP is marked in A. B, The TTP-ARE complexes (TTP) were identified by a supershift
(ssTTP) using a TTP Ab (TTP). The relative intensity of the TTP-ARE complexes (as indicated be the numbers 1.5, 1, and 1.4) was quantitated using
the LI-COR Odyssey software (supplementary Fig. 4A). C, Whole cell extracts of BMDMs treated for 4 and 6 h with LPS alone or cotreated with IL-10
or IL-6 were analyzed for TTP expression and SDS-PAGE mobility by Western blotting using Ab to TTP. Equal protein loading was controlled by
reprobing with an anti-ERK Ab. The position of hyperphosphorylated (hyper-p.) and hypophosphorylated (hypo-p.) TTP is marked. D, Whole cell extracts
of RAW 264.7 treated for 6 h with LPS alone or cotreated with IL-10 or IL-6 were analyzed as in C. E, Whole cell extracts of RAW 264.7 cells treated
for 4 or 6 h with LPS alone or cotreated with IL-10 or IL-6 were assayed for in vitro binding of TTP to TNF- ARE using RNA EMSA. The relative
intensity of the TTP-ARE complexes (as indicated by the numbers 1, 2, 1.3, 1.3, 1.8, and 1.3) was quantitated using the LI-COR Odyssey software
(supplementary Fig. 4B). To control the position of the TTP-ARE complexes extracts from HeLa-Tet-off cells expressing TTP (Tet) or without TTP
expression (Tet) were used. The data are representative of three independent experiments.
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mRNAs in the presence of the p38 MAPK inhibitor SB in TTP/
and control WT BMDMs. Two hours after LPS stimulation, SB
was added in combination with actinomycin D. p38 MAPK inhi-
bition caused a 4-fold decrease of mRNA stability of TNF-
(TNF- without SB: t1⁄2  31 min; TNF- with SB: t1⁄2  8 min)
and an 8- to 10-fold decrease in IL-1 mRNA stability (IL-1
without SB: t1⁄2 2 h; IL-1 with SB: t1⁄2  14 min; Fig. 6). In
TTP/ cells, the inhibition of p38 MAPK caused only a modest
(2-fold) decrease in mRNA stability of TNF- mRNA (TNF-
without SB: t1⁄2  80 min; TNF- with SB: t1⁄2  37 min with SB)
and no detectable decrease of IL-1 mRNA stability (IL-1 with-
out SB: t1⁄2  2 h; IL-1 with SB: t1⁄2  2 h). These data
indicate that the augmentation of mRNA decay by inhibition of
p38 MAPK is to a large part TTP dependent. The contribution of
TTP to the effects of p38 MAPK inhibition depends on the nature
of the target mRNA.
We conclude that the IL-10-mediated reduction of p38 MAPK
activity increases TTP-dependent mRNA decay. The combined ef-
fect of IL-10 on p38 MAPK activity and TTP expression contrib-
utes to the anti-inflammatory properties of IL-10.
Discussion
This study provides evidence that the mRNA- destabilizing fac-
tor TTP plays an important role in anti-inflammatory effects of
IL-10. BMDMs deficient in TTP show a strongly reduced anti-
inflammatory response to IL-10. Two cytokines, TNF- and IL-
1, were here demonstrated to be inhibited by IL-10 in a TTP-
dependent manner. IL-10 appears to regulate TTP function in two
ways (Fig. 7). First, IL-10 increases TTP expression in LPS-treated
BMDMs. This augmented expression depends on Stat3, the key
immediate effector of IL-10 effects. Second, IL-10 reduces at later
time points the activity of p38 MAPK in LPS-treated BMDMs,
hereby releasing TTP from the p38 MAPK-mediated inhibition.
Since the increased expression of TTP is not sufficient to initiate an
anti-inflammatory response (as demonstrated by IL-6-mediated
up-regulation of TTP), we conclude that the TTP-dependent IL-10
effects can be best explained by the combination of higher TTP
expression and reduction of p38 MAPK activity.
TTP is known for its mRNA-destabilizing activity most notably,
but not exclusively, toward TNF- mRNA via AREs in 3 UTR.
Thus, the IL-10-mediated rise in TNF- decay rate is consistent
with the elevated TTP levels and activity. In addition to TNF-,
our data suggest that IL-1 is also a TTP target. The 3 UTR of the
murine IL-1 (GenBank accession no. NM_010554; http://www.
ncbi.nlm.nih.gov/GenBank/) contains three elements (UAUUUA
UA, AUAUUUAU, and UAUUAUUUAU) with similar sequences
as the nonameric canonical sequence (UUAUUUAUU) recognized
by TTP (45, 46). IL-1 has so far not been described as TTP target
despite of several recently published global screens for novel TTP
targets (36, 47). However, these searches revealed that in such
global screens important targets might be missed (e.g., TNF- in
the study of Stoecklin et al. (36)). In addition, the finding that TTP
regulates also mRNAs with no obvious AREs in 3 UTR adds
another degree of complexity to searches for TTP targets (47). The
role of TTP in IL-10 responses is also in agreement with a study
reporting IL-10-mediated ARE-dependent destabilization of
CXCL1 mRNA (16). Importantly, in that study, the IL-10-induced
mRNA decay was not detectable before 2 h of LPS/IL-10 treat-
ment. This time point correlates well with the appearance of TTP
expression (42) and with our data showing that IL-10-mediated
decay of TNF- mRNA is not apparent before 2 h of LPS
treatment.
FIGURE 6. Effects of p38 MAPK inhibition on TTP-dependent re-
duction of mRNA for TNF- and IL-1. A and B, WT and TTP/
BMDMs were treated with LPS for 2 h, followed by treatment with SB
or solvent control. Actinomycin D was added simultaneously with SB.
The decay rates of TNF- (A) and IL-1 (B) were monitored by qRT-
PCR for the times indicated. Remnant TNF- or IL-1 mRNA in per-
centage of the amount at the time point 0 of actinomycin D treatment is
depicted.
FIGURE 7. Model of IL-10-mediated anti-inflammatory effects. IL-10
activates the transcription factor Stat3 that drives the expression of at least
three effector genes. The still unidentified repressors of transcription are
depicted by question marks. The other effector is TTP that requires the
activity of a third effector, the DUSP1 phosphatase, that reduces the ac-
tivity of p38 MAPK, thereby increasing the TTP-destabilizing activity to-
ward specific ARE-containing mRNAs. The activity of DUSP1 can be
mimicked by, for example, the p38 MAPK inhibitor SB.
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TTP-deficient cells are known to produce 2- to 3-fold more
TNF- (both mRNA and cytokine) than WT cells (26, 48). At the
same time, IL-10 mRNA was shown to be targeted by TTP for
degradation (36) and we found that the TTP-deficient BMDMs
produce more IL-10 cytokine (supplemental Fig. S1). Thus, TTP
cells produce more of both the proinflammatory TNF- and the
anti-inflammatory IL-10. Yet, the TTP cells still respond to IL-10
treatment (by e.g., Stat3 activation) and LPS treatment (by e.g.,
p38 MAPK activation) similarly as the WT cells (Fig. 4). We
conclude that despite the 2- to 3-fold higher production of pro- and
anti-inflammatory cytokines the TTP-deficient cells display
comparable immediate-early response to pro- (LPS) or anti-
inflammatory (IL-10) stimuli as WT cells.
We were not able to detect any differences in the TTP expres-
sion or p38 MAPK activity, the two key factors influencing the
TTP function, when we compared the two protocols for IL-10
treatment. Thus, the higher absolute contribution of TTP to IL-10
responses in the pretreatment protocol suggests that IL-10 induces
a cofactor of TTP during the pretreatment period. TTP serves as an
adaptor protein linking mRNA to the mRNA processing and deg-
radation machinery located in stress granules and processing bod-
ies (21, 22). Some of the components of these complexes may be
up-regulated by IL-10 during the pretreatment phase to enhance
TTP function. Alternatively, IL-10-activated Stat3 may increase
transcription of micro-RNAs such as micro-R16 that was shown to
assist TTP in degradation of ARE-containing mRNAs (49). The
influence of the experimental protocol on the IL-10 effects may
also partially explain the discrepancy between our study and the
study of Kontoyiannis et al. (14) who found no evidence for a role
of TTP in IL-10 responses in the simultaneous treatment protocol.
Instead, they proposed a rapid (within 15 min of IL-10 treatment)
inhibition of p38 MAPK as the main mechanism of IL-10 action.
We did not detect any inhibition of p38 MAPK activity by IL-10
at early time points regardless of applied protocol for IL-10 treat-
ment (supplemental Fig. S2, A and B). These data are in agreement
with several other studies showing no effect of IL-10 on p38
MAPK activity at early time points (2, 12, 50, 51). In a kinetics
analysis of p38 MAPK activity, IL-10 was found to exhibit a mod-
est inhibitory effect on p38 MAPK activity at later time points
(after 3 h of LPS plus IL-10 treatment) (18). The IL-10-mediated
inhibition of p38 MAPK correlated with the induction of the dual-
specificity phosphatase DUSP1, a MAPK phosphatase (18). We
observed a similar reduction in p38 MAPK phosphorylation in
terms of both, the magnitude and kinetics, and found that DUSP1
was required for this effect. The inhibition of p38 MAPK was
caused specifically by IL-10 but not by IL-6 and correlated with
the ability of IL-10 (but not IL-6) to induce sustained Stat3 acti-
vation. Consistently, IL-10 but not IL-6 was reported to increase
expression of DUSP1 in LPS-treated macrophages (18). DUSP1
function as a critical p38 MAPK-inactivating enzyme provides the
most likely explanation for the susceptibility of DUSP1/ mice
to LPS-mediated toxic shock (52, 53). We speculate that the inhi-
bition of the proinflammatory p38 MAPK by IL-10 at the later
stages of macrophage stimulation is a key factor in immune ho-
meostasis since p38 MAPK influences inflammation-related tran-
scription, RNA stability, translation, as well as secretion. To
mimic the inhibition of p38 MAPK by IL-10 at the late phase of
stimulation, we used the p38 MAPK inhibitor SB and examined
the effect of p38 MAPK on the TTP-dependent decrease of target
mRNA molecules. Interestingly, whereas in the case of TNF- a
different decay rate (i.e., different decay rate in TTP/ and
TTP/ cells) was observed also without p38 MAPK inhibition,
for IL-1 mRNA the TTP-dependent decay was detectable only if
p38 MAPK was inhibited (Fig. 5). A similar requirement for p38
MAPK inhibition has been recently described also for the TTP
target CXCL1 (KC) mRNA (54). These findings indicate that the
p38 MAPK-mediated control of TTP activity has a differential
impact on target mRNAs. Although the TTP-dependent decay of
some mRNAs (e.g., TNF-) proceeds in the presence of p38
MAPK activity, the degradation of other mRNAs (e.g., IL-1 and
CXCL1) is strongly dependent on the kinase inhibition. This
mechanism may play an important role in the specificity of TTP-
mediated RNA decay: depending on the activation status of p38
MAPK or other kinases implicated in regulation of TTP activity
(e.g., ERK of MK2), TTP would discriminate between various
targets. The critical role that p38 MAPK plays in TTP-mediated
RNA decay also suggests that the time point that is taken to de-
termine RNA stability has a decisive effect on the outcome of the
assay. The activation/inactivation profile of p38 MAPK is likely to
vary between different experimental settings (e.g., amount and
quality of LPS, the use of primary or immortalized cells, the origin
of primary cells such as bone marrow or peritoneum) so that this
aspect may also contribute to the variability of published data. For
example, we did not observe an IL-10-mediated increase in TNF-
mRNA decay in peritoneal-derived macrophages.
Suppression of inflammatory responses by IL-10 is one of the
key features in immune homeostasis. Despite many years of re-
search, the question of how a single cytokine can specifically in-
hibit various inflammatory reactions with such a high efficiency
remains unresolved. Recent studies suggest that known as well as
yet unknown IL-10 effectors interfere on different levels and by
different mechanisms with the intracellular inflammatory net-
works. This multitasking system employed by IL-10 is likely to be
essential for the efficiency and specificity of the anti-inflammatory
properties of IL-10. For example, the efficient and dominant inhi-
bition of Tnf gene transcription by IL-10 still requires the remain-
ing TNF- mRNA to be removed from the system, i.e., by TTP.
Although the primary IL-10-elicited signaling events that involve
the IL-10 receptor, Jak1 and Tyk2 kinases, as well as the tran-
scription factor Stat3, are to a large part common to all cell types,
the more complex effects downstream of Stat3 may be cell type
dependent. Thus, the function and activity of the Stat3-induced
IL-10 effectors may be regulated by the environment within the
particular cell type, hereby helping to explain the still incoherent
and sometimes contradictory studies of the anti-inflammatory ef-
fects of IL-10.
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Summary
The opportunistic human fungal pathogen Candida
glabrata is confronted with phagocytic cells of the
host defence system. Survival of internalized cells
is thought to contribute to successful dissemina-
tion. We investigated the reaction of engulfed
C. glabrata cells using fluorescent protein fusions
of the transcription factors CgYap1 and CgMig1
and catalase CgCta1. The expression level and
peroxisomal localization of catalase was used to
monitor the metabolic and stress status of inter-
nalized C. glabrata cells. These reporters revealed
that the phagocytosed C. glabrata cells were
exposed to transient oxidative stress and starved
for carbon source. Cells trapped within macro-
phages increased their peroxisome numbers indi-
cating a metabolic switch. Prolonged phagocytosis
caused a pexophagy-mediated decline in peroxi-
some numbers. Autophagy, and in particular
pexophagy, contributed to survival of C. glabrata
during engulfment. Mutants lacking CgATG11 or
CgATG17, genes required for pexophagy and
non-selective autophagy, respectively, displayed
reduced survival rates. Furthermore, both CgAtg11
and CgAtg17 contribute to survival, since the
double mutant was highly sensitive to engulfment.
Inhibition of peroxisome formation by deletion of
CgPEX3 partially restored viability of CgATG11
deletion mutants during engulfment. This sug-
gests that peroxisome formation and maintenance
might sequester resources required for optimal
survival. Mobilization of intracellular resources
via autophagy is an important virulence factor
that supports the viability of C. glabrata in the pha-
gosomal compartment of infected innate immune
cells.
Introduction
Candida glabrata belongs to the diverse group of human
fungal pathogens and is phylogenetically closely related
to Saccharomyces cerevisiae (Kaur et al., 2005, Marcet-
Houben and Gabaldon, 2009). The high similarity of
C. glabrata to S. cerevisiae suggests that also for fungi,
relatively small genetic changes may be sufficient for
adaptation to a pathogenic lifestyle (Dujon et al., 2004).
C. glabrata is a common commensal, but can turn into an
opportunistic pathogen with a rising frequency of isolates
among immunocompromised patients and elder people
(Li et al., 2007; Pfaller and Diekema, 2007; Presterl et al.,
2007). In the host environment, C. glabrata has to evade
or survive attacks of the cell-mediated immune system
(Nicola et al., 2008). Counterstrategies of fungal patho-
gens differ between species. Candida albicans destroys
macrophages by hyphal outgrowth. Alternatively, Crypto-
coccus neoformans either lyses macrophages or escapes
via phagosomal extrusion (Alvarez and Casadevall, 2006;
Ma et al., 2006). C. glabrata engulfed by macrophages do
not undergo morphological transitions such as C. albicans
(Leberer et al., 2001). An open question concerns how
C. glabrata is coping with cells of the immune system,
such as macrophages.
The phagosome is a hostile environment for fungi
(reviewed in Nicola et al., 2008). After internalization of
microbial cells, the organelle maturates into the phagolyso-
some containing mature hydrolytic enzymes and a more
acidic pH 4.5–5.5 (Geisow et al., 1981; Levitz et al., 1999).
Additionally, the NADPH oxidase complex generates reac-
tive oxidative species to attack internalized microorgan-
isms (for review see Romani, 2004; Segal, 2005). Thus,
commensal and pathogenic fungi are exposed to reac-
tive oxygen species (ROS) produced by polymorpho-
nuclear leucocytes, macrophages and dendritic cells
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(Miller and Britigan, 1997; Missall et al., 2004; Gildea et al.,
2005). On the fungal side, antioxidant defence enzymes
such as catalase, superoxide dismutase, thioredoxin- and
glutathione-dependent peroxidases and reductases guard
against oxidative stress and are thus considered virulence
factors (Johnson et al., 2002; Cox et al., 2003; Missall
et al., 2004; Chaves et al., 2007). Oxidative stress as
defence strategy is not restricted to combat fungal infec-
tions. Invading bacteria, such as Staphylococcus aureus,
or the malaria parasites Plasmodium sp., face ROS stress
upon engulfment (Becker et al., 2004; Voyich et al., 2005).
ROS sensed by microbes act also as signalling molecules.
The C. albicans catalase, an enzyme which decomposes
hydrogen peroxide, has been investigated more closely.
C. albicans induces catalase when engulfed in neutrophils
or in macrophages (Rubin-Bejerano et al., 2003; Lorenz
et al., 2004; Enjalbert et al., 2007). Moreover, hydrogen
peroxide promotes the morphological transition of C. albi-
cans cells to hyphal growth, a form invading the host tissue
(Nakagawa, 2008; Nasution et al., 2008). Finally, C. albi-
cans devoid of catalase was eliminated more efficiently in
a mouse infection model (Nakagawa et al., 2003). The
filamentous fungus Aspergillus fumigatus lacking the cata-
lases expressed in the mycelium exhibited delayed infec-
tion in a rat model of invasive aspergillosis (Paris et al.,
2003). In contrast, C. glabrata catalase was not a virulence
determinant in an immunocompromised mouse model
(Cuellar-Cruz et al., 2008). In mice infected with a C. neo-
formans mutant devoid of all four catalases, mortality was
unchanged (Giles et al., 2006). Thus the relative impor-
tance of individual ROS scavenging enzymes varies
between fungal pathogens.
Besides being exposed to oxidative stress, cells
engulfed by macrophages adjust their metabolic pro-
gramme (Fan et al., 2005; Barelle et al., 2006). Engulfed
C. albicans cells induce many genes involved in non-
fermentative carbon metabolism (Prigneau et al., 2003;
Lorenz et al., 2004). Phagocytosed C. glabrata induces
genes encoding enzymes involved in b-oxidation, the gly-
oxylate cycle and gluconeogenesis (Kaur et al., 2007).
Moreover, the glyoxylate cycle, which is required to
channel fatty acid-derived two carbon units into metabo-
lism, was early recognized as a virulence determinant for
C. albicans (Lorenz and Fink, 2001). Other human fungal
pathogens also induce glyoxylate cycle components
during infection conditions (Rude et al., 2002; Canovas
and Andrianopoulos, 2006; Derengowski et al., 2008).
However, A. fumigatus and C. neoformans do not require
the glyoxylate cycle for virulence (Idnurm et al., 2007;
Schöbel et al., 2007). Some of the enzymes of the gly-
oxylate cycle are localized in the peroxisomal matrix (for
review see, e.g. Kunze et al., 2006). Peroxisomes are
inducible, single-membrane organelles which harbour
enzymes for the oxidative catabolism of fatty acids, the
glyoxylate cycle and others. Generally, peroxisome
number and size vary according to metabolic needs (for
review see Yan et al., 2005; Platta and Erdmann, 2007).
Autophagy continuously recycles almost all constitu-
ents of the cell (for review see Mizushima and Klionsky,
2007; Kraft et al., 2009). Different types of autophagy help
organisms to overcome periods of nutrient starvation by
recycling intracellular components to sustain vital cellular
functions. It seems to be linked to the unique niches and
morphology of fungal pathogens (for review see Palmer
et al., 2008). For certain pathogenic fungi, autophagy has
been identified as a virulence factor. C. neoformans
requires an intact autophagy pathway during infection (Hu
et al., 2008). Peroxisomes and their contents are deliv-
ered to the vacuole by the pexophagy pathway, a special-
ized form of autophagy (Guan et al., 2001; Kim et al.,
2001; Farre and Subramani, 2004). In S. cerevisiae selec-
tive pexophagy is dependent on Atg11 and partly on Atg17
which is also important for non-selective autophagy
(Cheong et al., 2005; Yorimitsu and Klionsky, 2005).
Here we investigated responses of C. glabrata during
its encounter with the macrophage phagosome compart-
ment from which it cannot escape. We developed in vivo
reporters to track fungal responses to this environment. To
detect oxidative and glucose starvation stress of cells, we
used fluorescent protein fusions of the C. glabrata ortho-
logues of the S. cerevisiae transcription factors Yap1 and
Mig1 (Kuge et al., 1997; Carlson, 1999). We found the
C. glabrata catalase gene CgCTA1 and catalase activity
regulated by oxidative stress and glucose starvation.
Additionally, we demonstrated GFP–CgCta1 localization
to peroxisomes. C. glabrata peroxisomes have not been
described so far and were here defined by several inde-
pendent criteria. We found that C. glabrata cells engulfed
by mouse macrophages experience a mild oxidative
stress and sustained carbon starvation. Additionally, per-
oxisomes became transiently induced in engulfed cells.
We explored the role of peroxisomes with various mutants
lacking peroxisome biogenesis or autophagy pathways
mediating destruction of peroxisomes. We report here that
autophagy and, surprisingly, pexophagy is a likely viru-
lence factor for C. glabrata. Mutants lacking CgAtg11
and/or CgAtg17 were killed more efficiently by macro-
phages during engulfment. Thus, for engulfed C. glabrata
cells, nutrient deprivation represents a serious challenge
and mobilization of intracellular resources via autophagy
is a major contributor to sustain viability.
Results
C. glabrata catalase CgCta1 is induced by hydrogen
peroxide and carbon starvation
Candida glabrata harbours one catalase gene (CgCTA1,
CAGL0K10868g), related to the yeast peroxisomal cata-
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lase CTA1 gene. The two catalase genes of S. cerevisiae
are regulated differently. CTT1, coding for the cytoplasmic
catalase, is induced by stress conditions (Marchler et al.,
1993). The CTA1 gene is expressed only during growth on
non-fermentable carbon sources (Cohen et al., 1985;
Hartig and Ruis, 1986). To find out the regulatory pattern
of the C. glabrata catalase, we assayed its activity in
crude protein extracts from cells grown either on glucose
or on a non-fermentable carbon source. Cells adapting to
ethanol as carbon source showed a substantial induction
of catalase activity (Fig. 1A). Moreover, mild oxidative
stress of 0.4 mM H2O2 induced C. glabrata catalase acti-
vity about 10-fold suggesting regulation by both glucose
starvation and oxidative stress (Fig. 1B). To verify if the
CgCTA1 gene encodes the only catalase activity in C. gla-
brata, we replaced the open reading frame (ORF) with the
S. cerevisiae URA3 gene (Fig. S1). Catalase activity was
undetectable in extracts derived from the mutant strain
(Fig. 1A and B). A centromeric plasmid (pCgCTA1) har-
bouring the CgCTA1 ORF including a 1.8 kb upstream
region fully restored wild-type level catalase activity to the
cta1D mutant (Fig. 1A and B). To demonstrate that the
regulation of catalase activity occurs at the level of tran-
scription, CgCTA1 mRNA levels were analysed from cells
shifted to medium lacking glucose or exposed to 0.4 mM
H2O2. Glucose-starved cells displayed a continuous
increase of CgCTA1 mRNA immediately after shift to
glucose-free medium (Fig. 1C). Hydrogen peroxide stress
caused a rapid increase within 10 min. Taken together,
regulation of the C. glabrata catalase gene CgCTA1 by
carbon source availability and oxidative stress combines
elements of both S. cerevisiae catalases.
CgCta1 confers hydrogen peroxide stress resistance
The similarity of the CgCTA1 gene to the S. cerevisiae
CTA1 gene suggested its peroxisomal localization. To
clarify the intracellular localization, we fused a green fluo-
rescent protein (GFP) to the CgCta1 N-terminus (GFP–
CgCTA1) to preserve the putative peroxisomal targeting
sequence 1 (PTS1) (Fig. 1C, lower panel). The preceding
1.8 kb of the CgCTA1 5′ untranslated region conferred a
wild type-like expression pattern in hydrogen peroxide-
stressed cells (Fig. 1C). Basal catalase activity of GFP–
CgCta1 was detectable in unstressed cells, whereas
hydrogen peroxide stress-induced activity was reduced to
about 20% of the wild-type level (Fig. 1B).
We assessed if the reduced activity of GFP–Cta1 inter-
feres with hydrogen peroxide stress resistance. C. gla-
brata cta1D mutant cells transformed with either pGFP–
CgCTA1, pCgCTA1 or the empty plasmid (pACT) were
grown in synthetic medium, the cultures were split and
one part treated with 0.4 mM H2O2. Both were subse-
quently exposed to higher doses of hydrogen peroxide.
Growth was scored after 24 h (Fig. 1D). The cta1D mutant
cells containing the empty plasmid failed to grow in
medium containing 5 mM H2O2. In contrast, the strain
carrying the pCgCTA1 plasmid was resistant to medium
supplemented with up to 20 mM H2O2, whereas pre-
incubation with 0.4 mM H2O2 pushed the growth limit to
40 mM H2O2, similar to the wild-type parent strain (DHTU).
Cells expressing the GFP–CgCta1 derivative displayed
lower basal resistance. However, naïve cells without pre-
treatment tolerated 5 mM H2O2 and failed to grow only at
about 20 mM H2O2. Pre-treatment with 0.4 mM H2O2
shifted tolerance to about 30 mM H2O2. Thus, the GFP-
tagged CgCta1 derivative, when compared with the
untagged version, conferred resistance to oxidative stress
to reduced but overall high level. These results suggested
that H2O2 stress resistance of strains carrying the
plasmid-encoded catalase derivatives encompasses the
oxidative stress load of 0.4 mM H2O2 determined for the
in vivo situation (Enjalbert et al., 2007). Our data also
showed that the C. glabrata strains tolerated a substantial
higher oxidative stress load compared with S. cerevisiae
laboratory strains, which failed to grow at concentrations
higher than 3 mM H2O2 (Davies et al., 1995; Cuellar-Cruz
et al., 2008).
Localization of GFP–CgCta1 is dependent on the
carbon source
Cells expressing GFP–CgCTA1 were exposed to different
stress conditions. In rich medium, GFP–CgCta1 fluores-
cence was hardly detectable, reflecting its low basal
expression of CgCTA1. Oxidative stress caused induction
of the GFP–CgCta1 fluorescence signal. To compare dif-
ferent expression levels directly, unstressed cells were
marked by staining their nucleic acids with DAPI. For
microscopy these marked unstressed cells were mixed to
cells from the same culture treated for 1 h with 0.4 mM
H2O2. The micrograph demonstrates induction of the
fusion protein by oxidative stress and its initial localization
in the cytoplasm (Fig. 2A). GFP–CgCTA1 became also
induced after the glucose concentration in the growth
medium dropped below 0.03% (Fig. S2A). We then inves-
tigated GFP–CgCta1 distribution in cells growing on
non-fermentable carbon sources. Cells expressing GFP–
CgCTA1 were grown in medium supplemented with 0.5%
glucose and 1.5% ethanol. After 5 h, glucose was
exhausted, and cells were switching to the non-
fermentable carbon source. (Fig. 2B, left panel). Although
the vast majority of GFP–CgCta1 was still located in the
cytoplasm, small vesicles accumulating catalase became
visible (see insert). After 20 h, almost all GFP–CgCta1
was accumulated in vesicular structures (Fig. 2B, middle
panel).
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Fig. 1. Oxidative stress and carbon source
stress regulate C. glabrata catalase CgCTA1.
A. To measure catalase activity upon glucose
depletion, cells were grown to log phase in
YPD and shifted to medium with 2% or 0.1%
glucose and grown for 4 h. Catalase activity
was determined as described in Experimental
procedures.
B. Cells were incubated in YPD with 0.4 mM
H2O2 for 45 min. Crude cell extracts were
prepared and then assayed for catalase
activity.
C. Northern blot analysis of CgCTA1 mRNA
levels from wild type, ARCg cta1D mutant and
complemented mutant strain was performed
under stress conditions (glucose starvation,
0.4 mM H2O2). Samples were taken at the
indicated time points. CgACT1 mRNA levels
were used as loading control. mRNA levels
were visualized by hybridization of radioactive
probes and autoradiography. The
pCgC–GFP–CgCTA1 construct with GFP
inserted at the N-terminus is illustrated.
D. C. glabrata ARCg cta1D mutant
complemented with pGFP–CgCTA1,
pCgCTA1 or an empty plasmid was grown in
synthetic medium to log phase, adjusted to
105 cells ml-1 and exposed to indicated doses
of hydrogen peroxide. Optical density after
24 h of incubation at 37°C is indicated.
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Fig. 2. Intracellular localization of C. glabrata
catalase.
A. Localization of GFP–CgCta1 was
determined by fluorescence microscopy in
ARCg cta1D cells transformed with
pCgCTA1–GFP–CgCTA1. Cells were
incubated for 1 h after induction of oxidative
stress with 0.4 mM H2O2. Unstressed cells
were stained with DAPI (2 mg ml-1) for 10 min.
Aliquots of both cultures were pooled prior to
microscopy. White arrows indicate unstressed
cells.
B. ARCg cta1D and ARCg pex3D mutant
strains transformed with pCgC–GFP–CgCTA1
were grown in synthetic medium with 0.5%
glucose and 1.5% ethanol for 20 h. White
arrows indicate vesicular structures. Inserts
show enlarged pictures of single cells.
Possible peroxisomal targeting signals 1
(PTS1) detected at the C-terminus of CgCta1,
ScCta1 and CaCct1 (Q6FM56, P15202,
Q5AAT2; Neuberger et al., 2003).
C. Fluorescence signals of strains as in (B)
after growth in medium with 0.2% oleic acid
for 20 h.
D. Number of peroxisomes in C. glabrata cells
during growth with ethanol (1.5%) and oleic
acid (0.2%) as main carbon source.
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CgCta1 can localize to peroxisomes
We suspected that the vesicles accumulating GFP–
CgCta1 were peroxisomes. The PTS1 of CgCta1 was
a boundary case compared with S. cerevisiae Cta1
(Fig. 2B, lower panel). To interfere with C. glabrata per-
oxisome assembly, we chose to eliminate the CgPEX3
gene (CAGL0M01342g). The S. cerevisiae orthologue
Pex3 has an essential function for peroxisome biogenesis
(Hohfeld et al., 1991). The CgPEX3 ORF was replaced
with the ScURA3 gene and the correct integration was
tested by Southern blot (Fig. S1). In these pex3D mutant
cells, GFP–CgCta1 remained distributed in the cyto-
plasm, even in 1.5% ethanol grown cells (Fig. 2B, right
panel). With oleic acid as sole carbon source, S. cerevi-
siae cells increase number and size of peroxisomes
(Thieringer et al., 1991). GFP–CgCta1 accumulated in
vesicles in cells growing in medium containing 0.2% oleic
acid, whereas in pex3D mutant cells fluorescence was
dispersed in the cytoplasm (Fig. 2C). The number of
stained vesicles also increased substantially in cells
growing on a non-fermentative carbon source (1.5%
ethanol) (Fig. 2D). These data suggest that C. glabrata
accumulates GFP–CgCta1 in CgPex3-dependent struc-
tures resembling peroxisomes.
To visualize peroxisomal structures in C. glabrata, we
fused a generic peroxisomal targeting signal peptide
(KNIESKL) derived from the S. cerevisiae citrate syn-
thase to the C-terminus of YFP (Lewin et al., 1990;
Kragler et al., 1993). The YFP–KNIESKL fusion gene
expression was driven by the strong CgADH1 promoter.
YFP fluorescence marked peroxisomes, which increased
their number during growth on ethanol (Fig. 3A, upper
panel) and were absent in pex3D mutant cells (Fig. 3A,
lower panel). This result confirmed the requirement of
CgPex3 for C. glabrata peroxisome biogenesis.
The above results indicated a partial organellar local-
ization of catalase, depending on the type of carbon
source. To show this, we prepared cell extracts of cta1D
mutant cells expressing CgCTA1. We separated these in
an organellar pellet and a cytosolic supernatant fraction
by centrifugation and tested the fractions for catalase
activity. After oxidative stress, the entire induced catalase
activity was found in the cytoplasmic supernatant
(Fig. 3B). In extracts from cells growing with ethanol as
main carbon source, catalase activity was found in the
cytosolic supernatant, but about one-fourth of total activity
was present in the pellet fraction (Fig. 3C, left panel). To
confirm that the pellet fraction contained organelles, we
used cytochrome c oxidase activity as marker enzyme for
mitochondria. Most of the cytochrome c oxidase activity
was found in the pellet fraction (Fig. 3C, right panel).
Separation of extracts derived from cells grown in medium
containing 0.2% oleic acid showed a further shift of cata-
lase activity towards the pellet fraction (Fig. 3D). Activity of
CgCta1 in the various fractions was distributed corre-
sponding to the previously observed intracellular localiza-
tion of GFP–CgCta1. Together, these results showed a
dual localization of C. glabrata catalase depending on the
presence of peroxisomes.
Phagocytosis induces GFP–CgCta1 expression
Fungal pathogens are exposed to a stressful environ-
ment, when they come into contact with phagocytic cells
(Nicola et al., 2008). The regulation and localization of
GFP–CgCta1 made it useful to report the environ-
mental conditions during phagocytosis. C. glabrata cta1D
mutant cells expressing GFP–CgCTA1 grown to expo-
nential phase were used for infection of primary mouse
macrophages. We used time-lapse live microscopy to
follow the fate of individual engulfed cells (Fig. 4A).
Freshly phagocytosed C. glabrata cells reacted to this
environment with a detectable GFP–CgCta1 fluores-
cence signal within 40 min (Fig. 4A and Fig. S2C). Fur-
thermore, during prolonged phagocytosis, GFP–CgCta1
accumulated in peroxisomes. To support the idea of per-
oxisome proliferation during phagocytosis, we followed
localization of the YFP–KNIESKL fusion protein during
infection of macrophages. Cells were fixed and stained
for microscopy immediately after infection and after 2.5,
5, 10 and 24 h (Fig. 4B). We counted cells with visible
peroxisomes per macrophage at various time points
(Fig. 4C, left panel; Fig. S3). The number of cells with
peroxisomes and the number of peroxisomes within
these cells transiently increased, reaching a peak after
5 h (Fig. 4C). After 24 h, the vast majority of cells
displayed a cytoplasmic/vacuolar YFP–KNIESKL fluo-
rescence signal. Thus, engulfed cells show transient
proliferation of peroxisomes.
GFP–CgYap1 and CgMig1–CFP localization changes in
phagocytosed cells
The localization of CgCta1 suggested that engulfed
C. glabrata cells might experience oxidative stress
and/or carbon source starvation. To confirm this inde-
pendently, we created additional fluorescent reporter
constructs. In S. cerevisiae, the glucose-regulated tran-
scriptional repressor Mig1 is rapidly exported from the
nucleus in cells starved for glucose (De Vit et al., 1997).
S. cerevisiae Yap1 accumulates rapidly in the nucleus
of cells exposed to mild oxidative stress (Kuge et al.,
1997). To preserve the localization signals of the ortholo-
gous transcription factors, CgYap1 was N-terminally
fused to GFP whereas CgMig1 was C-terminally fused
to CFP. To be detectable, both fusion genes were
expressed from centromeric plasmids and driven by the
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CgADH1 promoter. Nuclear localization was confirmed
by simultaneous staining of nucleic acids with DAPI
(Fig. 5A and B).
GFP–CgYap1 was located in the cytoplasm in
unstressed C. glabrata DHTU cells. Upon exposure to
mild oxidative stress (0.4 mM H2O2), GFP–CgYap1
rapidly accumulated in the nucleus (Fig. 5A, upper
panel). The fusion gene could complement the transcrip-
tion defects of the corresponding deletion mutant (our
unpublished observation). Within the first hour upon
engulfment, cells with nuclear GFP–CgYap1 were visible
(Fig. 5A, middle panel). We determined the percentage
of yeast cells with nuclear GFP–Yap1 per macrophage
after 30 min, 1 h and 5 h (Fig. 5A, lower panel) and
found a peak at about 1 h. The CgMig1–CFP fluores-
cence signal accumulated in the nucleus after addition
of glucose (2%) to the medium of glucose-starved
cells, and was also nuclear in the glucose-rich environ-
ment of the macrophage culture medium (DMEM)
(Fig. 5B, upper panel). Immediately after phagocytosis,
CgMig1–CFP accumulated in the cytoplasm and
remained there constantly, indicating glucose starvation
(Fig. 5B, lower panel). These data showed that within
the phagosome oxidative stress is transient, whereas
macrophages are highly effective in depriving the carbon
source.
Fig. 3. CgCta1 localizes to peroxisomes upon glucose depletion.
A. C. glabrata DHTU and ARCg pex3D mutant cells expressing YFP–KNIESKL driven by the CgADH1 promoter were grown in synthetic
medium with 2% glucose or 1.5% ethanol for 20 h. Localization of YFP was recorded by fluorescence microscopy and bright field (BF)
microscopy. An overlay of YFP and BF microscopy is shown in the left panel.
B. The ARCg cta1D strain carrying pCgC–CgCTA1 was exposed for 1 h to oxidative stress (0.4 mM H2O2). Pellets containing mitochondria and
small organelles and post-mitochondrial supernatants were assayed for catalase activity.
C. The same strain was grown in synthetic medium with 1.5% ethanol for 20 h. Catalase activity was measured in pellets and supernatants.
Activity of cytochrome c oxidase was measured in pellet and supernatant fractions as described in Experimental procedures (right panel).
D. Catalase activity in pellets and supernatant fraction collected from ARCg cta1D containing pCgC–CgCTA1 grown in synthetic medium with
0.2% oleic acid for 20 h.
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Peroxisomes are transiently induced
during phagocytosis
Peroxisome numbers declined at later stages of engulf-
ment (Fig. 4B). In S. cerevisiae, key factors for pexo-
phagy are Atg11 (Yorimitsu and Klionsky, 2005) and
Atg17, which is also essential for non-selective autophagy
(Cheong et al., 2005). We deleted the C. glabrata
CgATG11 and CgATG17 homologues (CAGL0H08558g,
CAGL0J04686g) in wild-type (DHTU) and pex3D cells
(Fig. S1). We investigated engulfed C. glabrata cta1D,
pex3D, atg11D, atg17D, pex3D atg17D, pex3D atg11D and
atg11D atg17D mutant cells expressing GFP–CgCta1
after 5 and 24 h (Fig. 6A and E). After 5 h, GFP–Cta1 was
located in peroxisomes in the cta1D, atg11D and atg17D
mutant cells. In contrast it accumulated in the cytoplasm
of pex3D, pex3D atg11D and pex3D atg17D mutant cells.
However, after 5 h, wild type, atg11D and atg17D had
similar numbers of cells with peroxisomes, whereas after
24 h, peroxisomes were more abundant in atg11D and
atg17D mutants (Fig. 6B). In atg11D mutants, peroxisome
numbers remained constant between 5 and 24 h engulf-
ment. C. glabrata atg17D cells displayed a slight reduction
of peroxisomes after 24 h of engulfment, similar to S. cere-
visiae atg17D cells during prolonged starvation conditions
(Cheong et al., 2005), Upon internalization, the cytoplas-
mic localization of CgMig1–CFP demonstrated the same
glucose starvation status in the atg11D, pex3D atg11D
mutants and wild type (Fig. S2B).
We investigated if the turnover of peroxisomes and
mobilization of internal resources are relevant for survival
during engulfment. Indeed, the atg11D and atg17D
mutants had a significantly reduced viability after 24 h
compared with wild type, cta1D and pex3D strains. Fur-
thermore, in pex3D atg11D and pex3D atg17D double
mutants, the absence of pexophagy might be compen-
sated by absence of peroxisome biogenesis. Consistently,
we found that the loss of Pex3 partially reversed the effect
of atg11D with respect to survival during engulfment
(Fig. 6C). In contrast, the double mutant pex3D atg17D did
not show this phenotype, indicating a broader function
for CgAtg17-dependent non-selective autophagy during
engulfment. Strikingly, the atg11D atg17D double mutant,
lacking both selective and non-selective autophagy, was
highly sensitive to phagocytosis.
To simulate the phagosome environment in vitro we
combined nutrient starvation and acidic pH. We incubated
C. glabrata wild type, atg11D, pex3D atg11D, atg17D,
pex3D atg17D and atg11D atg17D mutant cells in medium
lacking nitrogen and carbon sources at pH 3.5 at 37°C for
24 h. The survival was determined by counting colony-
forming units (cfu) after 24 h relative to 2 h treatment
(Fig. 6D). In comparison with the wild type, all mutants
showed diminished survival. Intriguingly, the pex3D
atg11D strain survived better than the atg11D strain. Fur-
thermore, the double mutant atg11D atg17D displayed the
lowest survival rate, similar to the macrophage model. In
the macrophage, after 24 h, most of the engulfed atg11D
atg17D cells had lost GFP–CgCta1 fluorescence presum-
ably due to cell death (not shown). However, after 5 h the
GFP–CgCta1 fluorescence signal indicated numerous
peroxisomes (Fig. 6E). These results indicated that
autophagy is beneficial for survival of C. glabrata during
engulfment in macrophages, possibly counteracting acute
nutrient starvation.
Discussion
Phagocytic cells internalize microbial cells and attack
them with a range of microbicidal strategies (Chauhan
et al., 2006; Nicola et al., 2008). Microbial pathogens
have developed a number of strategies to improve their
survival in the host environment (Urban et al., 2006). Here
we used three reporters (CgCta1, CgYap1 and CgMig1) to
visualize aspects of the response of the human fungal
pathogen C. glabrata to macrophage engulfment. We
found that C. glabrata cells engulfed by primary mouse
macrophages suffer from transient oxidative stress, show
signs of carbon source starvation, and transiently induce
peroxisomes. Our results revealed that the recycling of
internal resources, especially peroxisomes, plays an
important protective role for C. glabrata during engulfment
in the phagosome.
The presence and/or proliferation of peroxisomes in
fungal cells points to adjustment of carbon metabolism.
We demonstrated accumulation of peroxisomes in C. gla-
brata during growth on non-fermentable carbon sources
and during engulfment in macrophages. Peroxisomes
were visualized using two fluorescent reporter constructs
Fig. 4. GFP–CgCTA1 is induced upon phagocytosis and is located in both cytoplasm and peroxisomes.
A. C. glabrata cells before and after being phagocytosed. Exponentially growing ARCg cta1D cells transformed with pCgC–GFP–CgCTA1 were
washed in PBS containing 0.1% glucose and added to macrophages in a 4:1 ratio at 37°C. Still pictures at the indicated times are shown as
overlay of bright-field and fluorescence signals.
B. Exponentially growing wild-type cells transformed with pCgADH1–YFP–KNIESKL1 were washed in PBS containing 0.1% glucose and
added to macrophages in a 4:1 ratio at 37°C. Cells were fixed and stained with Phalloidin Texas-Red after 0, 2.5, 5, 10 and 24 h for
fluorescence microscopy.
C. Percentage of phagocytosed C. glabrata cells with visible peroxisomes per macrophage from the total cell number of C. glabrata cells per
macrophage after 0, 2.5, 5, 10 and 24 h (left panel). Number of visible peroxisomes within phagocytosed C. glabrata cells after 0, 2.5, 5, 10
and 24 h (right panel).
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GFP–CgCta1 and YFP–KNIESKL and further confirmed
by other criteria. They were induced on medium contain-
ing ethanol and oleic acid as carbon source. Furthermore,
peroxisomes were dependent on the CgPEX3 gene, a
peroxisomal integral membrane protein, whose ortho-
logue in S. cerevisiae is essential for peroxisomal biogen-
esis (Hohfeld et al., 1991). Peroxisomal catalases such as
S. cerevisiae Cta1 (Simon et al., 1991) are scavengers
of hydrogen peroxide generated during peroxisomal
b-oxidation. We find that C. glabrata catalase expression
is regulated by oxidative stress and carbon source, and its
intracellular localization correlates with the presence of
peroxisomes. This combines the regulation of both yeast
catalases. The CgCTA1 gene lacks synteny with the yeast
CTA1 gene and other fungal catalases (Gordon et al.,
2009). It is tempting to speculate that the shuffling of the
C. glabrata genome fostered the accumulation of regula-
tory elements for oxidative stress and carbon source
response.
In a phagocytosis model using bone marrow-derived
mouse macrophages, GFP–CgCta1 expressed under the
control of the CgCTA1 promoter was induced in the ear-
liest stages after internalization. This could be due to
oxidative stress or acute carbon starvation. Intracellular
localization of two other fluorescent reporters (CgYap1
and CgMig1) supported rather low oxidative stress load
and starvation for glucose of engulfed C. glabrata cells.
High-level expression was necessary for detection of
GFP–transcription factor fusions and could potentially
interfere with signalling. However, both factors are tightly
regulated by post-translational modifications and thus
buffered for expression level. We found that in a popula-
tion of engulfed cells a minor fraction displayed signs of
acute oxidative stress. This is consistent with other
reports. Only a small portion of C. albicans cells derived
from mouse kidneys displayed an acute oxidative stress
response when examined for CaCTA1 expression
(Enjalbert et al., 2007).
The C. glabrata transcriptional response might have
been selected to the specific conditions of phagocytosis.
Microarray data indicated induction of a group of about 30
genes by both oxidative stress and glucose starvation
(Roetzer et al., 2008). Moreover, phagocytosed C. gla-
brata cells induce genes involved in gluconeogenesis,
b-oxidation, glyoxylate cycle, and transporters for amino
acids and acetate (Kaur et al., 2007). Induction of peroxi-
somes after internalization by macrophages indicated
adjustment of metabolism within the phagosome. Cells
utilizing non-fermentable carbon sources, e.g. fatty acids
or ethanol, require peroxisomal b-oxidation and the partly
peroxisomal glyoxylate cycle. The induction of non-
fermentative carbon metabolism genes is beneficial for
the survival of C. albicans (Lorenz et al., 2004; Barelle
et al., 2006). In a mouse infection model, Fox2, the
second enzyme of the b-oxidation pathway, and isocitrate
lyase (Icl1) an enzyme of the glyoxylate cycle, were
required for C. albicans virulence (Lorenz and Fink, 2001;
Piekarska et al., 2006). However, C. albicans mutants
defective in the import receptor of PTS1-targeted peroxi-
somal proteins, CaPex5, displayed no attenuation of viru-
lence (Piekarska et al., 2006). The survival of C. glabrata
devoid of peroxisomes in a pex3D mutant was not com-
promised in our infection model. Also, C. neoformans
pex1D deletion mutants were not attenuated for virulence
(Idnurm et al., 2007). These data support the view that
peroxisomes are not a major virulence determinant.
Instead, the peroxisomal metabolic pathways, which can
function to sufficient extent in the cytosol, appear to con-
tribute to virulence.
In engulfed C. glabrata cells peroxisome numbers
declined at later time points. Also at later time points
GFP–CgCta1 accumulated partly in the cytosol. Peroxi-
somes are not known to export proteins, thus the cytosolic
fluorescence was most probably due to de novo synthesis
or peroxisome turnover. Peroxisomes are degraded by
pexophagy, a selective autophagic pathway (Hutchins
et al., 1999; Farre and Subramani, 2004). In S. cerevi-
siae, mutants lacking Atg11 and Atg17 had a severe delay
of pexophagy (Kim et al., 2001; Cheong et al., 2005;
2008). In C. glabrata, we found that mutants lacking
atg11D or atg17D had reduced survival in macrophages
and in vitro during starvation. Moreover, the C. glabrata
double mutant atg11D atg17D displayed a striking additive
decrease of survival. In S. cerevisiae, the atg11D atg17D
double mutant strain did not contain any detectable
autophagic bodies and had a severe autophagy defect
(Cheong et al., 2008). We suggest that C. glabrata atg11D
atg17D is unable to induce autophagic processes in order
Fig. 5. Localization of GFP–CgYap1 and CgMig1–CFP during early stage of phagocytosis.
A. C. glabrata wild-type cells transformed with pCgADH1–GFP–CgYAP1 were grown in synthetic medium. Cells were stressed by addition of
0.4 mM H2O2 for 10 min. Nuclei were stained with DAPI. An overlay of GFP and DAPI staining is shown in the right panel. GFP–CgYap1
visualized by fluorescence microscopy under phagocytosis conditions (lower panel). Cells were washed in PBS 0.1% glucose and added to
macrophages in a 4:1 ratio and incubated at 37°C for 10 min to follow the route of tagged transcription factors. Samples were fixed and
stained with Phalloidin Texas-Red. Percentage of cells with nuclear GFP–Yap1 was calculated after 30 min, 1 h and 5 h. White arrows point to
nuclear GFP–CgYap1 in yeast inside the phagosome.
B. C. glabrata wild-type cells transformed with pCgADH1–CgMIG1–CFP were grown in synthetic medium until glucose depletion. Cells were
incubated in fresh medium containing 2% glucose for 10 min or 1¥ DMEM. Lower panel depicts localization of CgMig1–CFP under
phagocytosis conditions. Cells were treated as described in (A).
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to sustain prolonged phagocytosis. Notably, homologues
of proteins of the autophagy core machinery have been
found from yeast to mammals, but both Atg11 and Atg17
are not conserved and might be a target for antifungal
drugs (reviewed by Xie and Klionsky, 2007).
Autophagy is required for C. neoformans virulence (Hu
et al., 2008). Furthermore, C. neoformans genes involved
in autophagy, peroxisome function and lipid metabolism
became also induced during infection (Fan et al., 2005).
C. neoformans could escape from macrophages through
extrusions of the phagosome, without killing the phago-
cytic cell (Alvarez and Casadevall, 2006). It has been
suggested that this is a pathway for dissemination within
the host. Therefore, survival in the macrophage indirectly
contributes to virulence. A C. albicans mutant lacking
CaATG9 was defective for autophagy, but nevertheless
was able to kill macrophages (Palmer et al., 2007). In
contrast to C. albicans, C. glabrata is trapped inside the
phagosome. In C. glabrata pex3D atg11D cells, we found
the sensitivity of atg11D partially reversed. We suggest
from this genetic observation that autophagy of peroxi-
somes is beneficial for engulfed C. glabrata cells. C. gla-
brata pex3D atg17D mutants did not display this effect.
Selective pexophagy, which is affected in both atg11D and
atg17D mutants, might help to mobilize intracellular
resources during prolonged engulfment. S. cerevisiae
uses autophagy to recycle proteins to overcome nitrogen
starvation (Onodera and Ohsumi, 2005). Autophagic pro-
cesses, such as pexophagy, are contributing to virulence
of important fungal plant pathogens (Veneault-Fourrey
et al., 2006; Asakura et al., 2009). However, an A. fumi-
gatus mutant strain lacking Atg1 also remained virulent
(Richie et al., 2007). Thus the role of autophagy for fungal
pathogens is also dependent on their morphology (Palmer
et al., 2008).
Beside the carbon and nitrogen starvation conditions
inside the phagosome, other restrictions, such as pH,
hydrolytic enzymes and antimicrobial peptides, might act
in a synergistic manner. We infer from the phenotype of
our autophagy mutants that macrophage engulfment is
essentially a starvation situation in combination with
acidic pH. Acidification of the phagosome aids the
destruction of some microbes, but it might also contribute
to the escape of others. For example, lysosomal acidifi-
cation induced germ tube formation of C. albicans and
therefore contributed to its escape from the macrophage
(Kaposzta et al., 1999). The observed oxidative stress
response of C. glabrata might result from a switch of
metabolism rather than a macrophage-derived oxidative
burst. It has been reported that in S. cerevisiae, a shift to
oleic acid as carbon source induced a specific Yap1-
dependent subset of oxidative stress response genes
(Koerkamp et al., 2002). However, we believe that the
importance of autophagy for survival suggests a starva-
tion situation. Furthermore, in our model system, the tran-
sient induction and degradation of peroxisomes is not
supporting substantial metabolism in the phagosome.
Our results demonstrate that monitoring of the intracel-
lular localization of proteins tagged with fluorescent
reporters is a highly informative tool to reveal intracellular
signalling and metabolic conditions. Here we show that
the macrophage is efficiently depriving engulfed C. gla-
brata cells from nutrient sources. Autophagic processes,
prolonging the survival of engulfed cells, are potentially
aiding the dissemination of C. glabrata and the establish-
ment of infection.
Experimental procedures
Yeast strains and plasmids
Yeast strains used in this study are listed in Table 1. Rich medium
(YPD), synthetic medium (SC) and yeast nitrogen base medium
(YNB) without amino acids and ammonium sulfate were prepared
as described elsewhere (Current Protocols in Molecular Biology;
Wiley). All strains were grown at 30°C or 37°C as indicated.
Oleate medium contained 0.2% oleic acid, 0.3% yeast extract,
0.5% peptone and 0.5% KH2PO4 (pH 6). Oleate plates were
incubated at 37°C for 7 days. Glucose concentration between
0.5% and 0.03% (w/v) was determined using the Freestyle mini
(Abbott). To assess viability of cells during starvation (Fig. 6D),
cfu were determined by spreading on rich medium, usually after
2 h of incubation at 37°C and after the indicated time (24 h).
Oligonucleotides used in this study are listed in Table S1. C. gla-
Fig. 6. Induction and pexophagy of peroxisomes upon phagocytosis.
A. Log-phase C. glabrata ARCg cta1D, ARCg pex3D, ARCg atg11D, ARCg pex3D atg11D, ARCg atg17D and ARCg pex3D atg17D mutant cells
transformed with pGFP–CgCTA1 were used to infect mouse macrophages in a 4:1 ratio at 37°C. Cells were fixed for microscopy after 5 and
24 h.
B. Percentage of cells with visible peroxisomes after phagocytosis in macrophages after 5 and 24 h.
C. Log-phase C. glabrata ARCg cta1D, ARCg pex3D, ARCg atg11D, ARCg pex3D atg11D, ARCg atg17D and ARCg pex3D atg17D and ARCg
atg11D atg17D mutant cells were used to infect mouse macrophages in a 1:2 ratio at 37°C. The viability of the engulfed cells was assessed by
hypotonic lysis of the macrophages and quantification of colony formation (cfu) on rich medium. Assays were performed in triplicate. A one-way
ANOVA was performed and P-values were calculated comparing the numbers of recovered colonies of the indicated strains (**P < 0.005).
D. C. glabrata wild type, ARCg atg11D, ARCg pex3D atg11D, ARCg atg17D, ARCg pex3D atg17D and ARCg atg11D atg17D mutant cells were
grown to exponential phase in rich medium; after washing with PBS supplemented with 0.1% glucose, 2 ¥ 105 cells were incubated in selective
medium without nitrogen sources and glucose and pH 3.5 at 37°C. After 24 h colony formation (cfu) of mutant cells was determined. Percentage
of viable cells was calculated relative to 2 h treatment.
E. Log-phase ARCg atg11D atg17D mutant cells transformed with pGFP–CgCTA1 were used to infect mouse macrophages in a 4:1 ratio at 37°C.
Cells were fixed for microscopy after 5 h. Overlay of GFP/Texas-Red and BF is shown.
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brata strains ARCg cta1D, ARCg pex3D, ARCg atg11D, ARCg
pex3D atg11D, ARCg atg17D, ARCg pex3D atg17D and ARCg
atg11D atg17D were obtained by replacing the ORFs with the
S. cerevisiae URA3 gene or HIS3 gene generated by genomic
integration. Knockout cassettes were synthesized using fusion
PCR according to Noble (Noble and Johnson, 2005) from the
plasmids pRS316 and pRS313 (Sikorski and Hieter, 1989) with
the oligonucleotides CTA1-1 to 6, PEX3-1 to 6, ATG11-1 to 6 and
ATG17-1 to 6. Correct genomic integration was verified by
genomic PCR (primer series Ctrl) followed by Southern analysis
using probes generated with primers CTA1-4/CTA1-6, PEX3-1/
PEX3-3, ATG11-4/ATG11-6 and ATG17-1/ATG17-3 or ATG17-4/
ATG17-6. Probes for Southern and also for Northern analysis
(CTA1-5/CTA1-3 and ACT1-5/ACT1-3) were amplified by PCR
from genomic DNA.
Plasmids used in this study are listed in Table 2. To generate
pGEM–ACT–CgCTA1, 1800 base pairs of the CgCTA1 promoter
were inserted as a SphI/NotI PCR product obtained with primers
CTAPro-up and CTAPro-down into the plasmid pGEM–ACT
(Gregori et al., 2007). The coding sequence for CgCTA1 was
amplified from genomic DNA using primers CTA-up-Not and
CTA-down-Nsi, cut and inserted as a NotI/NsiI fragment. GFP
was inserted as a NotI/NotI fragment at the N-terminus of
CgCTA1. To generate pYFP–KNIESKL YFP was inserted as a
NotI/NotI fragment obtained by PCR with primers YFP–Not-Start
and YFP–SKL-Stop into the plasmid pGEM–ACT–CgADH1
(Roetzer et al., 2008). CgYAP1 was amplified using primers
CgYap5/CgYap3 containing a NotI or a NsiI site; GFP was
inserted as NotI/NotI fragment into the plasmid pGEM–ACT–
CgADH1 at the N-terminus of CgYAP1. CgMIG1 was amplified
using primers Mig1-5sac/Mig1-3nco and inserted into NcoI and
SacII cut pGEM–ACT–CgADH1–MSN2–CFP (Roetzer et al.,
2008). All cloned PCR fragments used in this study were con-
trolled by sequencing.
Catalase and cytochrome c oxidase assay
Crude extracts were prepared by breakage of yeast cells with
glass beads. Catalase activity was assayed spectrophotometri-
cally at 240 nm as described in Durchschlag et al. (2004); protein
concentrations were assayed at 280 nm. For the cytochrome c
oxidase assay, 0.5 g l-1 Sodium dithionite was added to reduce
cytochrome c (0.1 mg ml-1) solution. Cytochrome c has a sharp
absorption band at 550 nm in the reduced state. Absorption
spectra of cytochrome c were recorded between 410 and
570 nm. Five minutes after addition of crude extracts, spectra
were measured to determine the oxidized state of cytochrome c
(Lemberg, 1969).
Separation of organelles
Cells were re-suspended in washing buffer (20 mM Hepes
pH 7.4, 50 mM NaCl, 0.6 M sorbitol), incubated with protease
inhibitor PMSF and broken using glass beads. The supernatant
was centrifuged for 12 min at 6900 rcf to separate (post-
mitochondrial) supernatant and the organellar pellet.
Northern and Southern blot analysis
RNA extraction and separation followed essentially the described
protocol (Current Protocols in Molecular Biology; Wiley). Hybrid-
Table 1. Strains used in this study.
C. glabrata strain Genotype Source
DHTU his3D trp1D ura3D Kitada et al. (1996)
DHT6 his3D trp1D Kitada et al. (1996)
ARCg cta1D his3D trp1D ura3D cta1D::ScURA3 This study
ARCg pex3D his3D trp1D ura3D pex3D::ScURA3 This study
ARCg atg11D his3D trp1D ura3D atg11D::ScURA3 This study
ARCg pex3D atg11D his3D trp1D ura3D pex3D::ScURA3 atg11D::ScHIS3 This study
ARCg atg17D his3D trp1D ura3D atg17D::ScURA3 This study
ARCg pex3D atg17D his3D trp1D ura3D pex3D::ScURA3 atg17D::ScHIS3 This study
ARCg atg11D atg17D his3D trp1D ura3D atg11D::ScURA3 atg17D::ScHIS3 This study
Table 2. Plasmids used in this study.
Plamid Genotype Source
pRS316 CEN6, ARSH4, ScURA3 Sikorski and Hieter (1989)
pRS313 CEN6, ARSH4, ScHIS3 Sikorski and Hieter (1989)
pACT14 ARS, CEN and TRP1 marker from C. glabrata Kitada et al. (1996)
pGEM–ACT ARS, CEN and TRP1 marker from C. glabrata Gregori et al. (2007)
pCgC–GFP–CgCTA1 CgCTA1–GFP–CgCTA1 (CgCTA1p: SphI/NotI, CgCTA1 ORF NotII/NsiI,
GFP NotI/NotI) CgTRP1
This study
pCgC–CgCTA1 CgCTA1–CgCTA1 (SphI/NotI and NotII/NsiI); CgTRP1 marker This study
pCgCADH1–YFP–KNIESKL CgCADH1–YFP–KNIESKL (NotI/NotI fragment); CgTRP1 This study
pCgADH1–CgMSN2–CFP CgADH1–CgMSN2–CFP (CgADH1p: SphI/SacII and CgMSN2: SacII/NsiI);
CgTRP1
Roetzer et al. (2008)
pCgADH1–CgMIG1–CFP CgADH1–CgMIG1–CFP (CgMIG1: SacII/NcoI); CgTRP1 This study
pCgADH1–GFP–CgYAP1 CgADH1–GFP–CgYAP1 (CgYAP1: NotII/NsiI); CgTRP1 This study
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ization of [a-32P]-dATP-labelled probes occurred overnight in
hybridization buffer (0.5 M Sodium phosphate buffer pH 7.2/7%
SDS/1 mM EDTA) at 65°C. For DNA extraction, 10 ml yeast cells
(grown to an OD600 = 6) were collected, washed once and
re-suspended in Lysis buffer (2% Triton X-100/1% SDS/100 mM
NaCl/10 mM Tris pH 8/1 mM EDTA). Genomic DNA was isolated
by PCI (phenol/chloroform/isoamyl alcohol) extraction. Digestion
of 10 mg of genomic DNA was performed overnight with XcmI for
CgPEX3, EcoRV for CgCTA1 and ClaI/NcoI for CgATG11
(5 U mg-1 DNA). The labelled probes were hybridized overnight
in hybridization buffer at 65°C. Signals were visualized by
autoradiography.
Microscopy
GFP-fluorescence microscopy was performed as described pre-
viously (Görner et al., 1998). GFP was visualized in live cells
without fixation. All cells were monitored using a Zeiss Axioplan 2
fluorescence microscope. Images were captured with a Spot
Pursuit (Sony) CCD camera using Spotbasic software. Time-
lapse microscopy was performed on an Olympus cell-imager
system (IX81 inverted microscope) equipped for cell culture
observation. Cells were incubated in a glass chamber at 37°C
connected to an active gas mixer (Ibidi, Martinsried, Germany).
Pictures were taken with a Hamamatsu ORCA-ER camera and
analysed using cellM&cellR software (Olympus). Nomarski con-
trasted, bright-field microscopy pictures are indicated as BF.
Quantification and statistical analysis of peroxisomes in C. gla-
brata cells (Figs 2D, 4C and 6B) have been added in Fig. S3.
Macrophage cell culture
Primary bone marrow-derived macrophages (BMDMs) were
obtained from the femur bone marrow of 6- to 10-week-old
C57Bl/6 mice. Cells were cultivated in DMEM supplemented with
10% FCS in the presence of L cell-derived CSF-1 as described
(Baccarini et al., 1985). Mice were housed under specific
pathogen-free conditions. For infection assays, BMDMs were
seeded at 5 ¥ 105 cells per dish in 3.5 cm dishes containing
medium without antibiotics. Log-phase C. glabrata cells were
washed with PBS supplemented with 0.1% glucose and added to
macrophages in a 4:1 ratio and incubated at 37°C. For micro-
scopy, cells were fixed with 2% formaldehyde for 5 min. After
washing with PBS, cells were incubated in 1% Triton X-100 for
1 min. After washing with PBS, cells were dyed with Phalloidin
Texas-Red for 30 min. Coverslips were fixed to slides with
Mowiol. For cfu assays, BMDMs were seeded at 2 ¥ 105 cells per
dish. Exponentially growing C. glabrata cells were washed with
PBS supplemented with 0.1% glucose and added to macro-
phages in a 1:2 ratio and incubated at 37°C. After 45 min, cells
were washed three times with PBS to remove not phagocytosed
yeast cells and fresh medium was added. At the indicated times,
deionized water was added to lyse macrophage cells. C. glabrata
cells were spread on YPD plates, colonies were counted after
incubation at 37°C for 2 days.
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Supporting information
Additional Supporting Information may be found in the online
version of this article:
Fig. S1. Southern blot analysis of cta1D, pex3D, atg11D and
pex3D atg11D deletion strains. Both CgCTA1 and CgPEX3 were
replaced by ScURA3. CgATG11 was replaced by ScURA3 in the
single mutant and by ScHIS3 in the double mutant ARCg pex3D
atg11D. CgATG17 was replaced by ScURA3 in the single mutant
and by ScHIS3 in the double mutants ARCg pex3D atg17D and
ARCg atg11D atg17D. Amplified probes and chromosomal restric-
tion enzyme locations are indicated. Chromosomal DNA derived
from ARCg cta1D digested with EcoRV and ARCg pex3D with
XcmI resulted in shortened fragments relative to wild type. Diges-
tion of chromosomal DNA from the ARCg atg11D strain with NcoI
and from the ARCg pex3D atg11D double mutant strain with ClaI
led to shorter fragments in both cases, since CgATG11 contains
neither a NcoI site nor a ClaI site. Picture is a composite of two
exposures of the same blot, due to different amounts of DNA
(lower panel). Chromosomal DNA derived from ARCg atg17D
digested with AflIII and ARCg pex3D patg17D or ARCg atg11D
atg17D with NdeI resulted in shortened fragments.
Fig. S2. Glucose depletion leads to induction of GFP–CgCTA1
and cytoplasmic localization of CgMig1–CFP.
A. GFP–CgCTA1 is induced upon glucose depletion and is
located in the cytoplasm. C. glabrata ARCg cta1D cells trans-
formed with pCgC–GFP–CgCTA1 were grown in rich medium
with glucose to exponential phase and washed twice and incu-
bated in rich medium including 0.5% glucose. Every 10 min
concentration of glucose was determined (see Experimental pro-
cedures) and samples were fixed for microscopy. GFP fluores-
cence was visible at about 40 min after glucose exhaustion.
B. Localization of CgMig1–CFP in ARCg atg11D and ARCg
pex3D atg11D mutants during internalization by macrophages.
CgMig1–CFP was visualized by fluorescence microscopy under
phagocytosis conditions. C. glabrata wild-type cells transformed
with pCgADH1–CgMIG1–CFP were grown to exponential phase,
washed in PBS 0.1% glucose and added to macrophages in a 4:1
ratio and incubated at 37°C for 1 h. Samples were fixed and
stained with Phalloidin Texas-Red.
C. GFP–CgCTA1 is induced upon phagocytosis. Still pictures
from time-lapse analysis are shown as overlay of bright-field and
fluorescence signals. Exponentially growing ARCg cta1D cells
transformed with pCgC–GFP–CgCTA1 were washed in PBS con-
taining 0.1% glucose and added to macrophages in a 4:1 ratio at
37°C.
Fig. S3. Quantification details.
Table S1. Oligonucleotides used.
Please note: Wiley-Blackwell are not responsible for the content
or functionality of any supporting materials supplied by the
authors. Any queries (other than missing material) should be
directed to the corresponding author for the article.
216 A. Roetzer, N. Gratz, P. Kovarik and C. Schüller
© 2009 Blackwell Publishing Ltd, Cellular Microbiology, 12, 199–216
